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ABSTRACT 
It is common practice for endurance athletes to manipulate training load prior to an 
important competition, known as tapering. An effective strategy aims to alleviate 
accumulated fatigue, whilst maximising physiological adaptation and facilitating a peak 
performance. Improvements in performance of 0.5 to 6.0% have been reported after a 
successful taper, a margin that could potentially have a dramatic influence on performance 
outcome at the elite level. This thesis explored the strategies currently employed by elite 
endurance athletes and investigated novel training manipulations during the taper to further 
enhance performance, to gain a more thorough understanding of the physiological 
mechanisms, and to identify a minimally invasive physiological biomarker capable of 
monitoring recovery status during the taper. Tapering strategies in elite endurance athletes 
were shown to be individualised and influenced by the preceding training load. Algorithms 
were developed, capable of explaining a large proportion of the variance (53-95%) in 
tapering strategy training variables (with the exception of interval volume), for a given 
pre-taper training load (Chapter III). A tapering strategy implemented using the algorithms 
was ‘most likely’ to improve 1,500 m treadmill performance (ES = 0.53). When the 
intensity of final interval session was increased from 100% to 115% race speed, the effect 
on treadmill performance was ‘unclear’ (ES = 0.22) and perhaps due to insufficient 
recovery to respond positively to the increased intensity interval session (Chapter IV). 
When continuous volume was reduced further (by 60%), the novel high intensity strategy 
was ‘very likely’ to improve 1,500 m track performance (ES = 0.74), compared to the 
algorithm-derived taper (ES = 0.40) (Chapter VI). In middle-distance runners, training 
above race speed in the final days of the taper might be more beneficial than current 
practice, although training volume must be further reduced to compensate. It was possible 
to measure plasma concentrations of interleukin-6 and soluble interleukin-6 receptor from 
capillary samples (Chapter II), although these markers in addition to C-reactive protein, 
testosterone and cortisol were not sensitive enough to detect changes in recovery status 
during tapering (Chapters IV and V). Measures of muscle maximum voluntary contraction 
force (algorithm-derived taper: 9%; ES = 0.39; novel taper: 6%; ES = 0.29), and rate of 
force development (algorithm-derived taper: ES = 0.53; novel taper: ES = 0.26) improved 
in response to tapering (Chapter IV), and could represent alternative non-invasive markers 
of recovery and taper effectiveness to facilitate peak performance.  
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Chapter I 
General Introduction 
1.1 Background 
The physiological superiority of elite endurance athletes is determined partly by genetic 
predisposition (Bouchard & Lortie, 1984, Bouchard, 1998). Endurance training also has a 
profound effect on key physiological adaptations including; maximal oxygen uptake 
(V̇O2max), fractional utilisation of V̇O2max, running economy and oxygen uptake (V̇O2) 
kinetics, all of which are important determinants of endurance performance (Basset & 
Howley, 2000; Bransford & Howley, 1976; Coyle, 1999; Hill & Lupton, 1923; Jones, 
2006; Jones & Carter, 2000; Joyner & Coyle, 1998; Whipp & Wasserman, 1972). 
Additionally, it is evident that the magnitude of the physiological response to training is 
subject to genetic influence (Bouchard et al., 1988). Therefore, favourable genetics 
combined with chronic adaptation from effective training, creates a phenotype with 
physiological characteristics optimised for elite endurance performance.  
Winning a gold medal at a global competition such as the Olympic Games, is the pinnacle 
of sporting success in track and field athletics. However, a systematic training process over 
many years is critical in developing an endurance athlete to perform successfully at the 
elite level (Smith, 2003). For example, over 10 years of arduous training, underpinned by 
scientific principles, were required for Paula Radcliffe to reach her athletic potential and 
achieve the world record for the marathon (2:15:24 h:min:s) (Jones, 2006). The primary 
aims of endurance training are to cause adaptation to the pulmonary, cardiovascular and 
neuromuscular systems that improve the delivery of O2 from atmospheric air to the 
mitochondria and therefore allow improved endurance performance by maintaining a 
higher speed over a specific race distance (Jones & Carter, 2000). Optimal physiological 
adaptation to training will only occur however, if the magnitude of training load is applied 
in an appropriate manner over time, providing stimuli large enough (i.e. overload or 
overreaching) to initiate the desired responses, in combination with recovery periods 
sufficient to allow ‘supercompensation’ (Halson & Jeukendrup, 2004; Meeusen et al., 
2013; Smith, 2003).  
Whilst many elite athletes continually strive to push the limits of human performance, and 
epitomise the Olympic motto of ‘Citius, Altius, Fortis’, failure to balance increases in 
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training load with adequate recovery and regeneration periods can result in prolonged 
maladaptation and underperformance (Meeusen et al., 2013). This negative response is 
known as overtraining syndrome and is characterised by a persistent reduction in 
performance, despite a decrease in training load, and has been associated with a multitude 
of physiological, psychological, immunological and biochemical symptoms, which vary 
between individuals (Fry et al., 1991). Nevertheless, a phase of intensified or ‘overloaded’ 
training is commonly built into the training plan prior to a competition period, in an 
attempt to optimise physiological adaptation for the benefit of performance (Aubry et al., 
2014). Since physiological stress is high and between-session recovery is typically 
minimal during this time, temporary physiological disturbances are allowed to manifest, 
including; glycogen depletion, neuromuscular fatigue, decrements in red cell volume and 
hemoglobin, imbalance in anabolic and catabolic tissue activities, and ultimately an acute 
suppression of performance (Halson & Jeukendrup, 2004;  Halson et al., 2002; Hellard et 
al., 2013; Mujika and Padilla, 2003). Consequently, the challenge for coaches is to 
implement a change in training load after this intensified period which is sufficient to 
alleviate accumulated fatigue, whilst maintaining or further enhancing physiological 
adaptation. This strategy is known as tapering and aims to facilitate the peaking of 
performance at the appropriate time for major competition (Mujika & Padilla 2003).  
1.2 Introduction to Tapering  
Tapering can be achieved by manipulating the training load variables of volume, frequency 
and intensity over a particular duration (Houmard, 1991). In relation to endurance runners, 
to which this review will focus on, the volume of training typically represents the distance 
covered (km) and frequency refers to how regularly the training is undertaken and reflects 
the recovery period between training sessions. Intensity describes the physiological 
demand of the training and can be expressed in several different ways. Endurance athletes 
commonly train at relative intensities, running at speeds based on percentages of their own 
individual maximal aerobic capacity, maximal heart rate or race pace (Jones, 2006). In an 
attempt to optimise athletic performance, a variety of different tapering strategies have 
been investigated. Such strategies include the manipulation of a single training variable, in 
addition to alterations of a combination of variables, over differing durations. The pattern 
of the taper describes the manner in which the training variables are manipulated leading 
into competition. Several tapering patterns have traditionally been employed in an attempt 
to establish the optimal strategy for performance (Figure 1.1). A linear pattern consists of a 
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progressive reduction in training of equal proportion. Although the term ‘tapering’ would 
imply that training is always reduced in a progressive manner, it can also be reduced in a 
non-progressive standardised approach, known as a step taper (Mujika, 1998). In contrast, 
an exponential pattern initially reduces training dramatically before beginning to plateau 
nearer to competition. An exponential pattern can take the form of a fast or slow decay of 
training reduction, with a slow decay maintaining more training than a fast decay. For 
example, at 7 d into a 14-d fast decay taper, the athlete would be completing 
approximately 25% of normal training compared to 35% in a slow decay taper. A higher 
proportion of normal training is completed using a linear pattern compared to an 
exponential pattern; at 7 d into a 14-d linear taper, the athlete would be undertaking 60% 
of their normal training, compared to 25% and 35% in fast and slow decay exponential 
patterns. 
 
 
Figure 1.1. A schematic representation of the different tapering patterns: linear taper, 
exponential taper with slow or fast time constants of decay of the training, and step taper 
(figure from Mujika & Padilla, 2003). 
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1.3 Tapering Strategies and Performance  
An optimal taper aims to maximise the elimination of accumulated fatigue from daily 
training, whilst retaining or further enhancing end-point performance (Bosquet et al., 2007; 
Mujika & Padilla, 2003). Previous research has demonstrated performance improvements 
of between 0.5 to 6.0% using competitive performance measures in response to tapering in 
running, swimming, cycling and triathlon (Mujika & Padilla, 2003). In a meta-analysis of 
the available literature, Bosquet et al. (2007) reported a mean performance improvement of 
1.96% in competitive runners, swimmers and cyclists. Given this observation, the potential 
performance gain resulting from an optimal tapering strategy could prove extremely 
valuable for an athlete competing at the elite level. For example, the mean taper-induced 
improvement in swimming performance was 2.2% at the 2000 Sydney Olympic Games, in 
events ranging from 50 m freestyle to 400 m medley (Mujika et al., 2002). This was in 
excess of the differences between the gold medallist and the 4
th
 placed swimmer (1.6%) 
and between the 3
rd
 and 8
th
 placed swimmers (2.0%) in these events.  
The application of a taper in elite sport is largely the exclusive domain of the coach and 
athlete, and is predominantly based on their own empirical observations and experiences 
with little input from exercise scientists (Mujika et al., 2002). In the past, there has been a 
paucity of scientific literature attempting to predict the optimal taper and improve 
subsequent endurance running performance. However, there have been a number of studies 
(Houmard et al., 1990; Houmard et al., 1994; McConell et al., 1993; Mujika et al., 2000; 
Mujika et al., 2002; Shepley et al., 1992; Wittig et al., 1989) that have intervened with 
various training manipulations in runners, as part of a structured taper (Table 1.1). Further 
tapering methods have been proposed by way of theoretical mathematical modelling 
(Thomas et al., 2009). It should be noted however, that few studies have isolated the 
effects of each training variable during the taper. This creates difficulty in identifying an 
optimal strategy, since the specific effect of 1 particular training variable on performance 
may be masked by the interaction with other training variables. 
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Table 1.1.  Effects of tapering strategies on running performance.  
 Author (year) 
Taper 
duration 
(d) 
Participants 
Training load 
variables 
Performance 
measure 
Performance 
outcome 
Mujika et al. 
(2000) 
6 Well-trained 
middle-distance 
runners 
  
↓ volume 50% 
or 75% 
 
800 m indoor time 
trial 
 
No change 
Mujika et al. 
(2002) 
6 Well-trained 
middle-distance 
runners 
↓ frequency 
33% 
↓ high intensity 
volume 80% 
800 m indoor time 
trial 
 
No change 
Wittig et al. 
(1989) 
 
21 Well-trained long-
distance runners 
 
↓ volume 70% 5 km race No change 
Houmard et al. 
(1990) 
21 Well-trained 
distance runners 
(V̇O2max 61.8 ± 
1.1 ml·kg·min
-1
) 
↓ volume 70% 
↓ frequency 
17% 
 
 
 
5 km indoor 
simulated race 
No change 
McConnell et 
al. (1993) 
28 Well-trained 
distance runners 
(V̇O2max 63.5 ± 
1.2 ml·kg·min
-1
) 
↓ volume 66% 
↓ frequency 
50% 
↓ intensity, all 
running <70% 
2maxOV  
 
5 km indoor 
simulated race 
Race time 
worsened by 1% 
Houmard et al. 
(1994) 
7 Trained distance 
runners 
(V̇O2peak 55.3 ± 
3.2 ml·kg·min
-1
) 
↓ volume 85% 
↑ intensity, all 
running as 400 
m intervals at 5 
km race pace 
 
5 km treadmill 
time trial  
3% improvement 
Shepley et al. 
(1992) 
7 Highly-trained 
middle-distance 
and cross-country 
runners 
(V̇O2max 66-71 
ml·kg·min
-1
) 
↓ volume 90% 
↑ intensity, all 
running as 500 
m intervals at 
pace equivalent 
to 115 – 120% 
2maxOV  
Treadmill time to 
exhaustion at  
pace equivalent to 
season’s best 
1,500 m 
performance 
22% improvement 
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1.3.1 Training Volume and Frequency 
The work of Hickson et al., (1982) provided the first evidence that performance can be 
maintained with large reductions in training volume. After 10 weeks of continuous running 
and interval cycling training (40 min·d-1, 6 d·wk-1) in recreationally active participants, 
daily volume was reduced by either by 33% (to 26 min·d-1) or 66% (to 13 min·d-1), with 
training intensity and frequency maintained for a further 15 weeks. In both groups, short-
term endurance performance (time to exhaustion at V̇O2max) was maintained after the 15 
week period, despite the reduction in volume. Prolonged endurance performance (time to 
exhaustion at 80% V̇O2max) was maintained in the 33% group, but declined by 10% in the 
66% group. It is not clear however, how long prolonged endurance performance might 
have been maintained in the 66% group before the decline occurred. 
Further literature on trained athletes suggests that dramatic reductions in volume during 
tapering do not compromise running performance for taper periods of up to 3 weeks. Using 
an extreme example, power output at the ventilatory threshold in response to an 8 week 
training programme was unchanged in cyclists after 4 d of complete rest (Neary et al., 
1992). Mujika et al. (2000) found that 800 m running performance was unaffected by 
either a 50% or a 75% reduction in high and low intensity volume over 6 d. Over a longer 
3 week taper period, training volume was reduced by 70% in a group of male distance 
runners (Wittig et al., 1989). Performance time was not different for a 5 km race following 
this strategy, suggesting that although performance can be maintained with a reduction in 
training volume, alterations to this training variable alone might not be the key to 
achieving an improvement in performance after a taper. 
Performance time for a simulated 5 km indoor race was also unaffected by a reduction in 
training volume (70%) and frequency (17%) over 3 weeks in well-trained distance runners 
(Houmard et al., 1990). It was reported that 800 m and 1,600 m performance times were 
improved, however the results should be interpreted with caution, since the athletes only 
raced over 5 km and performance times for 800 m and 1,600 m were taken from 2- and 4-
lap splits of the 5 km race. Since elapsed time was provided verbally every 400 m, athletes 
were likely to be motivated to improve on their time from the pre-taper 5 km and may have 
run the initial part of the race faster in an attempt to achieve this. This indicates that 
different pacing strategies were employed in the race and verbal indication of elapsed time 
may have confounded the effect of the tapering, as overall 5 km performance did not 
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improve. In addition, participants were homogenous for performance and were encouraged 
to race each other. Whilst this may increase the validity of the performance measure, it is 
not clear whether different tactical behaviours may have influenced the performance 
outcome. 
Nevertheless, it was confirmed that a reduction in training volume and frequency during a 
6-d taper maintains 800 m running performance in well-trained middle distance runners 
(Mujika et al., 2002). After 18 weeks of training, participants were assigned to either a 
moderate frequency taper (resting every third day) or a high frequency taper (daily 
training). Both tapers were characterised by a non-linear progressive reduction in high 
intensity training volume down to 20% of pre-taper levels. However, the moderate 
frequency taper represented a 33% reduction in training frequency through non-daily 
training. Time trial performance after the reduced volume, moderate frequency taper 
remained unchanged (126.6 ± 2.8 vs. 127.1 ± 2.1 s). However, performance time for 800 m 
improved by 1.27% following the reduced volume, high frequency taper (121.8 ± 4.7 vs. 
124.0 ± 4.9 s; P < 0.05). Despite no difference in the overall volume reduction between the 
2 groups, when the volume reduction was achieved by reducing training frequency, 
performance was not improved. This suggests that training frequency should not be 
manipulated as an alternative method to reduce training volume. In support, a 6-d taper 
involving a linear reduction in training volume down to 80% and incorporating a 17% 
reduction in frequency, did not improve 20 km cycling time trial performance (Neary et al., 
2003). In addition, Bosquet et al. (2007) concluded from a meta-analysis that performance 
improvements are more sensitive to reductions in training volume, rather than to 
reductions in the other training load variables of intensity and frequency [effect size 0.72 ± 
0.36 vs. 0.33 ± 0.17 and 0.35 ± 0.17 (± 95% confidence intervals)]. It was also suggested 
from the available literature on running, cycling and swimming that 41-60% represents the 
optimal reduction in training volume (Bosquet et al., 2007).  
1.3.2 Training Intensity 
Although performance can be maintained after a reduction in the volume of training, it 
seems that the preservation of intensity is fundamental to maintaining physiological 
adaptations and preventing a decline in performance. This was also demonstrated by the 
early work of Hickson et al. (1985), albeit in recreationally active individuals. After 10 
weeks of continuous running and interval cycling training (40 min·d-1, 6 d·wk-1), intensity 
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was reduced by either 33% or 66%, with training volume and frequency maintained for a 
further 15 weeks. The 33% group experienced a 9% reduction in V̇O2max by 10 weeks and 
a 21% reduction in prolonged endurance performance (time to exhaustion at 80% V̇O2max) 
after 15 weeks. Although short-term endurance performance (time to exhaustion at V̇O2max) 
was maintained in this group after 5 weeks, there was a marked reduction in the 66% 
group. The 66% group also experienced a greater reduction in V̇O2max than the 33% group 
and prolonged endurance performance was reduced by 30% after 15 weeks.  
In 9 out of 10 well-trained distance runners, simulated 5 km race performance suffered a 1% 
decline (12 s) (P < 0.05) after 4 weeks of training at an intensity < 70% V̇O2max 
(McConnell et al., 1993). It was reported that the runners would usually complete 
approximately 76% of the total training distance at intensities > 70% 2maxOV in a normal 
training week, again suggesting that the maintenance of intensity is important during 
tapering. Weekly training volume was also reduced by approximately 66% and training 
frequency was reduced by 50% in this study. However, sub-maximal and maximal 
treadmill tests were performed the day before the 5 km performance tests and although this 
was also the case before the baseline performance test, it may have confounded the effects 
of the tapering strategy. Training was not supervised, although all training prescribed 
during the tapering phase was individualised. This finding recommends that training 
intensity must not be compromised during the tapering period and the maintenance of high 
intensity training is necessary protect performance from deteriorating when large 
reductions in volume and frequency are also implemented (McConnell et al., 1993).  
Trained young swimmers underwent a training programme consisting of approximately 
5,800 m·d-1, over 6 d·wk-1 for 8.5 weeks (Papoti et al., 2007). Daily training involved a 
combination of slow/regeneration (~10%), moderate (~70%), heavy (10%) and severe 
(~10%) intensities. The 11-d taper that followed was characterised by a non-linear 
progressive reduction in training volume (48%), without alteration to frequency and 
training intensity. Performance over a 200 m time trial was improved by 1.6% (P < 0.05), 
supporting the notion that an optimal reduction in training volume (Bosquet et al., 2007), 
combined with the maintenance of high training intensity can increase performance. 
In further support of the inclusion of high intensity training during tapering, a 3% 
improvement in 5 km treadmill time trial performance (P < 0.05) was evident after a 7-d 
taper, whereby all running (85% reduction in volume) was completed as interval training 
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at ~100% V̇O2max (Houmard et al., 1994, Figure 1.2). Intervals were 400 m unless other 
distances (100 m and 200 m) were required to meet the calculated training distance. 
Although it was stated that participants usually completed 6-10% of total weekly volume 
as high intensity training during normal training, it was not reported whether the intensity 
prescribed (~100% V̇O2max) was higher than in normal training. It is also worth noting that 
a treadmill time trial may not mimic a legitimate race situation and lacks logical validity, 
despite controlling for environmental conditions that may influence results on an outdoor 
track. Participants were required to indicate to investigators when a change in speed was 
desired, which again limits validity of the test. Elapsed time was given regularly 
throughout the time trial which may have introduced bias toward the post-taper trial where 
athletes were likely to be more motivated to improve and may have altered their pacing 
strategy. Treadmill time trials also appear to be less reliable than field-based running time 
trials (Hopkins et al., 2001), perhaps since athletes are typically less familiar with treadmill 
running. Training during the tapering period was carried out on a 400 m track, heart rate 
was monitored and all training was supervised. This suggests that the athletes completed 
the exact training prescribed by the investigators with precision during the taper, which 
adds to rigor to this investigation. 
Figure 1.2. Example of taper training volume for an individual running 10 km·d
-1 
during 
normal training. Weekly training volume was reduced by 85% in total and all running 
volume during the taper was performed as 400 m intervals at 5 km pace or slightly faster 
(~100% V̇O2max) (figure from Houmard et al., 1994). 
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Whilst the completion of high intensity training during the taper appears to be important, it 
was demonstrated that an increase in intensity during the taper compared to regular 
intensity, could have profound positive effects on performance (Shepley et al., 1992). In 
highly-trained cross-country runners, interval training intensity prior to tapering was 
approximately 95-100% V̇O2max (~25 km·wk
-1
) (Shepley et al., 1992). During the taper, 
intensity was elevated to 115-120% of V̇O2max, in a low-volume strategy (7.5 km·wk
-1
; 
~90% reduction from regular training volume), which consisted of 3-5 500 m runs·d
-1
 with 
a recovery period of ~7 min. The 7-d taper improved running time to fatigue at 1,500 m 
speed by 22% (~70 s; P < 0.05), although the performance outcome measure lacks logical 
validity and is therefore recognised as a limitation to the study. Time to exhaustion 
protocols have also been found to be less reliable than time trials (Currell & Jeukendrup, 
2008; Laursen et al., 2007). Despite this, the study also found that running time to fatigue 
was unaffected by a low intensity, moderate-volume taper and by a rest-only taper (+6% 
and -3%, respectively). The study employed a repeated-measures design and each 
participant performed each of the 3 tapering strategies in a random order, separated by 4 
weeks of normal training. Randomisation removes potential for order effects on the 
performance outcome and the repeated measures design excludes the influence of 
individual differences that might occur with independent groups (e.g. age or performance 
standard). The coach of the athletes taking part was a co-investigator in the study and 
supervised all training to ensure it was completed as instructed. Participants did not receive 
any feedback regarding their performance times until the entire investigation was complete 
to avoid providing incentive to improve and confounding the effects of the taper.  
It is clear that the preservation of high intensity training during the tapering period is 
crucial to prevent a decline in performance, but evidence points to an augmentation in 
intensity during this period to improve performance. It would seem that after large 
reductions in training volume, the remaining volume should be completed as high intensity 
intervals at a pace equivalent to, or above V̇O2max to enhance performance. It is 
questionable however, whether all volume during the taper must consist of high intensity 
intervals and the lower intensity continuous running discarded, since the majority of 
volume during regular training is usually comprised of this type in endurance runners 
(Smith, 2003). There is a need therefore, to further investigate high intensity strategies and 
to assess the outcome using a field-based performance measure.  
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Considering the evidence discussed above for differing manipulations to the component 
parts of training load (frequency, volume and intensity), it could be suggested that the 
definition of tapering in terms of a ‘reduction in training load’ is too simplistic. Whilst this 
definition could imply that all training load variables are reduced during the taper, in fact 
there are intricacies around how each variable should be manipulated (if at all), in order to 
optimise performance. 
1.3.3 Pattern of the Taper 
Several patterns of tapering have been investigated in an attempt to establish the optimal 
strategy to improve performance. Figure 1.3 provides an example of the pattern in which 
the constituent parts of the training load might be adjusted during the taper.  
 
Figure 1.3. A schematic example of a tapering strategy, whereby training volume is 
reduced in a linear pattern, training frequency is reduced linearly initially before 
plateauing and training intensity is maintained throughout. 
Investigations in the literature have implemented a number of different patterns to alter 
training load during tapering, however only 1 intervention study has compared the patterns 
in relation to performance. A systems model was first used to predict performance from 
simulations of different taper profiles: i) step taper vs. exponential decay taper, and ii) fast 
vs. slow exponential decay tapers (Banister et al., 1999). The simulations indicated that an 
exponential decay taper was superior to a step taper and a fast decay exponential taper was 
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more effective than a slow decay exponential taper, in optimising performance. The 
authors then attempted to validate the results in highly-trained triathletes. After a period of 
intensive training, participants tapered their training volume for 2 weeks either 
exponentially or via a step taper. Frequency was maintained, with the exception of 1 less 
training session in the final taper week. Intensity of training was maintained throughout the 
taper period. An exponential taper resulted in a 4% improvement in 5 km running 
performance, whereas a step taper produced a non-significant improvement of 1.2%. 
Participants then resumed training for a further 6 weeks of intensive training. A 13-d 
exponential taper was subsequently performed, in which the time constant of decay in 
training load was either fast (τ = 4 d) or slow (τ = 8 d). It was concluded that a fast 
exponential taper was a more effective pattern to reduce training volume than a slow decay 
exponential taper (6.3% vs. 2.4% improvement in 5 km time trial performance, 
respectively). Although the mechanisms are unknown, it is likely that a fast decay 
exponential taper provides more time for the athlete to overcome the fatigue accumulated 
during the last weeks of intensive and extensive training prior to the tapering period. 
Further validation is necessary however, since the performance measure was not well 
controlled. Participants selected their own outdoor 5 km running course and it is possible 
that environmental conditions may have differed between trials. It is also unknown as to 
whether the chosen courses were measured and timed accurately and if participants were 
supervised during the performance tests.  
Contrary to traditional tapering patterns, an investigation using mathematical modelling of 
data from national and international-level swimmers studied a more complex ‘two-phase’ 
pattern (Thomas et al., 2009). Computer simulations were employed to investigate the 
potential performance benefit of an increase in training load during the final days of the 
tapering period (Figure 1.4). Training load was quantified in arbitrary units for work done, 
as described previously by Busso (2003). In brief, a criterion performance test to measure 
mean power during 5 min all-out exercise was carried out and arbitrarily ascribed 100 
training units (TU). Each 5 min bout of exercise during training thereafter was weighted 
by intensity relative to the 5 min test (i.e. mean power output/5 min power ×100). Training 
load for a session comprised of 5 bouts of exercise at 85% of 5 min mean power for 
example, would be calculated as 425 TU. Linear and two-phase tapers lasting 
approximately 5 weeks were compared after 28 d of training overload at 120% of normal 
training load. Both tapers were identical until the final 3 d of a two-phase taper, during 
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which the training load was significantly increased by 29 ± 42%. Although the 
mathematical model predicted that the negative influence of fatigue was completely 
removed during both tapers and the positive influence of adaptation to training was 
enhanced slightly further during a two-phase tapering strategy, performance was improved 
similarly after both strategies (~4.0%, P < 0.05). It was suggested that the two-phase taper 
might further optimise performance if the 2
nd
 phase contained more work specific to the 
requirements of the upcoming competition, rather than an increase in training load per se. 
For example, it has been observed anecdotally that performance often progressively 
improves from the first round of a major competition to the final (Thomas et al., 2009). 
However, this could not be considered using the modelling procedure in this instance, 
since the quantification of training load required aggregation of the individual components 
(volume, intensity, etc.) and therefore individual contribution to the increased training load 
in the 2
nd
 phase was not clear.  
 
Figure 1.4. A schematic representation of linear and two-phase tapering patterns. Both 
protocols were characterised by a training overload at 120% of normal training for 28 d, 
followed by a linear taper for approximately 5 weeks. In a two-phase pattern, training 
load was abruptly increased in the final 3 d of the taper (figure from Thomas et al., 2009). 
This supports the findings of Bosch & Mendonca (2008), who studied performance in 
competitive swimmers following 2 different tapering strategies in a crossover design. The 
traditional taper maintained pre-taper volume for the first 5 days, followed by a 50% 
reduction over 7 days prior to competition. The modified taper consisted of a 50% 
reduction in volume over the first 7 days, followed by a gradual increase back to pre-taper 
volume over the next 4 days and a low-volume recovery session the day before 
competition. Total training volume over the 12 days before competition was not different 
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between the two approaches (11,400 m). There was no difference in 200m swim 
performance between the two strategies, confirming that an increase in volume in the 2
nd
 
phase of the taper was not more beneficial than traditional tapering patterns. 
Given the evidence for large reductions in training volume during tapering (Bosquet et al., 
2007; Houmard et al., 1990; Mujika et al., 2000; Neary et al., 1992; Wittig et al., 1989) 
and the inclusion of high intensity training to improve performance (Houmard et al., 1994; 
Papoti et al., 2007; Shepley et al., 1992), it is possible that the two-phase taper might be 
more effective if volume remains reduced and intensity is increased in the final days 
before competition. Further research is required to validate such a novel tapering pattern in 
the field and to understand the underlying physiological mechanisms. In particular, the 
time-course of the stress-adaptation response during the 2
nd
 phase of the taper in order to 
maximise performance on the day of competition.  
1.4 Taper Duration 
A taper period of 8-14 d appears to be optimal in endurance running, although strategies 
lasting from 6 d to 4 weeks might still be effective in some athletes (Bosquet et al., 2007). 
Identifying the optimal taper duration poses perhaps one of the greatest challenges for 
athletes and coaches, and anecdotally many feel insecure at the prospect of reducing 
training prior to competition. This anxiety is based on the premise that a prolonged 
reduction in training load during the taper may result in detraining. Detraining has been 
defined as the partial or complete loss of adaptations to training resulting from an 
insufficient training stimulus, which may take place during short periods of training 
cessation or from a significant reduction in habitual training load (Mujika & Padilla, 
2001a). Athletes and coaches must take care not to tip the balance between tapering and 
detraining, since the latter is characterised by losses in cardiorespiratory, metabolic and 
muscular adaptations to endurance training which are likely to be detrimental to 
performance (Mujika & Padilla, 2001a; Mujika & Padilla, 2001b).  
1.4.1 Risk of Detraining 
It has been reported that V̇O2max is unaffected by 10 d of complete training cessation in 
competitive male distance runners (61.2 ± 5.6 vs. 61.3 ± 6.2 mL∙kg∙min-1) (Cullinane et al., 
1986). Training volume was at least 80 km·wk
-1
 in the year preceding the study and was 
112 km·wk
-1
 in the 2 weeks immediately before. In contrast, V̇O2max declined by 7% after 
12 d of inactivity in endurance athletes, compared to values obtained in the trained state 
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(57.7 ± 2.6 vs. 62.1 ± 3.3 mL∙kg∙min-1; P < 0.05) (Coyle et al., 1984). An association was 
evident between trained V̇O2max and percentage decline in V̇O2max with training 
termination, whereby participants with the highest V̇O2max values prior to training 
cessation experienced the greatest declines (R
2
 = 0.93; P < 0.001). In support, previously 
sedentary individuals were trained for 12 weeks and then divided in to 3 groups to either: i) 
maintain training; ii) reduce training frequency by approximately 50%; or iii) completely 
terminate training for 2 weeks (Houmard et al., 1996). All groups experienced 
improvements in V̇O2max and time to exhaustion (both P < 0.05) during an incremental 
treadmill test after the period of training. Furthermore they were able to retain the training 
induced gains in 2maxOV and performance, despite 2 weeks of reduced training or complete 
inactivity. This supports the findings of Hickson et al. (1982), whereby recreationally 
active individuals could maintain the improvements in V̇O2max (10-20%) gained from the 
previous 10 weeks of training for up to 15 weeks of reduced volume (33% and 66%) 
training. However, in a group of endurance-trained runners, 14 d of training cessation 
resulted in a 4.6% reduction (P < 0.05) in V̇O2max (Houmard et al., 1992). The period of 
inactivity was accompanied by a decline in performance, whereby time to exhaustion 
decreased during an incremental treadmill test (11.8 ± 0.5 min vs. 13.0 ± 0.5 min; P < 
0.001). A concomitant decrease in resting plasma volume (5.1%) was also observed in the 
endurance-trained runners. This may somewhat explain the reduction in V̇O2max, since a 
decline in plasma volume might cause a reduction in stroke volume. Maximal heart rate 
increased (P < 0.001) after training cessation, in a possible attempt to offset a fall in stroke 
volume and maintain cardiac output. Despite this, V̇O2max was still found to decline and 
therefore heart rate did not increase sufficiently to fully compensate for changes in stroke 
volume (Houmard et al., 1992). 
It would seem that recently gained aerobic adaptations to training can be readily retained 
with reduced training or training cessation in previously sedentary individuals, compared 
to highly trained athletes whose extensive training history leads to more developed aerobic 
capabilities. The evidence presented suggests that 10 d could be the upper limit for 
retention of V̇O2max in highly trained athletes who have ceased training and that a 
reduction in plasma volume might be a contributing factor. However, the time course of 
cardiorespiratory adaptation-loss in highly trained individuals when training is sustained, 
but at a reduced load during tapering remains uncertain. 
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There is evidence for a shift in myosin heavy chain (MHC) isoform expression from type 
IIx and hybrid type IIa/IIx to type IIa, either through resistance or endurance training 
(Andersen et al., 1994; Andersen & Aagaard, 2000). Inactivity can reverse this process 
however, resulting in an increase type IIx MHC isoform expression (Staron et al., 1991). 
Short term training cessation did not result in changes in the muscle fibre distribution of 6 
highly-trained endurance runners after wearing a plaster cast for 7 d and refraining from 
training for a further 8 d (Houston et al., 1979). In addition, Houmard et al. (1992) found 
that cross-sectional area (CSA) of type I and type II muscle fibres was not different after 
14 d of training termination in endurance runners and fibre type distribution remained 
unchanged. This might suggest that tapering periods with severely reduced training of up 
to approximately 2 weeks will not induce changes in muscle fibre type, or cause a 
reduction in mean fibre CSA. After longer period of 4 weeks training cessation however, 
muscle power has been shown to decline (Neufer et al., 1987).  
Metabolic changes have been noted after 14 d of training cessation, indicated by an 
increase in respiratory exchange ratio (RER) at submaximal (4.3%) and maximal (2.9%) 
exercise intensities (Houmard et al., 1992). Three weeks of training cessation can result in 
a decrease in skeletal muscle mitochondrial enzyme activities (Mujika & Padilla, 2001b). 
The activity of citrate synthase, succinate dehydrogenase, β-hydroxyacyl-CoA 
dehydrogenase and malate dehydrogenase declined by approximately 20% (Coyle et al., 
1984; Coyle et al., 1985). Collectively, this evidence points to a shift toward increased 
carbohydrate metabolism after the removal of training stimuli, which is perhaps due to 
increased muscle glycogen storage. The potential impact on competition performance is 
unknown, although it could be speculated that reduced oxidative enzyme activity may have 
a negative impact on fractional utilisation of V̇O2max. 
Much of the detraining literature has investigated the effects of complete training cessation 
and even immobilisation on training-induced physiological adaptations. It is therefore 
unknown as to the time-course of detraining when the athlete remains training, but at a 
tapered level. Despite a decline in a small number of training-induced adaptations after 12-
14 d of inactivity, it could be speculated that some level of training stimulus from the taper 
training load would attenuate or even negate such declines over this duration, whilst still 
allowing the positive outcome of fatigue elimination.  
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1.4.2 Prior Training Load 
It is also necessary to consider whether the optimal taper duration is influenced by the 
preceding training load (Kubukeli et al., 2002; Smith, 2003) and the amount of fatigue 
carried into the taper (Bosquet et al., 2007). However, few experimental studies have 
attempted to investigate this question, perhaps due to the difficulty in quantifying the 
multifaceted manifestation of fatigue. Existing literature on overreaching and overtraining 
acknowledges a lack of physiological tools capable of accurate diagnosis and prevention 
(Halson & Jeukendrup, 2004; Urhausen & Kindermann, 2002). Despite this, work by 
Thomas et al. (2008) using mathematical modelling offers theoretical insight into prior 
training load and implications for the design of the tapering strategy. Using computer 
simulations of training and performance data from elite 100 m and 200 m swimmers over 2 
complete seasons, it was predicted that a 20% increase in training load for 28 d prior to the 
tapering period would require a longer taper duration to improve performance compared to 
after regular training (22.4 ± 13.4 d vs. 16.4 ± 10.3 d; P < 0.05). More recently however, 
Aubry et al. (2014) observed that peak performance was achieved within 2 weeks of 
tapering in triathletes, regardless of prior training load (i.e. overload or not) or whether 
they were diagnosed as functionally overreached or not prior to the taper. However, 
performance was assessed using an incremental cycling test to exhaustion, rather than a 
competition measure. It is still necessary therefore, to establish clarity on the time course 
of fatigue elimination in endurance runners for the peaking of performance.   
Additionally, it is important to consider whether a taper is always necessary before a 
competition. The aim of a taper is to alleviate accumulated fatigue and maintain or further 
enhance physiological adaptation (Mujika & Padilla 2003). However, there may be 
circumstances in which athletes are not suffering from the level of fatigue that would cause 
an acute suppression in performance and warrant a taper period. For example, if an athlete 
is prevented from training to their maximum capacity through injury or illness prior to 
competition and residual fatigue from earlier heavy training has already been alleviated.  
Alternatively, it may be counterproductive to implement an optimal taper before every 
competition of the season. Many sports now have busy competitive calendars before the 
season culminates with a major championship, due to an increase in commercial 
sponsorship and therefore increased opportunity for financial gain (Pyne et al., 2009). No 
study has experimentally investigated tapering strategies for multiple peaking, although it 
can be speculated that implementing optimal taper periods too frequently could comprise 
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long-term adaptation to training. Thus limiting the performance level that can be achieved 
at the most important competition at the end of the season. When competitions occur 
frequently, it may be necessary to implement short-duration ‘mini tapers’ before minor 
events (Tønnessen et al., 2014) and prioritise 2-3 important competitions to carry out an 
optimal taper (e.g. qualification event for major championships and major championships 
event) (Le Meur et al., 2012). Further research is required to determine how tapering 
strategies should be individualised and planned, with careful consideration of prior training 
load and peaking for the most important competition of the season.  
1.5 Possible Physiological Mechanisms of Tapering on Performance 
1.5.1 Insights from Mathematical Modelling 
The physiological mechanisms underlying the observed improvements in performance 
after tapering are not yet well understood. Insight might be gained from mathematical 
modelling, whereby mathematical analysis of the relationship between training load and 
performance has been conducted to facilitate understanding. Banister et al. (1975) 
developed a complex systems model to understand the fluctuation of athletic performance 
throughout periods of heavy training and tapering, estimated from the difference between 
two antagonistic transfer functions; a negative function representing fatigue and a positive 
function to represent fitness. In theory, a period of intensified training would result in a 
decline in performance due to an increase in fatigue that exceeds the gain in adaptation and 
fitness. A reduction in training thereafter, would alleviate fatigue more quickly than fitness 
would decline, thus resulting in an improvement in performance. In brief, daily training 
load [w(t)] is converted by the parameter vector of the model using two multiplying factors 
(k1  and k2) into fitness and fatigue impulses. Two time constants (𝜏1 and 𝜏2) represent the 
decay in accumulated fitness and fatigue, respectively and occur at different rates. The 
following parameters of the model parameter vector have been suggested; k1 = 1, k2 = 2, 𝜏1 
= 45 d and 𝜏2 = 15 d (Fitz-Clarke et al., 1991; Morton et al., 1990). The systems model can 
predict variations in performance at any time p(t) based on training dose [w(t)]. More 
recent extensions of the model have contributed to greater understanding of certain aspects 
of the taper, including the optimal pattern of the taper (Banister et al., 1999, described in 
section 1.3.3).  Mujika et al. (1996) investigated the effect of training and taper duration on 
performance in elite swimmers. The goodness of fit between the actual performance 
achieved by the swimmers at different times in the season and the modelled performance 
was statistically significant for 17 out of 18 individuals. The 3 and 4 week progressive 
19 
 
tapering periods resulted in 3% improvements in competition performance, which with the 
use of the model, the authors attributed to a significant reduction in negative influence of 
training, without comprising the positive influence of fitness, over this taper duration.  
Banister’s model however, assumes that fitness and fatigue impulses are always 
proportional to training load and that the parameters remain consistent over time. This 
concept fails to consider the impact of previous training on the magnitude and duration of 
fatigue induced by an acute training session. A recursive least squares algorithm was used 
to explore this and it was shown that the negative effect of a training bout is exacerbated 
when training intensity (Figure 1.5; Busso et al., 1997) and training frequency (Busso et al., 
2002) are increased. The Variable Dose-Response Model was subsequently proposed by 
Busso (2003) and attempts to describe performance responses to varying training loads 
over time. The development in this model is represented by a gain term for the negative 
function of fitness that varies with training load according to a first order relationship. 
Using training and performance data from 6 healthy individuals, goodness of fit of 
performance was improved with the variable dose-response model, compared to previous 
models of Banister et al. (1975), Calvert et al., (1976) and Busso et al. (1991) which used 
time-invariant gain terms for the positive and negative influences of training. Model 
simulations showed that the transient decreases in performance with intensified training 
could be as a result of a change in the response to the training dose. For example, a 
particular training session could be more difficult for the athlete to manage when overall 
training load is intensified, but a progressive reduction in training load would allow the 
athlete to respond more effectively to the same session or complete a more intense or 
prolonged session. Improved performance as a result of the tapering period may therefore 
be attributed to both the recovery from previous training and restoration of the ability to 
respond to training. A combination of delayed physiological responses to previous training 
and early reaction to training done during the taper is likely to facilitate enhanced 
performance (Mujika et al., 2004). Experimental data on athletes and their responses to 
heavy training and tapering offers support for this theory (Halson et al., 2002). Following 2 
weeks of normal training, training was intensified for 2 weeks in endurance-trained 
cyclists. Power output and performance time in a simulated time-trial, whereby target 
amount of work was to be completed in the shortest possible time, declined (P < 0.05) 
after the onset of the intensified training period, and further fatigue and performance 
decrements occurred when the intensive training stimuli continued. When training load 
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was subsequently reduced, time-trial performance improved by 2% from baseline in the 2
nd
 
week of the recovery period. This may also help to explain the findings of Thomas et al 
(2009) where mathematical modelling of a two-phase taper based on elite swimmers 
resulted in significant improvement in performance.  
 
Figure 1.5. Variation in training dose (estimated from training intensity) and change in 
performance response over each week of training in 2 individuals (figure from Busso et al., 
1997). 
Whilst mathematical modelling offers insight into the effects of training on performance, 
there are several limitations to this approach and findings should be considered with 
caution. Firstly, existing models require a single system input to represent training load, 
typically calculated from volume weighted by intensity. This limits the scope of the model 
in not accounting for and over-simplifying the diversity of training completed by elite 
athletes (Hellard et al., 2006). It has been suggested that a sport-specific multifactorial 
model with several inputs would provide a clearer understanding of the effects of different 
types of training on performance, although this approach would be more complex, time 
consuming and perhaps not realistic for elite athletes (Busso & Thomas, 2006). 
Performance, the system’s output, can be defined more easily. The challenge arises 
however, in achieving an adequate number of performance observations across all periods 
of training, which is not always feasible in elite athletes. For multiple linear regression, 15 
21 
 
observations per parameter is recommended (Stephens, 1986), but since the models of 
Banister and Busso are non-linear, more performances per parameter are required (Hellard 
et al., 2006). In the study by Mujika et al. (1996) on elite swimmers for example, the mean 
number of measured performances was 18. This is perhaps explains the reason for many of 
the models being developed on small sample sizes, using data from non-elite participants 
and therefore limits application to elite athletes. Regardless, it is not recommended that 
models from the literature are applied to individuals and used to predict training (Busso 
and Thomas, 2006). Mathematical models are also unable to discern the complex 
physiological processes that are involved in training adaptation and insight from modelling 
is limited to understanding the dynamic and temporal changes in performance during and 
after intensification (Busso and Thomas, 2006). 
1.5.2 Muscle Glycogen 
The importance of muscle glycogen as a metabolic substrate for endurance exercise has 
been widely acknowledged since the 1960’s, after the development of the muscle biopsy 
technique (Bergström & Hultman, 1966; Bergström et al., 1967). The rate of muscle 
glycogen utilisation increases with exercise intensity and is the primary source of fuel in 
the early stages of exercise and for intensities exceeding ~75% V̇O2max (Hargreaves, 1996; 
Hermansen et al., 1967; Romjin et al., 1993). The ability of muscle glycogen to produce a 
greater energy yield per unit of O2 and a more rapid rate of ATP resynthesis compared to 
fat and protein perhaps explains why it remains the preferential fuel for the maintenance of 
moderate to intense exercise. Relative to fat and protein however, muscle glycogen stores 
are finite and become severely reduced or even depleted as a result of prolonged 
submaximal exercise, such as marathon running (Sherman et al., 1983). In response to high 
intensity intermittent exercise, it has also been demonstrated that rapid depletion of muscle 
glycogen occurs in type II fibres in particular (Gollnick et al., 1973). Although it has been 
suggested that periods of training with low muscle glycogen stores might stimulate other 
physiological adaptations beneficial to endurance performance (Hansen et al., 2005; 
Hawley & Burke, 2010; Yeo et al., 2008), it is well known that sub-optimal muscle 
glycogen is associated with a reduced capacity to perform both submaximal (Bergstrom et 
al., 1967) and supramaximal exercise (Maughan & Poole, 1981). As such, to ensure 
optimal endurance performance, athletes are encouraged to maximise the availability of 
muscle glycogen prior to competition. 
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During periods of heavy training however, athletes frequently undertake training sessions 
with low muscle glycogen availability either by intent (Stellingwerff, 2013) or by 
circumstance, often through multiple training sessions in a day (Philp et al., 2012). 
Successive days of intense prolonged training without adequate carbohydrate consumption 
can result in a gradual reduction of muscle glycogen content and deterioration in 
performance (Costill et al., 1971). Even with optimal carbohydrate intake, glycogen stores 
are replenished at a rate of approximately 5-7% per hour, therefore requiring up to 20 h to 
re-establish stores following a glycogen depleting training session (Coyle & Coyle, 1993). 
The tapering period may provide the opportunity for athletes to replenish muscle glycogen 
as a result of a reduced training load and consequently, lowered glycogen utilisation and 
greater recovery time between training sessions. In cyclists, muscle glycogen 
concentration increased by 17% and 25% after 4 and 8 d of tapering, suggesting that 
changes occur progressively with taper duration (Neary et al., 1992). The same group also 
found that a 7-d taper in cyclists, where training volume was gradually reduced (by ~60%) 
and intensity maintained (85-90% maximal heart rate), improved muscle glycogen and 40 
km time trial performance to a greater extent (34% and 4.3%) than a 7-d taper where 
training volume was maintained and intensity was gradually reduced (to 55% maximal 
heart rate) (29% and 2.2%; Neary et al., 2003). Both performance time and muscle 
glycogen concentration were unchanged in the control condition, where regular training 
load was maintained (Neary et al., 2003). Similar findings were evident in endurance 
runners, where a low volume, high intensity 7-d taper resulted in a 15% increase in muscle 
glycogen and 22% improvement in treadmill time to exhaustion at 1,500 m race speed 
(Shepley et al., 1992). In comparison, a moderate volume, low intensity taper did not result 
in increased muscle glycogen and the margin of improvement in performance was much 
smaller (6%; Shepley, et al., 1992).  
There is also evidence that muscle glycogen ‘supercompensation’ can occur with dietary 
manipulation (Bergstöm et al., 1967; Goforth et al., 1997; Madsen et al., 1990). The 
traditional carbohydrate loading strategy however, involved a muscle glycogen depleting 
exercise bout, followed by 2-3 d of low carbohydrate intake (depletion phase), before a 
similar period of high carbohydrate intake (supercompensation phase) (Bergstöm et al., 
1967). Whilst muscle glycogen concentration has shown to supercompensate by up to 100-
fold and improve exercise capacity compared to a mixed diet (Karlsson & Saltin, 1971), 
this strategy could limit the intensity and responses to training during the depletion phase 
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and could be a risk to athletes close to competition, due to potential increased 
susceptibility to illness from restricting carbohydrate after exhaustive exercise (Gleeson et 
al., 2004).  However, it was subsequently evident that supercompensation could occur in 
trained athletes by merely reducing training load and consuming a high carbohydrate diet (> 
50% total energy from carbohydrate) (Costill et al., 1981; Sherman et al., 1981). For 
example, muscle glycogen concentration in trained female athletes was 13% greater after a 
7-d taper coupled with a high carbohydrate diet compared to a moderate carbohydrate diet 
(Walker et al., 2000).  This was also associated with elevated carbohydrate oxidation, RER 
values and blood lactate concentration during cycling to volitional exhaustion at 80% 
V̇O2max, which was also improved (Walker et al., 2000). In addition, carbohydrate loading 
has also been shown to improve performance in time trial performance tests (Rauch et al., 
1995; Williams et al., 1992).  
Whilst high glycogen availability is desirable in the competition setting where it may 
contribute to optimal performance (Hargreaves, 2004; Hawley et al., 1997; Temesi et al., 
2011), athletes should take care to match energy intake with the reduced energy 
expenditure consequential of a taper period, to avoid changes in body composition that 
might be detrimental to performance (Mujika et al. 2004). It was evident for example, that 
triathletes did not modify their total energy or carbohydrate intake during 2 weeks of 
tapering compared to 4 weeks of intensified training and percentage body fat increased 
from 11.5% to 12.1% (Margaritis et al., 1990). Whilst this may not have been large enough 
to impact on performance, more substantial changes could be expected after longer tapers. 
Nevertheless, these findings suggest that the taper provides an opportunity for athletes to 
optimise muscle glycogen stores, which may subsequently contribute to increased 
performance. Although a high carbohydrate diet and high intensity training appear to be 
key to increasing/restoring muscle glycogen levels during tapering, a prior depletion phase 
is not recommended.  
1.5.3 Neuromuscular Changes 
Increased strength and power have been commonly observed as a result of tapering and 
such increases have been correlated with improved performance in swimmers (Cavanaugh 
& Musch, 1989; Costill et al., 1985; Johns et al., 1992; Raglin et al., 1996), and in 
endurance-trained runners (Luden et al., 2010; Shepley et al., 1992). Although, some 
studies have reported no change in muscular force after tapering (Hooper et al., 1998; 
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Houmard et al., 1994). Equivocal findings might be due to variances in participant training 
status, the type of tapering strategy undertaken and differences in the methodology 
implemented to measure force production and rate of force development.  
Increased maximal voluntary isometric strength of the knee extensors after both high 
intensity-low volume and low intensity-moderate volume tapers was found in cross-
country and middle distance runners (Shepley et al., 1992). Percutaneously nerve-
stimulated evoked contractile properties of the right knee extensors also improved during 
both tapers and the gains in peak twitch torque were 13% and 19%, respectively. Similar 
positive changes occurred in a rest-only taper group, but performance in a treadmill test to 
exhaustion at approximately 1,500 m velocity declined by 3% in this group. This suggests 
that improvements in performance following a taper are influenced by a multiplicity of 
physiological factors, rather than muscular strength and power alone.  
Single muscle fibre analysis indicated that highly trained collegiate swimmers exhibited a 
30% higher peak isometric force, a 67% faster shortening velocity and a 250% higher 
absolute fibre power in type IIa fibres of the deltoid muscle after a 21-d low volume taper 
(Trappe et al., 2000). Type I fibres also increased their shortening velocity by 32%. In 
support, Luden et al. (2010) found that peak force (11%) and absolute power (9%) of type 
IIa fibres in the gastrocnemius muscle were improved in distance runners after 3 weeks of 
tapering. The reported changes in contractile properties at the single fibre level are perhaps 
due to an increased packing density of myofibrillar proteins (Metzger & Moss, 1987), 
altered myosin ATPase activity and/or changes in calcium sensitivity (Trappe et al., 2000) 
and  are likely to be related to the observed post-taper improvements in whole muscle 
strength and power. 
It has been suggested that reduced training during tapering may allow for an increase in 
maximal tension development through changes in contractile mechanisms and/or neural 
controls on fibre recruitment (Costill et al., 1985). Increases in strength were observed 
despite an unchanged percentage motor unit activation, which may be due to positive 
changes in muscle fibre size during the tapering period (Shepley et al., 1992). This is 
supported by a study in male collegiate swimmers, where type IIa fibre diameter and cross 
sectional area (CSA) increased by 11% and 24%, respectively following a 3 week 
reduction in training (Trappe et al., 2000).  Furthermore, tapers of between 7 and 21 d have 
been linked to increased type II CSA (Neary et al., 2003) and type IIa fibre diameter 
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(Luden et al., 2010). Changes in both protein synthesis and breakdown during tapering 
may explain the marked type II muscle fibre growth. Trained muscle typically displays 
higher rates of protein synthesis at rest (Pikosky et al., 2006), suggesting that heavy phases 
of training suppress the rate of muscle protein synthesis, as has been shown in rats (Seene 
et al., 2004). Conceptually, when the training overload is removed in the form of taper, 
protein synthesis can proceed at high rates. Furthermore, overtraining can also elevate 
rates of protein catabolism (Seene et al., 2004). Therefore, altered protein balance might 
also be contributed to by a decrease in the rate of protein breakdown with the removal of 
heavy training during the taper.  
Although protein turnover was not measured, Luden et al. (2010) observed an exaggerated 
post-exercise gene response following 3 weeks of tapering. The growth-related MRF4 
gene displayed an augmented exercise response following the taper. Conversely, the 
MuRF-1 gene was attenuated after tapering and is associated with proteolysis of 
myofibrillar proteins (Reid, 2005). This supports the notion that that muscle is less 
susceptible to myofibrillar breakdown when training load is reduced. In combination, this 
gene response is compatible with muscle hypertrophy and may explain the observed 
increase in size and function of type II fibres after tapering (Luden et al., 2010). A possible 
explanation is that high volume training in the months prior to tapering, of low intensity 
exercise in particular, induces negative changes to type II muscle fibre size, particularly 
since the activity of AMPK is increased after long duration exercise and inhibits the 
activity of mTOR and thus supresses the rate of protein synthesis (Baar, 2006). This is 
supported by Fitts et al. (1989) who observed a 15% decrease in the type IIa fibre size of 
swimmers, after training volume was doubled for 10 d. In contrast, type I fibre size was 
unaltered after this period. Tapering may therefore have the reverse effect on type II fibre 
size, given the removal of a large proportion of low intensity training volume, whilst high 
intensity training is continued.  Further research is required to investigate protein turnover 
during tapering and to study the time-course of the acute up-regulation of genes to the 
formation of proteins that cause greater adaptation and might contribute to improved 
performance.  
Other potential mechanisms responsible for improved performance after tapering may be 
related to local changes in enzyme activity, which have a positive impact on metabolic 
efficiency (Mujika et al., 2004). In the high intensity-low volume taper group, Shepley et 
al. (1992) observed an 18% increase in citrate synthase activity after 7 d. The improvement 
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in time-to-fatigue running performance at 1500 m speed in this study was therefore 
attributed to an increased capacity to maintain a high rate of oxidative energy production, 
despite the potentially performance-limiting effects of increasing intracellular temperature, 
hydrogen ion and lactate concentration and superoxide free radicals. In support, a 
significant increase in cytochrome oxidase activity was evident post-taper in cyclists, 
providing an indication of enhanced respiratory capacity of the muscle (Neary et al., 1992). 
At the single fibre level, a high intensity-low volume taper caused myofibrillar ATPase 
and succinate dehydrogenase in type I fibres to increase by 11% and 12%, respectively 
(Neary et al., 2003). In type II fibres myofibrillar ATPase, succinate dehydrogenase, β-
hydroxyacyl CoA dehydrogenase and cytochrome oxidase increased by 15-16%. After a 
high volume-low intensity taper however, cytochrome oxidase (10%) and β-hydroxyacyl 
CoA dehydrogenase (17%) increased in type I fibres, but only β-hydroxyacyl CoA 
dehydrogenase (18%) increased in type II fibres. The metabolic changes that occur at the 
single fibre level as a result of tapering are likely to contribute to the observed differences 
in performance at the whole-body level. Similar to the changes in muscle fibre size, it is 
evident that the metabolic properties in endurance athletes are more responsive to a high-
intensity taper. This may be due to the specific contractile properties of type II fibres and 
greater potential of this fibre type to increase their oxidative enzyme capacity (Neary et al., 
2003).  
The evidence presented suggests that muscular strength and power production might be 
attenuated during periods of intensive training, due to a combination of factors including 
altered protein synthesis and shifts in fibre type volume. However, muscle function is able 
to recover during the tapering period when training load is reduced, and therefore appears 
to be improved compared to pre-taper levels.  
1.5.4 Hormonal Changes  
It has been suggested that the measurement of plasma testosterone (T) and cortisol (C) 
could be indicative of changes in anabolic and catabolic tissue activity, respectively. The 
T:C ratio may  represent the balance between anabolic and catabolic activity and a 
significant decrease could represent overstrain and under recovery (Adlercreutz et al. 
1986), although findings in response to tapering are equivocal (Mujika et al., 2004). Flynn 
et al. (1994) found no difference in total T, free T, and total T:C ratio (T:C) or free T:C in 
male cross-country runners after a 3 week taper, with no performance benefit following the 
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taper, which suggests that the tapering strategy was not adequate to reduce previously 
accumulated training stress. Following a 6-d taper, the hormonal markers; total T, free T, 
C, total T:C and free T:C remained stable and were not associated with any changes in 
performance (Mujika et al., 2000). However, total T was found to correlate inversely with 
the low intensity continuous training distance covered during taper and positively with 
high intensity interval distance. In support, total T was significantly increased after either a 
moderate or high frequency taper of 6 d, where low intensity continuous training was 
removed from the main part of the training sessions (Mujika et al., 2002). The authors 
suggested an increase in total T was a result of the exclusion of low intensity continuous 
running for main part of training sessions during the taper. The mechanism responsible for 
this observation is perhaps initiated by an enhanced pituitary response to the prior period 
of heavy training, bringing about a positive influence on androgenic-anabolic activity 
during the subsequent taper (Mujika et al., 2002). Previous investigations have shown a 
delay in the relationship between luteinising hormone (LH) concentration (an indication of 
enhanced pituitary activity) during intense training and T levels during reduced training or 
tapering, characterised by a reduction in physiological stress (Busso et al., 1992; Mujika et 
al., 1996). More specifically, Busso et al. (1992) found that variations in LH concentration 
during 4 weeks of heavy training in weightlifters were positively associated with changes 
in the T:sex-hormone-binding-globulin ratio during 2 weeks of reduced training that 
followed (R = 0.90; P < 0.05). This relationship was also found in highly trained 
swimmers, where the percentage change in LH throughout 12 weeks of heavy training was 
positively correlated with the plasma concentration of non-sex hormone binding globulin 
bound T (the sum of free T and albumin-bound T) after 4 weeks of tapering (R = 0.72; P < 
0.72) (Mujika et al., 1996).  It was initially thought that positive changes in testosterone 
during tapering may mediate the increases in muscle fibre size observed after the tapering 
period (Sinha-Hikim et al., 2002). However, more recent evidence suggests that the small 
and transient changes in circulating testosterone induced by exercise are not associated 
with increases in lean body mass, hypertrophy or strength (West & Phillips, 2012). 
Resting C can be chronically elevated during heavy endurance training (Fry & Kraemer, 
1997; Houmard et al., 1990; Luger et al., 1987), which might be explained by the 
metabolic action of this hormone. Cortisol increases substrate availability by mobilising 
amino acids in the muscle and stimulating gluconeogenesis in the liver, thereby increasing 
hepatic glucose output, in addition to limiting glucose uptake into the muscle (Orth et al., 
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1998). As a result of increased C, glucose utilisation in muscle is reduced, perhaps in an 
attempt to prevent severe depletion of muscle glycogen during periods of high-volume 
training (Bonifazi et al., 2000). This potentially protective effect may be linked to 
interleukin-6 (IL-6) release from the muscle, since infusion of recombinant human IL-6  
(rhIL-6) at a concentration elicited after strenuous exercise resulted in a significant 
increase in C (Steensberg et al., 2003). Changes in resting C may therefore be indicative of 
the progressive increase in muscle glycogen storage observed with tapering, when training 
volume is reduced (Neary et al., 1992; Shepley et al., 1992). In support, over 2 seasons, the 
1.5-2.1% improvement in major competition performance after tapering in elite swimmers 
was positively related to corresponding 22-49% increases in post-competition peak lactate 
and negatively correlated (R = -0.66) with the 19-29% change in resting pre-competition 
plasma C (Bonifazi et al., 2000). A similar conclusion was drawn by Mujika et al. (2002) 
following a 6-day high frequency taper, where strong correlations were found between 
changes in peak blood lactate after an 800 m running race and performance, serum C (R = 
-0.75), total T:C and free T:C ratios (R = 0.82). A reduction in plasma C with tapering 
therefore, is perhaps a prerequisite for increased muscle glycogen concentration and 
improved performance. 
Collectively, this evidence suggests that the tapering period can create a hormonal milieu 
favourable to anabolic processes and particularly muscle glycogen storage. It not clear 
however, how the anabolic and catabolic processes would be affected in long distance and 
marathon runners, since a large proportion of their training volume during the tapering 
period is likely to consist of lower intensity continuous running. 
1.5.5 Haematology 
Trained athletes typically display elevated blood volume, haemoglobin mass and red cell 
volume compared to untrained individuals (Kjellberg et al., 1949; Heinicke et al., 2001). 
These adaptations are beneficial to endurance performance given their close relationship 
with V̇O2max (Levine, 1993; Schmidt & Prommer, 2010; Vanoverschelde et al., 1993). 
Increased blood volume improves venous return, which is necessary for increased stroke 
volume and subsequently, a high cardiac output (Coyle et al., 1990; Hopper et al., 1988; 
Kanstrup & Ekblom, 1982). In addition, it widely accepted that elevated red cell volume 
and haemoglobin mass reflects a greater capacity for O2 to be transported between the 
respiratory surfaces and metabolising tissues (Jensen, 2009). 
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Tapering has been shown to increase total blood volume and red cell volume after a high 
intensity-low volume strategy (Shepley et al., 1992). Despite the taper duration in this 
instance representing the minimal time-course for the maturation of erythrocytes (Israels & 
Israels, 2006), it is possible that the tapering period induced a positive balance between 
haemolysis and erythropoiesis. The sudden reduction in training load may have reduced 
the rate of intravascular haemolysis and stimulated the reticuloendothelial system’s 
capacity for reuptake of dying erythrocytes (Hallberg & Magnusson, 1984).  This view is 
supported by Mujika et al. (2002), who found that serum haptoglobin was significantly 
increased after 6 d of tapering in middle distance runners, in addition to an observed trend 
towards an increase in reticulocytes. This evidence once more reflects the anabolic 
environment that appears to be created by a period of tapered training. 
1.5.6 Other Considerations 
Whilst the taper is crucial to ensure athletes are ready to produce an optimal performance, 
they must also be able to regulate their rate of work output during the race. This 
distribution of work or energy expenditure over a particular distance is also referred to as 
‘pacing’ or a ‘pacing strategy’ (Abiss & Laursen, 2008) and enables the athlete to cover 
the race distance in the shortest possible time, without catastrophic failure in any 
physiological  system (St Clair Gibson et al., 2006). Whilst there has been greater attention 
on assessing the optimal pacing strategies for performance, little is known about the 
influence of tapering on pacing in competition. 
 It has been suggested that pacing is determined by a combination of central and peripheral 
regulation. According to Ulmer (1996), the teleoanticipation process creates a brain 
algorithm to initiate a starting pace via efferent neural commands, based on knowledge of 
the distance to be completed and previous experience. In addition, the environmental 
conditions, current health status (St Clair Gibson et al., 2006) and possibly muscle 
glycogen content (Rauch et al., 2005) might all provide input into the decision making 
process. The central governor model further develops the teleoanticipation theory and 
suggests that alterations are continually made to pace during the race, initiated by afferent 
input from the peripheral physiological systems and receptors that monitor change 
resulting from the current pace (Lambert et al., 2005; St Clair Gibson et al., 2006). Despite 
complex information processing between the brain and periphery in regulating pacing 
however, it is unknown whether the initial pace set in a feedforward manner might be 
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interfered with by the effects of tapering on recovery from accumulated fatigue. For 
example, athletes might train with overload prior to the taper to maximise adaptation 
(Aubry et al., 2014) and become unaccustomed to performing without the accumulated 
fatigue that is consequential of the normal training process (Halson & Jeukendrup, 2004). 
This overload practice might influence the memory and negatively impact the decision 
making process in selecting race pace. It is possible therefore, that the change in fatigue 
status after tapering might need to be taken into account when informing the brain 
algorithm, to achieve an optimal pacing strategy and an improvement in performance. 
1.5.7 Summary 
The physiological mechanisms fundamental to the process of tapering have not yet been 
well defined in endurance runners and most of what is known is speculative (Child et al., 
2000; Mujika et al., 2000). It appears that a myriad of physiological changes occur during 
the taper, including metabolic, neuromuscular, hormonal and haematological responses, 
which may all contribute to improving performance. This is perhaps due to the complex 
interaction of the physiological determinants associated with endurance performance and 
the influence of differing tapering strategies implemented in existing investigations. 
Adding to the confusion might also be the differing training status of participants in 
tapering studies. However, the available evidence appears to suggest that the tapering 
period allows for the restoration of physiological capacities that may have been previously 
suppressed by intensified training, which may then lead to amplified physiological 
responses to the training completed during the taper. Despite this, athletes may not always 
approach competition following the same training load or state of fatigue (e.g. due to 
illness or injury) and may require modification of their typical tapered training to fully 
recover and peak for competition, or to avoid detraining. This may also influence the 
selected pacing strategy and capability to deliver an optimal performance.  
To optimise a tapering strategy in an elite population therefore, where the prior approach 
may not always be the same, it is fundamental to understand individual fatigue status 
preceding the taper and rate of recovery during the taper. Given the existing mechanistic 
literature and the available analysis methodologies and technologies, it may be possible to 
identify a biomarker of training stress and recovery to objectively monitor the 
effectiveness of a tapering strategy and readiness to compete on an individual level. This 
may inform coaches to apply real-time adjustments to the planned training load, which 
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could be necessary to achieve optimal restoration of physiological capacities and responses 
to training before competition. In an elite population however, it is not feasible to employ 
the invasive procedures such as muscle biopsies, necessary to monitor a number of 
physiological changes associated with a taper (e.g. muscle glycogen concentration). 
Therefore, it is necessary to identify biomarkers that are associated with the physiological 
changes during tapering, which can be measured both quickly and with minimal 
invasiveness.  
1.6 Potential Biomarkers of Recovery during Tapering  
1.6.1 Interleukin-6 
It has been suggested that certain cytokines could represent markers of training stress in 
athletes (Jürimäe et al., 2011). Interleukin-6 is a pleiotropic cytokine with a variety of 
biological roles including exercise-induced immunoregulatory effects, generation of acute 
phase reactions and metabolic functions to maintain energy homeostasis during exercise. 
The polypeptide messenger molecule, IL-6, is predominantly produced in the working 
skeletal muscle during exercise (Ostrowski et al., 1998) and this production can explain the 
exercise-induced elevation in plasma IL-6 (Steensberg et al., 2000). It has been well-
documented that IL-6 increases to a much greater extent than any other cytokine during 
exercise (Febbraio & Pedersen, 2002; Pedersen, 2009; Pedersen & Febbraio, 2008; 
Petersen & Pedersen, 2005) and more than 100 fold increases have been found after 
marathons and other prolonged bouts of running (Nieman et al., 2005; Ostrowski et al., 
1999; Suzuki et al., 2000). Since skeletal muscle is the source of IL-6 production during 
exercise, it is not surprising that exercise modes involving large muscle groups, such as 
running, result in more dramatic increases in plasma IL-6. However, approximately 50% 
of the plasma IL-6 fold change from pre- to post-exercise can be explained by the duration 
of exercise (Fischer, 2006) and therefore a longer duration of exercise at the same relative 
intensity would result in a greater IL-6 response. Although muscle damage is not required 
to cause the elevation in plasma IL-6, eccentric loading of the muscle during prolonged 
running may lead to increased micro muscular damage, which may result in a delayed peak 
concentration and a slower return to resting levels (Hellsten et al., 1997; Macintyre, 2001; 
Toft et al., 2002). 
Significantly, IL-6 release has been shown to be elevated in glycogen depleted states and 
therefore may serve as an indirect measure of muscle glycogen status (Gleeson & Bishop, 
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2000). Gleeson and Bishop reported that the plasma IL-6 response to exercise was 
elevated when participants had been following a low-carbohydrate diet, compared to a 
high-carbohydrate diet. In support, IL-6 release was significantly augmented after just 1 h 
of a 5 h 2-legged knee extensor exercise in a glycogen-depleted leg compared to a non-
depleted control leg (Steensberg et al., 2001). Individual data indicated that the highest IL-
6 mRNA expression was found in participants with the lowest muscle glycogen post 
exercise. Furthermore it has been shown that carbohydrate ingestion attenuates the 
exercise-induced elevation in IL-6. Immediately after 2.5 h of running at approximately 
75% V̇O2max, the increase in IL-6 from baseline was lower in a carbohydrate feeding trial 
vs. the placebo trial (421% and 753%, respectively) (Nehlsen-Cannarella et al., 1997). 
Based on these data, it appears that low muscle glycogen acts as a trigger for a pro-
inflammatory response, suggesting that muscle glycogen, and post exercise nutritional 
recovery are essential components in regulating the well documented post-exercise IL-6 
response. 
Despite attempts to maintain energy homeostasis, athletes may spend prolonged periods of 
time in heavy phases of training with sub-optimal muscle glycogen stores. It remains 
unclear whether this is as a result of repeatedly engaging in glycogen depleting training 
sessions without adequate carbohydrate intake and recovery time, as a consequence of 
muscle damage-impaired glycogen replenishment, or as a combination of both factors. It 
could be speculated therefore, that athletes may exhibit high plasma IL-6 concentrations. 
It has been shown that intensified training in athletes can cause a chronic increase in 
resting plasma IL-6 concentrations (Robson-Ansley et al., 2007; Ronsen et al., 2002). 
Robson-Ansley et al. (2007) found that 2 weeks of intensified running training in trained 
male triathletes caused a significant increase in resting plasma IL-6 16 h post-exercise. 
Plasma IL-6 also showed a tendency to remain elevated above levels measured prior to the 
intensified training period even when training returned to normal. Moreover, as the final 
blood sample was taken only 1 week after the termination of the intensified training, it is 
not clear as to how long resting plasma IL-6 could remain elevated. In contrast, Halson et 
al. (2003) found no difference in plasma IL-6 concentration during or after 2 weeks of 
intensified cycling training compared to normal training concentrations. However, this 
was likely due to the mode of exercise, as systemic increases in IL-6 appear to be 
attenuated in cycling compared to running, which recruits a greater muscle mass. In 
addition, endurance runners often train multiple times per day, which has been associated 
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with an augmented IL-6 response post-exercise, compared to just 1 daily bout (Ronsen et 
al., 2002). After a longer period of intensified training in elite cyclists (8 weeks), the IL-6 
response to a 40 km time trial was 113% greater than before the training period 
(Farhangimaleki et al., 2009). A 3 week tapering period where training volume was 
reduced by 50% was necessary to reverse the elevated IL-6 response. Evidence suggests 
that prolonged intense training can significantly elevate both resting and post-exercise 
plasma IL-6 concentrations. The monitoring of IL-6 could therefore help to assess the 
effectiveness of a tapering strategy following a heavy period of training and potentially act 
as a peripheral indicator of muscle glycogen content.  
An additional benefit of monitoring IL-6 status is its role in establishing the anti-
inflammatory cascade (Steensberg et al., 2003). Infusion of rhIL-6, results in increased 
plasma interleukin-1 receptor agonist (IL-1ra), interleukin-10 (IL-10), C and C-reactive 
protein (CRP), independent of increases in tumor necrosis factor-alpha (TNF-α) 
(Steensberg et al., 2003). Interleukin-1 receptor agonist competitively blocks the binding 
of IL-1 to both type I and type II IL-1 receptors and in turn, prevents the protein from 
exerting its pro-inflammatory effects (Granowitz et al., 1991). It is possible that this 
process is facilitated by CRP, which may enhance the release of IL-1ra from monocytes 
during the latter stages of recovery from exercise (Pue et al., 1996). Interleukin-10 is 
another major anti-inflammatory cytokine and is known to hinder a number of immune 
pathways, including the inhibition of TNF-α production by monocytes (Petersen & 
Pedersen, 2005). Frequent intense exercise has been associated with alterations in 
leukocyte subpopulations and antimicrobial capacity, which may be partly explained by 
increases in C, as its anti-inflammatory actions have been well-documented (Barnes, 1998; 
Pedersen & Ullum, 1994; Steensberg et al., 2003). It is apparent that the release of IL-6 
from contracting muscles may facilitate a broad anti-inflammatory response and athletes 
engaging in prolonged intense exercise on a regular basis exhibit increased susceptibility 
to illness, which is not desirable immediately prior to competition (Pedersen & Ullum, 
1994). Regular monitoring of IL-6 could serve therefore as an indicator of stress or 
overtraining during normal training with an attenuation of the elevation during the 
tapering period. 
Certain cytokines are able to cross the blood-brain barrier (Szelényi, 2001) and it has been 
suggested that exercise-induced IL-6 release at the muscle could initiate signalling at the 
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brain (Robson-Ansley et al., 2010), which may in turn influence perceptions of fatigue 
and effort. This may have the further effect of influencing a centrally mediated pacing 
strategy during exercise performance (Lambert et al., 2005, St Clair Gibson et al., 2006). 
Infusion of low-dose rhIL-6 was associated with greater feelings of fatigue and inactivity 
and an inability to concentrate (Späth-Schwalbe et al., 1998), supporting the potential for 
IL-6 to affect perceptions of fatigue. Robson-Ansley et al. (2004) observed that rhIL-6 
administration prior to a 10 km time trial run significantly impaired performance 
compared to a placebo trial. Taken together, the evidence in response to systemically 
elevated IL-6 levels points to a centrally-mediated effect. However, despite the theory that 
raised plasma IL-6 levels may be involved in the severe fatigue experienced by athletes 
during heavy training, evidence to support this notion is equivocal (Halson et al., 2003; 
Robson-Ansley et al., 2009).  
Given the available evidence, there is a strong possibility that IL-6 could represent a 
potential biomarker for monitoring the effectiveness of a tapering strategy and 
physiological readiness to perform on an individual level. Providing that it can be detected 
with validity and reliability in a minimally/non-invasive manner, which is a necessity 
when working in the field with elite athletes. One aspect which potentially makes this 
problematic is the daily variability of IL-6 and the requirement to establish a significant 
change. However, the action of IL-6 is dependent on the availability of the soluble IL-6 
receptor (sIL-6R), which is more stable on a day-to-day basis than its complimentary 
protein (Robson-Ansley et al., 2010) and may therefore provide a more sensitive route. 
1.6.2 Soluble Interleukin-6 Receptor 
Concentrations of the sIL-6R have been shown to be associated with prolonged endurance 
exercise and with general feelings of fatigue (Robson-Ansley et al., 2009). It is possible 
that increases in sIL-6R could cause a greater sensitivity to IL-6. When bound, the IL-
6/sIL-6R complex acts as an agonist and is capable of stimulating cells that are not 
responsive to IL-6 alone. In rats, it was demonstrated that intracerebroventricular (ICV) 
infusion of recombinant human sIL-6R can enhance and prolong the decrements in 
locomotor activity and food intake experienced after ICV infusion of rhIL-6 (Schöbitz et 
al., 1995). Taken together, this suggests that the IL-6/sIL-6R complex acts antagonistically 
to heighten centrally mediated fatigue, which could exacerbate fatigue experienced during 
or after exercise. Increases in IL-6 in response to exercise generate acute phase reactions, 
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including the release of CRP. C-reactive protein has been shown to increase concentrations 
of sIL-6R in vitro, by inducing receptor shedding from neutrophils (Chalaris et al., 2007; 
Jones et al., 1999).  This is supported in vivo, where both CRP and sIL-6R concentrations 
are significantly elevated at rest, during a 6-d cycling event (Robson-Ansley et al., 2009). 
The release of IL-6 in response to exercise is highly dependent on exercise duration and 
modality (Fischer, 2006). Therefore, during tapering when the volume (duration of 
exercise) is reduced, it is likely that IL-6 responses will be supressed and in turn, reduce 
levels of CRP and sIL-6R and facilitate an improvement in performance due to reduced 
feelings of fatigue. 
1.6.3 Creatine Kinase 
Previous evidence has shown elevated CK values prior to tapering (Houmard et al., 1990). 
Creatine kinase is a muscle enzyme that often increases in the blood in response to 
strenuous or eccentric exercise, most likely due to increased cell membrane permeability, 
cellular disruption, damage or apoptosis (Brancaccio et al., 2010). Factors influencing the 
degree of CK entry into the blood include training volume (Millard et al., 1985) and 
exercise mode (Koller et al., 1998). It is possible that exercise induced muscle damage 
may be experienced during heavy training prior to tapering and monitoring of CK in the 
blood prior to, and during tapering may therefore reflect the mechanical-muscular strain of 
training and/or recovery. Although CK concentration in the blood has been shown to 
decline as a result of tapering in endurance runners (Child et al., 2000; Houmard et al., 
1990), changes were not accompanied by an improvement in performance. After 2 
different 6-d tapers in middle-distance runners, large inter-individual variation in blood 
CK response were also evident, with mean values unchanged from the pre-taper period 
(Mujika et al., 2000; Mujika et al., 2002). Despite this, there was a positive association 
between the volume of low intensity continuous running and plasma CK concentration 
during tapering, which indirectly implies that athletes can limit the exercise-induced 
muscle damage prior to competition by reducing the volume of this type of running during 
the taper (Mujika et al., 2000). Although assessing changes to CK in the blood may be 
useful to monitor recovery from an acute training bout, this biomarker does not appear to 
be a clear indicator of recovery during tapering and or indicative of performance in 
endurance runners.  
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1.6.4 Testosterone:Cortisol Ratio 
The T:C ratio has been previously identified as a marker of training stress (Adlercreutz et 
al., 1986), however as previously discussed (chapter 1.7.4), T:C responses to tapering are 
equivocal (Flynn et al., 1994; Mujika et al., 2000; Mujika et al., 2002). This is perhaps due 
to differences in the magnitude of prior training load, the tapering strategies implemented 
or the training status of the participants. This index of training stress is considered valuable 
for identifying periods of heavy training and less intensive training during a full season of 
training in elite athletes (Vervoorn et al., 1991), and therefore might only be useful to 
monitor recovery during a period of tapering in conjunction with previous longitudinal 
data. However, it is important to consider expense when monitoring long-term variations 
(Lac & Maso, 2004), although it is advantageous that T and C concentrations can be 
measured in saliva, providing a simple, non-invasive sampling alternative to blood 
collection (Lewis, 2006). Further research is required to confirm the responses of T and C 
to tapering in endurance runners and to indicate suitability as biomarkers of recovery and 
readiness to perform. 
1.6.5 Catecholamines 
The plasma and urinary concentrations of catecholamines have been previously measured 
in athletes to indicate training stress and to recognise overreaching and overtraining 
(Halson et al., 2002; Hooper et al., 1993; Lehmann et al., 1992; Mackinnon et al., 1997), 
and might offer another possible option for indicating recovery status prior to competition. 
Mujika et al. (1996) investigated the catecholamine responses in highly-trained swimmers 
to 12 weeks of intense training and during a 4 week taper involving a progressive 
reduction in training volume to ~25% of pre-taper levels. Plasma adrenaline, noradrenaline 
and dopamine concentration were unchanged throughout the study period, despite an 
improvement in performance following the taper. Furthermore, no changes in plasma 
adrenaline, noradrenaline or dopamine concentrations were observed in endurance trained 
cyclists over a 6 week period consisting of 2 weeks each of normal training, intensified 
training and recovery training (taper) (Halson et al., 2002). A performance decline was 
evident during the intensified training period, where time to complete a target workload 
was increased compared to normal training. Although plasma adrenaline and noradrenaline 
concentrations were correlated with training volume, there was no change in plasma 
adrenaline and noradrenaline between early-season, mid-season, late-season and taper 
sampling points in highly trained swimmers (Hooper et al., 1993). This suggests that 
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performance changes in response to an acute period of intensified or reduced training are 
not reflected by changes in catecholamine concentration. In contrast, it was found that 
plasma noradrenaline could predict the change in performance associated with tapering in 
elite swimmers and could account for 82% of the variance (Hooper et al., 1999). However 
the performance improvement in this study was less than that required for a meaningful 
change and the findings may be explained by the swimmers remaining on heavy training 
loads, particularly in the first week of the 2 week taper. Evidence for the sensitivity of 
catecholamines to changes in training load is inconsistent therefore and might not 
represent a reliable biomarker of recovery during tapering. Furthermore, the measurement 
of these hormones is not practical on a longitudinal basis due to expense and complexity of 
analysis (Mujika et al., 2004). 
1.7 Summary  
Existing evidence from both performance and mechanistic literature points to a reduced-
volume, high intensity taper, which is carried out in a progressive fast-decay pattern to 
achieve positive physiological responses and an improvement in performance. However, it 
is not clear as to how the duration required for the tapering period is affected by the 
preceding training load and fatigue status. The inclusion of high intensity training during 
tapering appears to be the key to improving performance, although further work is 
necessary to optimise the manipulation of training intensity during the taper and of 
particular importance, to assess the outcome using a field-based performance measure.  
A number of positive physiological changes have been observed as a result of the pre-
competition taper, including metabolic, neuromuscular, hormonal and haematological 
responses, all of which may contribute to some extent to improving endurance running 
performance. It would seem that the tapering period facilitates the restoration of 
physiological capacities that may have been previously suppressed by heavy training. This 
may also then lead to amplified physiological responses to the training completed during 
the taper, however a more thorough understanding of relationship between tapering and 
performance enhancement is essential to allow for further optimisation of strategies.  
From an applied perspective, the ability to monitor training stress and recovery during the 
taper might be advantageous to coaches and athletes, allowing them to evaluate the 
efficacy of the chosen strategy and modify training load if deemed necessary. The 
longitudinal monitoring of variations in IL-6, sIL-6R, T and C concentrations might be 
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indicative of training stress and energy homeostasis throughout a full season, although 
further research is required to investigate whether these minimally-invasive physiological 
biomarkers are sensitive enough to indicate taper effectiveness on an individual level to 
facilitate the peaking of competition performance. 
A summary of the components of tapering, current recommendations and observations 
from the literature is presented in Figure 1.6. Despite an increasing body of research 
investigating the effects of tapering on performance and the underlying physiological 
mechanisms, the tapering strategies currently employed by elite endurance runners prior to 
major competition remain unknown. The application of tapering strategies in elite sport 
appear to be predominantly determined by coach and athlete experiences, rather than from 
the scientific literature. This is perhaps due to the culture in track and field, with traditional 
views held by more experienced coaches and a resistance or fear to change, despite 
possible opportunities for optimisation. 
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Figure 1.6. A model of the components of tapering and the current observations and recommendations from the scientific literature. Question 
marks denote unknowns or areas where further research is required.
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1.8 Aims of the Thesis 
The aims of the current thesis are:  
1. To explore the strategies currently employed by elite athletes in order to inform future 
research directions.  
2. To gain a more thorough understanding of the physiological mechanisms underpinning 
the relationship between tapering and enhancement of performance. 
3. To optimise the manipulation of training intensity during the taper to enhance 
performance. 
4. To identify a minimally invasive physiological biomarker capable of monitoring 
recovery status during the taper, to allow individualisation of strategies. 
Specific hypotheses will be presented in experimental chapters after a more detailed 
introduction to the specific research question. 
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Chapter II 
A Comparison of Capillary and Venous Blood Sampling Methods for the 
Detection of Plasma IL-6 and sIL-6R 
2.0 Chapter Summary 
The purpose of this chapter was to quantify the relationship between venous and capillary 
blood sampling methods for the measurement of plasma IL-6 and sIL-6R, to assess 
suitability for measuring less invasively in the athletic population. Twelve physically 
active healthy male participants were recruited for the measurement of IL-6 at rest and 
during exercise and an additional group of 12 physically active healthy male participants 
for the measurement of sIL-6R at rest. Venous and capillary blood samples were collected 
at rest in all trials, and after 45 min and 75 min of exercise at 60% V̇O2max in the cycling 
and running trials. Plasma IL-6 and sIL-6R concentrations were measured using ELISAs. 
Mean plasma IL-6 concentration was not different between venous and capillary blood 
sampling methods in the cycling trial and the running trial at rest or in response to exercise, 
although there was some disagreement in the reported values between the 2 sampling 
methods (bias ± 95% limits of agreement; -3.99 pg·ml
-1
 to 3.56 pg·ml
-1 
and -3.88 pg·ml
-1
 
to 3.72 pg·ml
-1
 after cycling and running trials, respectively). Mean resting plasma sIL-6R 
concentration was higher from venous blood sampling, compared to capillary sampling 
(49.8 ± 15.4 ng·ml
-1
 vs. 43.6 ± 10.1 ng·ml
-1
 respectively; P < 0.05), despite a positive 
correlation between the 2 methods (R
2 
= 0.72; P < 0.05). To ensure precision of data 
interpretation, venous and capillary blood sampling methods should not be implemented 
interchangeably for the detection of plasma IL-6 and sIL-6R concentration. 
2.1 Introduction 
The polypeptide messenger molecule IL-6 has a variety of biological roles including 
exercise-induced immunoregulation, generation of acute phase reactions and metabolic 
functions to maintain energy homeostasis during exercise. There has been an increasing 
interest in the effects of chronic exercise training on IL-6 in athletic populations and it has 
been suggested that this cytokine could represent a marker of training stress in athletes 
(Jürimäe, et al., 2011). It has been observed that prolonged intense training can 
significantly elevate both resting (Robson-Ansley et al., 2007) and post-exercise 
(Farhangimaleki et al., 2009) plasma IL-6 concentrations, and that limited recovery 
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between heavy endurance exercise bouts is associated with an augmented post-exercise 
plasma IL-6 response (Ronsen et al., 2002). This is not desirable for athletes prior to 
competition, since increased plasma IL-6 concentration has been associated with a 
worsening of 10 km running performance and increased fatigue sensation (Robson-Ansley 
et al., 2004).  
Athletes may not exhibit excessively elevated plasma IL-6 values during heavy training, 
but rather have a greater sensitivity to IL-6, as is experienced in individuals with chronic 
fatigue syndrome (Arnold et al., 2002). It is possible that sIL-6R may be key in this 
process, as concentrations were elevated at rest during 6 d of prolonged cycling and were 
associated with general feelings of fatigue, despite no change in resting IL-6 on days 2-6 
(Robson-Ansley et al., 2009). Regular monitoring of plasma IL-6 and sIL-6R could 
therefore provide an indication of recovery from previous exercise bouts, in terms of 
energy homeostasis and inflammation status. This may facilitate coaches in prescribing 
training appropriate to the recovery status of their athlete and could be particularly useful 
during the tapering period prior to competition to facilitate the peaking of performance.  
It is of interest therefore, to explore alternative simple, minimally-invasive and 
inexpensive sampling techniques for measuring IL-6 and sIL-6R that can be used in the 
field for the athletic population. The gold standard for measurement of circulating IL-6 and 
sIL-6R is via venous blood sampling. However, this method is fairly invasive and requires 
training to attain competence in carrying out the procedure. Since the biochemical assays 
for detection of IL-6 and sIL-6R only require 25 µl and 3 µl of plasma in duplicate, 
respectively, there is also often an unnecessary surplus of blood remaining from a 
venepuncture sample.  
Previously, research has attempted to detect certain cytokines in a variety of other body 
fluids using non-invasive methods. Despite the evidence that salivary C concentrations are 
highly correlated with serum levels in response to exercise (O'Connor & Corrigan, 1987), 
it appears that concentrations of IL-6 in saliva are not associated with those found in the 
blood at rest or in response to exercise (Cox et al., 2008; Minetto et al., 2005; Minetto et 
al., 2007). Using recycling immunoaffinity chromatography, IL-6 was detected in the 
sweat of healthy premenopausal women after a 24-h period (Marques-Deak et al., 2006). 
The IL-6 concentrations detected in the sweat and concentrations detected from venous 
plasma were significantly correlated and the concentrations appeared comparable. 
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However, our laboratory was unable to detect IL-6 in the sweat of healthy males or 
females after exercise in the heat (Faulkner et al., 2014) and contradict the findings of 
Marques-Deak et al. (2006).  
Although slightly more invasive than sweat collection, capillary blood sampling is used 
regularly in the field with the athletic population for the measurement of lactate (Tanner et 
al., 2010) and plasma IL-6 has also been successfully detected using this blood sampling 
method (Smith et al., 2011). However the sampling method has not been validated against 
venous blood sampling and no study has investigated sIL-6R concentrations from capillary 
blood. While it is necessary to utilise techniques that are simple and as minimally invasive 
as possible, it also is important to ensure that the data reflect that of the systemic system.  
The aim of the current study was to quantify the relationship between venous and capillary 
blood sampling methods for the detection of plasma IL-6 and sIL-6R concentrations at rest. 
The secondary aims were to examine the relationship between sampling methods for IL-6 
after differing durations of exercise and in response to differing modes of exercise (cycling 
and running). It was hypothesised that plasma IL-6 and sIL-6R measured from capillary 
blood would be strongly correlated with that from venous blood. 
2.2 Methods 
2.2.1 Participants 
Approval from the Loughborough University Ethical Advisory Committee was gained 
prior to the commencement of all studies in this thesis. Written information was provided 
to potential participants, outlining the purpose of the study, experimental procedures and 
potential risks or discomfort that may be experienced whilst taking part in the study. 
Participants were fully briefed and were offered the opportunity to ask questions before 
signing a statement of informed consent (appendix A) and in experimental studies, 
completing a health screening questionnaire (appendix B).  
To minimise risk to participant health and to ensure current health status of the participant 
would not compromise study findings, participants were only recruited for the 
experimental studies if they met the following criteria; 
 Were non-smokers 
 Were free from any musculoskeletal injury 
 Had no personal history of cardiovascular or metabolic disease 
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 Were weight stable and not on a weight reduction/increase diet 
 Not taking anti-inflammatory medication 
 Not taking medication that affects metabolism or digestion 
 Had a body mass index (BMI) of less than 25 kg/m2 (i.e. not classed as overweight) 
 Had no known circulatory disorders (i.e. Raynaud’s disease) 
Twelve physically active healthy male participants volunteered to take part in the trials for 
the measurement of IL-6 at rest and during exercise (mean ± SD): age 23.8 ± 3.5 y, body 
mass 72.9 ± 5.8 kg, height 176.7 ± 0.1 cm, body mass index 23.4 ± 1.3 kg·m
-2
. An 
additional group of 12 physically active healthy male participants agreed to take part in the 
trial for the measurement of sIL-6R at rest (mean ± SD): age 22.6 ± 3.1 y, body mass 72.7 
± 8.1 kg, height 181.2 ± 7.2 cm, body mass index 22.1 ± 1.7 kg·m
-2
. Three participants 
took part in both the IL-6 and sIL-6R trials.  
2.2.2 Preliminary Exercise tests 
Preliminary submaximal and maximal ergometer tests were carried out at least 48 h prior 
to the main experimental trials to determine workloads equivalent to 60% V̇O2peak for both 
cycling and running. This exercise intensity was chosen to ensure participants were able to 
exercise for the complete duration required in the experimental trials. Aerobic cycling tests 
were carried out on an electromagnetically braked cycle ergometer (Lode Excalibur, 
Groningen, The Netherlands) and aerobic running tests on a motorised treadmill (HP 
Cosmos, Nussdorf-Traunstein, Germany). Expired air was measured continuously using an 
online breath-by-breath gas analyser (Ultima CPX, MedGraphics, MN, USA). Prior to use, 
2-point calibrations of both gas sensors were carried out using a known gas mixture (12% 
O2, 5% CO2) and a reference gas (21% O2). A bi-directional differential pressure 
pneumotach was calibrated using a 3 L syringe over 5 flow rates. Participants were fitted 
with nose clip and breathed through a mouthpiece housing the pneumotach, which was 
connected via the umbilical to the analyser. Oxygen uptake and carbon dioxide production 
were quantified using the BreezeSuite software (MedGraphics, MN, USA). Heart rate was 
monitored using short-range telemetry (RS200, Polar Electro, Kempele, Finland) during 
the preliminary tests. A heart rate transmitter belt was fitted across the chest and aligned 
beneath the sternum. The belt was worn next to the skin and water was applied to the 
electrodes beforehand to enhance signal detection. Participants were asked to rate their 
perceived exertion using Borg’s RPE scale (Borg, 1973) (appendix C). The scale is a 
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subjective measure of effort, ranging from 6 (indicating no exertion) to 20 (indicating 
maximal exertion). Participants were familiarised with the exercise equipment prior to the 
preliminary tests.  
On arrival at the laboratory, measurements of body mass, height, BMI were made using 
the following techniques and equipment: 
 Body mass – measured using a balance beam scales (Avery, Birmingham, UK) to 
the nearest 0.1 kg. Participants wore light clothing but footwear and items from 
pockets were removed. 
 Height – measured using a wall-mounted precision stadiometer (Seca, Hamberg, 
Germany) to the nearest 0.1 cm. Footwear was removed and participants stood with 
their heels, buttocks and upper back against the stadiometer. Feet were together and 
flat on the floor. The head was aligned in the Frankfurt plane before the sliding 
scale was lowered to touch the top of the head. Participants were instructed to take 
a deep inhalation of breath before the measurement value was recorded. 
 BMI – calculated by dividing body mass in kilograms by the square of height in 
meters. 
Maximal Cycle Ergometer Test 
An incremental cycling test to volitional exhaustion was used to determine peak V̇O2 
(V̇O2peak). The test protocol began at 100 W and was increased by 35 W every 3 min 
thereafter. Expired air was measured as described above, and heart rate and RPE were 
recorded at the end of each stage and at the end of the test. Mean V̇O2 in the final 30-s 
period of the test was accepted as V̇O2peak. The power (W) that would elicit 60% of 
V̇O2peak was estimated by plotting V̇O2 data against power (W) from the 3 min stages of 
the test. 
Submaximal Treadmill Test 
The relationship between V̇O2 and submaximal running speed was determined using a 
submaximal incremental test. The test was 16 min in duration and was divided in to 4 
stages. The initial running speed was between 8 and 11 km·h
-1
 depending on the 
participant’s fitness level and increased by 1 km·h-1 every 4 minutes. The speed at which 
heart rate reached 160 bpm was chosen as the constant speed for the maximal treadmill test, 
to ensure participants reached volitional fatigue within 10 ± 2 min (Buchfuhrer et al. 1983).  
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Maximal Treadmill Test  
Participants were given 20 min to recover from the submaximal test before beginning the 
maximal test. The test protocol consisted of a gradient increase of 1% every minute until 
the participants reached volitional exhaustion. Heart rate was monitored throughout the 
test and RPE at the end of the test. Expired air was measured as described above, and mean 
V̇O2 in the final 30-s period of the test was accepted as V̇O2peak. The speed that would 
elicit 60% of V̇O2peak was estimated by plotting V̇O2 data from the submaximal treadmill 
test against the corresponding submaximal running speed. 
Mean V̇O2peak was 49.5 ± 5.5 mL·kg·min
-1
 for cycling and 59.5 ± 9.2 mL·kg·min
-1 
for 
running. Exercise intensity equivalent to 60% V̇O2peak was 166 ± 18 W and 10.5 ± 1.5 
km·h
-1
 for cycling and running, respectively. The preliminary and experimental trials for 
cycling were separated by at least 7 d from the preliminary and experimental trials for 
running.  
2.2.3 Experimental Protocol 
Participants reported to the laboratory between 0700 h and 0800 h following a 10 h 
overnight fast, having remained inactive and refrained from caffeine and alcohol 
consumption in the previous 24 h. Body mass was measured, before participants were 
seated in a semi-supine position for resting venous and capillary blood sampling 
(described below). In the exercise trials, participants then cycled or ran at a workload 
equivalent to 60% V̇O2peak for 45 min. At 45 min, participants remained on the cycle 
ergometer or treadmill in a stationary position for approximately 2 min while simultaneous 
venous and capillary blood samples were obtained. Exercise was resumed for a further 30 
min and immediately after, final venous and capillary samples were taken simultaneously. 
Heart rate was monitored at 15-min intervals during the trials and participants consumed 
water ad libitum throughout.  
2.2.4 Blood Sampling 
Venous blood samples were collected by venepuncture from an antecubital vein in the 
right arm into a 10 mL vacutainer which had been pre-cooled and pre-treated with  
K
+
EDTA (BD Biosciences, San Diego, USA). Immediately after, the remaining samples 
were centrifuged at 4000×g for 10 min at 4°C and the separated plasma was pipetted in to 
multiple eppendorfs and stored at -80°C for subsequent analysis.  
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Capillary samples were obtained by fingerpick sampling from the left hand using an 
automated lancet. Prior to collecting the resting capillary sample, the hand and forearm 
were warmed for 5 min using a warm-air hot box to arterialise the blood at the sample site. 
Blood was collected into two pre-cooled 200 µl microvettes pre-treated with K
+
EDTA 
(Sarstedt, Leicester, UK). Immediately after, the remaining samples were centrifuged at 
4000×g for 10 min at 4°C and the separated plasma was pipetted in to multiple eppendorfs 
and stored at -80°C for subsequent analysis.  
2.2.5 Blood Analysis 
Plasma IL-6 and sIL-6R concentrations were analysed using sandwich ELISAs (appendix 
D) and corrected for any changes in plasma volume (appendix E) during exercise trials. 
2.2.6 Statistical Analysis 
Data were analysed using SPSS (Statistical Package for Social Sciences Inc. v19.0;  
Chicago, IL, USA) and were initially tested for distribution using the Shapiro-Wilk test. 
Data are presented as mean ± SD, unless specified otherwise. Statistical significance was 
accepted at P ≤ 0.05. 
The IL-6 data were log-transformed to satisfy assumptions of parametric tests. The log-
transformed levels of IL-6 in venous and capillary blood were compared between methods 
and across sampling points using repeated measures 2-factor ANOVA. The differences 
between capillary and venous concentrations for sIL-6R data were tested for distribution 
and consequently a paired-samples t-test was performed on the venous and capillary sIL-
6R data. The strength of the relationship between sampling methods for IL-6 and sIL-6R 
data was assessed using the Pearson-product-moment correlation coefficient (data log-
transformed and pooled for cycling and running trials). As the Pearson-product-moment 
correlation coefficient solely provides information on the strength of the relationship 
between measurements, Bland-Altman analysis (Bland & Altman, 1986) was performed to 
give an indication of the ‘agreement’ between variables. Data are presented as mean ± 
SEM. 
2.3 Results  
Mean plasma IL-6 concentration was not different between venous and capillary blood 
sampling methods during, or in response to cycling (P = 0.75 and P = 0.88, respectively; 
Figure 2.1A). There was however, a difference in venous compared to capillary-derived 
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IL-6 at rest in the cycling trial (0.48 ± 0.13 vs. 0.31 ± 0.16; P < 0.05; Figure 2.1A). The 
concentration of IL-6 in both venous and capillary samples increased in response to 
cycling exercise (P < 0.05) and the pattern of this response was not different between 
sampling methods (time × sample site; P = 0.08). The investigator was unable to take a 
venous blood sample from 1 participant at 75 min in the cycling trial and the statistical 
analysis was therefore performed using data from the remaining 11 participants at this 
time-point. In the running trial, mean plasma IL-6 was not different between venous and 
capillary blood sampling methods (P = 0.89; Figure 2.1B). There was a main effect of time 
as plasma IL-6 concentration in both venous and capillary samples increased in response to 
running (P < 0.05). The response was not different between sampling methods (time × 
sample site; P = 0.75). Mean resting plasma sIL-6R concentration was higher from venous 
blood sampling, compared to capillary sampling (49.8 ± 4.5 ng·ml
-1
 vs. 43.6 ± 2.9 ng·ml
-1
 
respectively; P < 0.05; Figure 2.1C). 
When IL-6 data was pooled from all time-points, there were positive associations between 
concentrations from venous and capillary blood sampling in the cycling trial (R
2
 = 0.87; P 
< 0.05; Figure 2.2A) and in the running trial (R
2 
= 0.86; P < 0.05; Figure 2.2B). A positive 
association between venous and capillary blood sampling for resting sIL-6R concentration 
was evident (R
2
 = 0.72; P < 0.05; Figure 2.2C). 
Bland-Altman plots (Figure 2.3) provide a schematic illustration of the agreement between 
venous and capillary sampling methods for the detection of IL-6 and sIL-6R. The 95% 
limits of agreement are shown in Table 2.1. 
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Figure 2.1. Plasma IL-6 concentration measured from venous blood sampling (■) and 
capillary blood sampling (□) in the cycling trial (A) and the running trial (B). Plasma sIL-
6R concentration measured from venous blood sampling (■) and capillary blood sampling 
(□) at rest (C). * indicates venous higher than capillary (P < 0.05). Data shown as mean ± 
SEM.  
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Figure 2.2. Association between venous and capillary blood sampling methods for the 
measurement of plasma IL-6 concentration in the cycling trial (A; R
2 
= 0.87) and in the 
running trial (B; R
2 
= 0.83) and for plasma sIL-6R at rest (C; R
2 
= 0.72), all P < 0.05. 
Dashed line represents the line of identity. 
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Figure 2.3. The 95% limits of agreement and mean difference between venous and 
capillary blood sampling for the measurement of plasma IL-6 in the cycling trial (A), in 
the running trial (B) and for plasma sIL-6R concentration at rest (C). 
52 
 
Table 2.1. Bland-Altman analysis of the venous and capillary blood sampling methods for 
plasma IL-6 concentrations measured in the cycling trial and the running trial and for 
resting Plasma sIL-6R concentration. 
Trial  Time (min) Bias ± SD 95% Limits of agreement  
Cycling     
IL-6 (pg·ml
-1
) 0 0.67 0.94 -1.17 to 2.50  
 45 -0.18 1.84 -3.79 to 3.43 
 75 -0.22 1.92 -3.99 to 3.56 
Running     
IL-6 (pg·ml
-1
) 0 0.13 1.73 -3.26 to 3.52 
 45 -0.18 1.29 -2.71 to 2.34 
 75 -0.08 1.94 -3.88 to 3.72 
Rest     
sIL-6R (ng·ml
-1
) 0 6.24 8.66 -10.73 to 23.22 
2.4 Discussion  
The current study demonstrates that, when plasma IL-6 concentrations from either venous 
or capillary blood are compared using ANOVA, which considers the group mean and 
associated variance, there is no difference between the 2 sample sites during, or in 
response to cycling or running exercise. In view of the strong positive correlations between 
venous and capillary IL-6, it appears that capillary sampling may offer an alternative to 
venous sampling to quantify plasma IL-6 concentrations. 
One unexpected finding was that despite high correlation, pre-exercise measurements of 
IL-6 differed between venous and capillary derived samples in the cycling trial. One 
possible explanation for this may be that the arterialisation protocol of the resting sample 
was not totally effective in fully arterialising the venous blood. Furthermore, it is possible 
that if the peripheral blood vessels were not sufficiently vasodilated in response to heating, 
then it would be expected that the venous to capillary delivery would be restricted (Gallen 
& Macdonald, 1990), resulting in a discrepancy and potential time-lag between venous and 
capillary appearance of IL-6. Although arterialisation protocols of 5-10 min heat exposure 
have been reported previously (Lobley et al., 2013, Pacy et al., 1991), some advocate 20 
min of heating to arterialise samples (Stephens et al., 2008). Given that no differences 
were evident between IL-6 concentrations measured in either venous or capillary blood in 
response to exercise where peripheral blood flow would be elevated, it suggests that this is 
53 
 
the likely cause. In order to validate this speculation, when repeating the pre-exercise 
protocol in the running trial, it was ensured that the arterialisation protocol was tightly 
adhered to by participants. In this trial, it was demonstrated that there was no difference 
between plasma IL-6 when sampled from either venous or capillary sites following 
effective arterialisation. Since the bias of 0.13 pg·ml
-1 
was similar to that observed in 
response to, and after exercise, it is suggested with confidence, that the repeated measure 
during the running trial is a true reflection of the baseline IL-6 taken from both venous and 
capillary sites. Therefore, this highlights the importance of ensuring full arterialisation, 
with a minimum of 5 min of heating, when taking a measurement using capillary blood 
sampling at rest. However, despite the statistical difference at rest in the cycling trial, the 
bias between sampling sites was only 0.67 pg·ml
-1
, which is unlikely to be of clinical 
relevance when classifying inflammation status, given that chronic low-level inflammation 
is defined as a 2- to 4-fold increase in circulating pro- and anti-inflammatory cytokines 
(Bruunsgaard, 2005). With regards to the relevance in an athletic population, the lower 
threshold for plasma IL-6 concentration to result in performance impairment is currently 
unknown. 
Despite ensuring the arterialisation protocol was tightly adhered to in the sIL-6R 
experiment, the mean resting concentration of plasma sIL-6R was higher from venous 
blood compared to capillary blood. Several previous investigations have reported 
discrepancies between capillary and venous blood samples for the measurement of blood 
glucose (Colagiuri et al., 2003), lactate (Foxdal et al., 1990), ionised magnesium 
(Matthiesen et al., 2002) and ex vivo stimulated and non-stimulated TNF-α and IL-10 
production (Eriksson et al., 2007). It was suggested that the rate of glucose consumption in 
the tissues can account for the difference between blood glucose concentrations from 
venous and capillary samples (Kuwa et al., 2001). Likewise, lactate uptake and utilisation 
by both the muscles in the inactive forearm, and in the heart and liver might explain the 
difference between capillary and venous samples for the measurement of lactate (Foxdal et 
al., 1990). It was speculated that the difference in ionised magnesium between capillary 
and venous blood at actual pH was due to the higher pH of capillary blood, which may 
have been as result of greater exposure to air in capillary tubes (Matthiesen et al., 2002). 
None of these explanations are likely to apply to the observed heterogeneous distribution 
of sIL-6R in blood plasma at rest in the current study. However, it has been demonstrated 
that capillary blood contains a higher white cell count than venous blood, in particular of 
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monocytes and neutrophils (Daae et al., 1988; Yang et al., 2001), which may help explain 
the observed differences between capillary and venous samples for the measurement of 
TNF-α and IL-10 (Eriksson et al., 2007). It could be speculated that this evidence might 
also support the finding of a difference in sIL-6R between capillary and venous samples. 
When stimulated with CRP, neutrophils experience a shedding of the membrane-bound IL-
6 receptor (Jones et al., 1999) and this process may be augmented in capillary blood where 
the neutrophil count could be higher than venous blood. However, the participants in the 
current study were healthy, active males and were therefore unlikely to display chronically 
elevated CRP levels. Despite the observed differences, the strong positive correlation 
between plasma sIL-6R concentrations from venous and capillary blood sampling methods 
would suggest it appropriate to apply a correction factor, allowing the use of capillary 
sampling to measure plasma sIL-6R concentrations. 
Although it might be more feasible to monitor plasma IL-6 in athletes on a regular basis 
using a less invasive capillary sampling method, the lower threshold for resting plasma IL-
6 concentration to result in performance impairment is unknown. Previously, when trained 
runners were infused with rhIL-6 to elicit plasma IL-6 values of 21.7 ± 15.4 pg·ml
-1
,
 
a 
significant decrement in 10 km time trial performance was observed compared to a 
placebo trial (Robson-Ansley et al., 2004). However, a wide range of resting plasma IL-6 
concentrations have been reported in endurance athletes, from 3.43 ± 3.75 pg·ml
-1
 in well-
trained distance runners (Cox et al., 2008), to 136 ± 16 pg·ml
-1 
in elite rowers during a 
normal training phase (Smith et al., 2011). This discrepancy is perhaps due to the large 
muscle volume recruited during rowing compared to running (Fischer, 2006). It might be 
necessary therefore, to routinely monitor the plasma IL-6 responses at rest in endurance 
athletes throughout a full competitive season, in order to identify the norm for an 
individual. Possible fluctuations should be monitored across a variety of training phases 
and deviations from the norm might be indicative of training stress and potential risk of 
performance impairment. 
In addition, capillary blood sampling may also be useful to monitor the plasma IL-6 
response to exercise in athletes. The current study observed a similar relationship between 
the 2 methods in response to exercise of differing durations and modes, despite exercise 
duration being a major determining factor in the amplitude of the IL-6 response, in 
addition to the volume of muscle mass involved. The measurement of plasma IL-6 in 
response to a single exercise session could be used to characterise recovery status, as the 
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cytokine response may actually reflect the concurrent and/or existing energy deficit 
(Jürimäe, et al, 2011). For example, increases of up to 100-fold have been observed after 
marathon running (Ostrowski et al., 1999). This is supported by the finding that the post-
exercise IL-6 response is dependent on pre-exercise muscle glycogen content (Steensberg 
et al., 2001) and it appears that increasing recovery time between training sessions 
attenuates the post-exercise elevation in IL-6 (Ronsen et al., 2002).  
Despite the potential advantages of capillary blood sampling in terms of practicality in the 
field and minimal discomfort for the athlete, it should be noted that the bias ± 95% limits 
of agreement indicated that venous and capillary sampling sites were not consistently in 
complete agreement. This suggests that it is inadvisable to use the 2 sampling methods 
interchangeably and one sampling method should be utilised consistently to avoid error in 
interpreting plasma IL-6 concentration at rest or in response to exercise. A further 
limitation is the need for an effective arterialisation protocol when sampling at rest and 
lengthy ELISA analysis required to quantify plasma concentrations of IL-6 or sIL-6. In 
addition the inter-assay coefficient of variation (CV) for IL-6 was 8.0%, which limits the 
sensitivity for detecting changes between samples run on different ELISA plates.  
However, the development of a new real-time biosensor for the detection of IL-6 (Huang 
et al., 2013), presents the possibility of instant feedback for coaches and athletes in the 
elite population.  
2.5 Conclusion 
It was possible to determine plasma IL-6 at rest and in response to different exercise 
modes and durations in both venous and capillary blood samples. Strong correlations were 
evident between capillary and venous IL-6 concentrations and there were no differences 
between methods at rest when blood was effectively arterialised and in response to 
exercise, suggesting that capillary blood can be used as an alternative sampling method to 
monitor plasma IL-6. A difference between methods was observed for the measurement of 
resting sIL-6R, although the observed positive correlation suggests that a correction factor 
can be applied to allow the use of capillary blood sampling. However, a consistent 
sampling method must be implemented and it is inadvisable to use venous and capillary 
sampling interchangeably for the measurement of both plasma IL-6 and sIL-6R 
concentrations.  
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Chapter III 
Tapering Strategies in Elite Endurance Runners 
3.0 Chapter Summary 
The aim of this chapter was to describe and compare the pre-competition training practices 
of elite British and Kenyan endurance runners. Training details from elite British middle-
distance, long-distance and marathon runners were collected via survey for 7 d in a regular 
training phase, and throughout a pre-competition taper. Data were also analysed 
retrospectively from diaries of Kenyan long-distance runners, which detailed training 
undertaken 1 week prior to the 2004 and 2005 Kenyan national trials. It was found that 
tapering methods differ between event groups, specifically that marathon runners reported 
a longer taper duration (14 d) than long-distance and middle-distance runners (both 6 d). 
The peak interval training intensity during tapering was faster than race-speed (P < 0.05) 
in British marathon (114%) and long-distance (112%) runners and also in Kenyan long-
distance runners (115%). In contrast, British middle-distance runners did not train faster 
than race-speed during tapering (100%). The extent to which training was manipulated 
during the taper was associated with training load prior to the taper in elite British 
endurance runners. Algorithms were generated to predict and potentially prescribe taper 
content based on regular training.  
3.1 Introduction 
The selection of a tapering strategy in elite sport is largely determined by the daily 
interaction and decision making between coach and athlete, based upon their own 
observations and experience with little or no scientific data input (Mujika et al., 2002). 
Previously, studies have manipulated the various training load variables as part of a 
structured taper (Houmard et al., 1994; McConell et al., 1993; Mujika et al., 2000; Mujika 
et al., 2002), or by way of theoretical mathematical modelling (Thomas & Busso, 2005). It 
appears that dramatic reductions in training volume can be implemented during this period 
(Mujika et al., 2000; Wittig et al., 1989), however it is clear that training intensity must not 
be compromised (McConell et al., 1993) and the inclusion of high intensity interval 
training during the taper is necessary to enhance performance (Houmard et al., 1994; 
Shepley et al., 1992). Since the tapering strategies of elite athletes have not been widely 
documented without experimental intervention, it is unclear whether this strategy is 
adopted in practice. The aim of the present study was to investigate the current tapering 
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practices of elite endurance runners and to explore relationships between regular and 
tapered training phases. Survey data was gathered on training during both regular training 
and tapering periods, across a number of endurance running events in elite British athletes 
in the 2012 Olympic year. The secondary aim was to compare the training practices in the 
final days before competition of British runners with highly successful Kenyan runners.  
3.2 Methods 
3.2.1 Survey  
A survey (Bristol Online Surveys, University of Bristol, UK) was made available to the 
athletes for a 5 month period, or alternatively a paper version was adopted (appendix F). 
The survey collected details of the main event contested at championships and personal 
lifetime best time for this event, in addition to training information specific to regular 
training (RT). RT was defined as the last week of full training before load modification as 
part of a taper prior to competition. Participants provided details of the duration and 
distance of training completed each day during this period, which was categorised into 
continuous or interval running. Interval running represented division of the training session 
into high intensity repetitions (≥ lactate turnpoint speed) interspersed with recovery 
periods (light jogging or rest) (Billat, 2001). Lactate turnpoint speed was estimated from 
season’s best 10 km performance (Jones, 2006; Petit et al., 1997) or prediction of this 
speed if athletes did not possess a 10 km performance (Daniels, 2005). Continuous running 
described the remaining training sessions, where running was uninterrupted and of lower 
intensity.  Although endurance athletes have been shown to accurately self-report training 
(Sylta et al., 2014), training data was cross-validated against global positioning system 
(GPS) data from the corresponding RT week for participants who were already habitual 
users of GPS. The above training information was also gathered for the entire tapered 
training period (TT) prior to major competition and was not limited to 1 week. Participants 
referred to training diaries to detail the required training data.  
3.2.2 Participants 
The survey inclusion criteria specified that participants were current senior British athletes 
and had competed at national, international and/or Olympic level in at least 1 of the 
following events; 800 m, 1,500 m, 3,000 m steeplechase, 5,000 m, 10,000 m or the 
marathon. Thirty-seven participants (male: n = 21; female: n = 16; age: 26.0 ± 4.6 y) met 
the criteria and completed the survey. Personal lifetime best performance times for the 
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specified competition event were within 2-12% and 1-14% of the British records in 2012 
for male and female athletes, respectively (Table 3.1). Middle distance events (MD) were 
defined as 800 m and 1,500 m and long distance events (LD) as 3,000 m steeplechase, 
5,000 m and 10,000 m (Winter et al., 2007). Where appropriate, marathon runners were 
considered as a separate group (MAR). 
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Table 3.1.  Personal best performance time (mean ± SD) and performance level expressed as percentage of the 2012 British record time for 
male and female participants in each event distance. 
 Male Female 
Event n Performance time 
(min:s.ms or h:min:s) 
Percentage of 2012 
British record 
n Performance  
time 
(min:s.ms or h:min:s) 
Percentage of 2012 
British record 
800 m 3 1:48.7 ± 0.8 93  3 2:02.4 ± 3.2 95 
1,500 m 7 3:41.3 ± 3.4 94  5 4:07.7 ± 5.3 96 
3,000 m steeplechase 2 8:45.5 ± 13.4 92 1 9:30.2 ± 0.0 99 
5,000 m 3 14:10.1 ± 25.2 94  1 15:55.8 ± 0.0 90 
10,000 m 2 28:34.5 ± 3.5 93  0 n/a n/a 
Marathon 4 2:15:46 ± 1:43.0 95 6 2:31:54 ± 2:48.8 88 
Table 3.2. Personal best performance time (mean ± SD) in 2004 and 2005 and performance level expressed as percentage of the 2012 Kenyan 
record time for participants in each event distance. 
  2004 2005 
Event n Performance time  
(min:s.ms) 
Performance level (% 
Kenyan record) 
n Performance time 
(min:s.ms) 
Percentage of 2012 
Kenyan record 
3,000 m SC 0 n/a n/a 1 08:04.2 ± 0.0 98 
5,000 m 4 13:01.4 ± 11.2 97 5 13:21.7 ± 21.1 94 
10,000 m 2 27:59.2 ± 27.8 94 1 28:09.0 ± 0.0 94 
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3.2.3 Survey Data Analysis 
Training frequency was calculated as the number of continuous running and interval 
training sessions. Volume was the sum of distance reported for continuous running and 
interval training. Mean speed was determined from the volume divided by duration of each 
continuous run or interval repetition and expressed as a percentage of personal best race 
speed to represent training intensity. Frequency, volume and intensity from TT were 
calculated as a percentage of the corresponding values from RT. The interval session that 
elicited the highest average speed during TT was defined as the peak intensity interval 
training session. The volume of this session was calculated, in addition to the number of 
days from competition. Taper duration represented the number of days prior to competition 
that athletes began to modify training load from RT.  
3.2.4 Training Diaries and Analysis 
As part of previous research investigating energy balance and hydration status in elite 
Kenyan athletes, information was gathered on training practice 1 week prior to the 2004 
Kenyan Olympic trials and the 2005 Kenyan World Championship trials (Fudge et al., 
2006; Fudge et al., 2008). The participants included Kenyan athletes (mean ± SD: age 20.1 
± 1.8 y) competing in 3,000 m SC, 5,000 m or 10,000 m. Personal best times in 2004 and 
2005 were within 1-7% and 1-8%, of the Kenyan records in 2012 respectively (Table 4.2). 
Information was provided on frequency and duration (min) of continuous running and 
frequency of interval running, in addition to volume (km) and duration (s) of repetitions 
completed. The mean speed of each participant’s personal best race performance was 
calculated. The mean speed of each interval training session was determined from volume 
divided by duration for each repetition completed and recorded as a percentage of race 
speed. Training data in preparation for the races in 2004 and 2005 were pooled for further 
analysis, with 2 runners providing data from both years.  
3.2.5 Statistical Analysis 
Data were analysed using SPSS (Statistical Package for Social Sciences Inc. v19.0;  
Chicago, IL, USA) and were initially tested for distribution using the Shapiro-Wilk test. 
Data are presented as mean ± SD or median (interquartile range). Statistical significance 
was accepted at P ≤ 0.05. 
Paired t-tests were used to compare self-reported training volume with GPS data and RT 
training variables with TT for each event group. One-way analysis of variance was used to 
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make event comparisons for TT variables, with Bonferroni post-hoc analysis. Pearson 
product moment correlation coefficient was used to assess the association between training 
in RT and in TT. Non-normally distributed data were analysed using the Wilcoxon signed-
rank test, the Kruskal-Wallis test with Bonferroni post-hoc analysis and Spearman’s 
correlation co-efficient. Multiple linear regression of RT training variables was used to 
predict taper duration and the proportion of RT training undertaken during TT for each 
variable. A correlation matrix (Table 3.3) was produced to determine RT predictors with 
the highest correlation with each TT dependant variable. Backward elimination was 
utilised as the method of entry in each regression analysis and the optimal model with a 
maximum of 3 predictor variables selected, due to the number of observations (n = 37).  
Normality of regression residuals was investigated by agreement of their frequency 
distributions with the superimposed normality curve. Homoscedasticity and linearity of the 
data was explored by plotting the standardised predicted values and the standardised 
residuals. Comparisons between British LD and Kenyan LD data were made using a one-
way MANOVA.  
Table 3.3. Correlation matrix of the associations between regular training (RT) and the 
proportion undertaken during tapering (TT) for all training variables (pooled data). 
    Tapered training  
Regular training  
Taper 
duration 
Continuous 
volume 
Interval 
volume 
Continuous 
frequency 
Interval 
frequency 
Continuous 
intensity 
Interval 
intensity 
Continuous volume 0.35* -0.70* 0.16 -0.39* 0.20 0.67* 0.42* 
Interval volume 0.31 0.09 -0.15 0.33* -0.08 0.37* 0.23 
Continuous 
frequency 
0.47* -0.70* 0.15 -0.63* 0.18 0.60* 0.20 
Interval frequency -0.36* 0.53* -0.35* 0.35* -0.41* -0.50* -0.29* 
Continuous 
intensity 
0.62* -0.41* 0.13 -0.22 0.05 0.97* 0.60* 
Interval intensity 0.31 -0.16 0.14 -0.12 0.15 0.69* 0.81* 
* P < 0.05 
3.3 Results  
3.3.1 Training  
Self-reported training data reported in the survey were cross-validated with GPS data for 
RT (volume: 129 ± 53 km vs. 132 ± 49 km; continuous intensity: 64 ± 10 vs. 64 ± 12% 
race speed; interval intensity: 99 ± 8 vs. 100 ± 7% race speed, respectively; all P > 0.05) 
and subsequently the self-report data were used for analysis. Differences between RT and 
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TT for volume, frequency and intensity of training confirmed the presence of a taper 
(Table 3.3). The MAR group reported a longer taper duration and a greater reduction in 
continuous running volume during TT than both MD and LD (all P < 0.05; Table 3.3). The 
proportion of RT interval running intensity during TT was greater in MD runners 
compared to MAR runners (P < 0.05; Table 3.4).  
3.3.2 Peak Intensity Interval Session during TT 
The interval training session that elicited the peak intensity during TT was completed at 
speeds exceeding personal best race speed in LD and MAR runners (112 (27)% and 114 
(3)%, respectively; both P < 0.05). The MD group did not elevate the speed of the peak 
intensity interval session above personal best race speed (100 (2)%). The MAR runners 
completed a higher volume of running during the peak intensity interval session than either 
MD or LD (5 (2) km vs. 2 (1) km and 2 (4) km; P < 0.05) and the session was further from 
competition (10 (7) d vs. 3 (2) d and 3 (2) d; P < 0.05). 
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Table 3.4. Training completed during regular training (RT) and tapered training (TT) for middle distance (MD: n = 18), long distance (LD: n = 
9) and marathon (MAR: n = 10) groups (male and female data combined). RT training volume is calculated as kilometres per week (km·wk
-1
), 
frequency as runs per week (run·wk
-1
) and intensity as a percentage of personal best race speed (%RS). For TT, all values are calculated as a 
percentage of the corresponding RT variable. Statistical comparisons between cohorts performed on the TT percentage data. Data presented as 
median (interquartile range). 
Training Variables 
M D L D MAR 
RT TT RT TT RT TT 
Taper duration (d) - 6 (3)
†
 - 6 (1)
†
 - 14 (8) 
Training volume (RT; km·wk
-1
, TT; %RT)  
           Continuous running  64 (41) 70 (16)*
†
 101 (60) 71 (24)*
†
 158 (40) 53 (12)* 
     Interval running  9 (5) 53 (45)* 13 (3) 67 (23)* 10 (4) 64 (34)* 
Training frequency (RT; run·wk
-1
, TT; %RT) 
           Continuous running  7 (2) 85 (33)* 9 (3) 88 (24)*
†
 11 (1) 73 (14)* 
     Interval running  3 (1) 100 (50) 2 (2) 100 (25) 1 (0) 100 (14) 
Training intensity (RT; %RS, TT; %RT) 
           Continuous running  60 (6) 96 (5)* 72 (6) 96 (6)* 84 (8) 97 (9)* 
     Interval running 96 (9) 104 (7)*
†
 108 (14) 100 (1) 110 (9) 99 (7) 
*different to RT (P ≤ 0.05), †different to MAR group (P ≤ 0.01)  
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3.3.3 RT and TT Relationships  
Higher weekly RT continuous running volumes and frequencies were associated with a 
greater reduction in continuous running volume during TT (both R = -0.70; P < 0.05; 
Figures: 3.1A, 3.1B). Similarly, there was a greater reduction in training frequency during 
the TT period when there was a high frequency of continuous running (R = -0.63; P < 0.05; 
Figure 3.1C) and interval training during RT (R = -0.41; P < 0.05). When expressed as a 
percentage of race speed, the intensity for both continuous and interval training during RT 
was positively associated with intensity during TT (continuous intensity: R
 
= 0.97 and 
interval intensity: R = 0.81; both P < 0.05; Figures: 3.1D, 3.1E). Taper duration was longer 
when the intensity of continuous running was a greater percentage of race speed (R = 0.62; 
P <0.05; Figure 3.1F). Based on these data, prediction models for taper duration and taper 
training load variables were created from the pooled data (Table 3.5). Regression residuals 
were normally distributed for all models presented, however heteroscedasticity was 
evident for the model predicting interval volume. The algorithms generated had strong 
correlations to TT variables and the highest prediction accuracy was demonstrated for the 
continuous intensity prediction model. 
3.3.4 British vs. Kenyan Comparison 
In both groups, peak interval intensity was significantly higher than race speed (P < 0.05; 
Table 3.5), but not different between groups (P = 0.26). The volume of the peak session 
was higher in Kenyan runners compared to British runners (P < 0.05; Table 3.6). The 
proximity of the peak interval intensity session to competition was not different for British 
and Kenyan runners. 
Frequency and total duration of continuous running was lower in Kenyan runners 
compared to British runners (5 ± 2 runs∙wk-1 and 246 ± 62 min vs. 7 ± 2 runs∙wk-1 and 333 
± 94 min, respectively; P < 0.05). Total interval frequency and interval volume were not 
different between British runners (2 ± 1 runs∙wk-1 and 11 ± 3 km∙wk-1) and Kenyan 
runners (2 ± 1 runs∙wk-1 and 9 ± 4 km∙wk-1). Average interval session intensity was higher 
in Kenyan runners compare to British runners (112 ± 4% vs. 105 ± 9%, respectively; P < 
0.05). 
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Figure 3.1. Associations between continuous running volume and frequency during the 
regular training phase (RT) and continuous running volume undertaken during the 
tapered training phase (TT) (expressed as a percentage of the RT phase) (A: R = -0.70; B: 
-0.70; P < 0.05) and between RT continuous running frequency and the proportion 
undertaken in TT (C: R = -0.63; P < 0.05). Associations between RT and TT for the 
intensity of interval running (D: R = 0.81; P < 0.05) and the intensity of continuous 
running (E: R = 0.97; P < 0.05), when expressed as a percentage of race speed. 
Association between continuous intensity in RT and taper duration (F: R = 0.62; P < 0.05). 
R = -0.70 
R = -0.70 
R = -0.63 
R = 0.81 
R = 0.97 
R = 0.62 
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Table 3.5. Prediction models for tapered training with regular training phase volume, frequency and intensity as predictors using pooled data.  
Tapered training 
variable 
Prediction models R
2
 SEE 
Taper duration Taper duration = 4.102 + (0.426*RT continuous intensity) + (-0.241*RT interval intensity)  0.54 3.4 
Continuous volume % of RT continuous volume in TT = 97.153 + (-0.106*RT continuous volume) + (-2.547*RT 
continuous frequency)  
0.53 10.1 
Interval volume % of RT interval volume in TT = 131.585 + (-0.238*RT continuous volume) + (-19.106*RT 
interval frequency)  
0.24 25.7 
Continuous frequency % of RT continuous frequency in TT = 130.800 + (0.211*RT continuous volume) + (1.059*RT 
interval volume) + (-10.016*RT continuous frequency) 
0.60 13.5 
Interval frequency No difference between RT and TT for any event group. Maintain RT interval frequency during TT - - 
Continuous intensity % of race speed in TT = -13.443 + (-0.070*RT continuous volume) + (0.946*RT continuous 
frequency) + (1.141*RT continuous intensity) 
0.95 2.9 
Interval intensity % of race speed in TT = 34.356 + (0.684*RT interval intensity) 0.66 4.4 
Key:  TT (tapered training), RT (regular training), RT predictors: taper duration (d), volume (weekly km), frequency (weekly training 
occurrences), intensity (% race speed). SEE (standard error of the estimate); taper duration (d), volume, frequency, intensity (%) 
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Table 3.6. Peak interval training intensity during the tapered training phase, volume of 
this interval session and proximity to competition for both Kenyan and British LD groups. 
 
*significantly different to personal best race speed (P ≤ 0.05), †significantly different to 
Kenyan athletes (P ≤ 0.05) 
3.4 Discussion 
To the author’s knowledge, the present study is the first to document the tapering strategies 
implemented by elite endurance runners in events from 800 m to marathon. The study also 
demonstrates for the first time that the volume, frequency and intensity of training 
undertaken during RT are indicative of the training characteristics of TT and that there are 
event-specific differences between tapering strategies. Furthermore, LD and MAR runners 
reported peak interval training intensity above race speed during TT, whereas MD runners 
trained at race speed. The main outcome of the present study is the development of 
algorithms which are capable of explaining a large proportion of the variance (53-95%) in 
tapering strategy training variables (with the exception of interval volume) for a given RT 
training load in endurance runners. This could provide a useful tool for coaches and 
athletes to aid tapering strategy design, based on the current practices of elite British 
athletes. 
 A meta-analysis of the effects of tapering on performance suggests that the optimal 
tapering strategy consists of a 41-60% reduction in training volume, whilst maintaining 
frequency and intensity for 2 weeks (Bosquet et al., 2007), whilst an insufficient reduction 
in training volume undermines the beneficial effects of a taper (Houmard et al., 1989; 
Neary et al., 2003). In contrast to the recommended common principles for tapering 
(Bosquet et al., 2007), our data suggest that despite general reductions in overall volume, 
tapering strategies are individualised, with the content based on the training undertaken in 
RT. For example, high RT weekly running volume was associated with a lower percentage 
of continuous running volume during TT, compared to athletes undertaking a low weekly 
running volume in RT. A possible explanation is that athletes undertaking a higher total 
running volume prior to the taper require a greater reduction in continuous volume during 
Group 
Peak interval training 
intensity (% personal 
best race speed) 
Volume of peak 
intensity interval 
session (km) 
Proximity to competition 
(d) 
Kenyan athletes  115 ± 4* 4.5 ± 1.4 3 ± 2 
British athletes 111 ± 13* 2.9 ± 2.0† 3 ± 1 
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this period in an attempt to alleviate an accumulated and chronic fatigue. This is supported 
by evidence that more superior performances in the careers of elite swimmers were 
achieved following an increase in training load leading up to the taper, and a sharp 
decrease in the taper period (Hellard et al., 2013). It has been suggested previously that the 
degree of fatigue prior to the taper might influence tapering strategy delivery (Bosquet et 
al., 2007), with greater fatigue requiring a longer taper in order to improve performance 
(Thomas & Busso, 2005; Thomas et al., 2008). This might explain why the MAR runners 
reported a longer taper and a greater reduction in continuous running volume during TT 
compared to MD and LD, potentially owing to greater residual fatigue at TT onset. It was 
also apparent that taper duration was extended when continuous running intensity was 
closer to race speed in RT, which was evident in the MAR group compared to LD and MD 
(84% vs. 72% and 60% of race speed, respectively). 
Evidence suggests that performance is not compromised after taper periods of up to 3 to 4 
weeks in endurance runners (Harber et al., 2004; Houmard et al., 1990; Mujika et al., 2000; 
Wittig et al., 1989), if intense training is included to maintain aerobic fitness (Luden et al., 
2010; McConell et al., 1993) and prevent a decline in performance. An increase in interval 
intensity from regular training during the taper appears to have profound positive effects 
on performance (Shepley et al., 1992). Consistent with this, all groups maintained (LD and 
MAR) or slightly increased (MD) the average intensity of interval training during TT 
compared to RT, and a strong positive association was evident between RT and TT for 
interval training intensity. Despite an increase in interval intensity compared to regular 
training, MD athletes did not run faster than race speed in the interval session that elicited 
the peak intensity during TT. In contrast, LD and MAR runners performed their peak 
intensity interval session above race speed (median: 112% and 114%, respectively). It is 
uncertain why MD athletes do not exceed race speed in the same way that other groups do 
during taper interval training. The volume of the peak intensity session was greater than 
race distance for the MD group, which may be a contributing factor to the absence of 
intensity above race speed. Furthermore, it may be that MD athletes complete intervals at a 
more race-specific speed in this session, in order to practice race pacing prior to 
competition. Moreover, 100% of race speed in middle distance events equates to higher 
absolute speeds than the same percentage of long distance event race speeds. Therefore, 
MD athletes could be reluctant to execute training close to competition at the absolute 
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speeds of 112-114% of race speed similar to LD and MAR runners, for fear of potential 
increased injury risk.  
The present study confirmed that both British and Kenyan LD runners performed the peak 
intensity interval session before competition at speeds above race pace, this session was 
completed the same number of days before competition and the total interval session 
frequency and volume was not different between nations during this period. However, the 
volume of the peak intensity session was higher in Kenyan runners with the frequency and 
total duration of continuous running being lower compared to British runners. 
Since no difference was found between Kenyan and British long distance runners, it can be 
speculated that completing the peak intensity interval session above race speed in the final 
days of the taper is common practice among elite athletes in this event group. A question 
remains as to whether this strategy would be beneficial to middle distance runners. 
Conceptually, it is possible that a single training session performed faster than race speed 
in the final days of the taper could better prepare the athlete for performance on race-day. 
Considering insight from the Variable Dose-Response Model (Busso, 2003), the peak 
interval intensity during TT may be completed at intensities above race speed because the 
athlete is more fully recovered from previous overload and has greater capacity to respond 
effectively to training during the taper, without significant additional fatigue (Mujika, et al., 
2004). In support, computer simulations displayed a positive effect on performance when 
training load was increased in the final days of the taper (Thomas et al., 2009). This may 
increase confidence and perceptually, race speed could feel more comfortable, having run 
much faster in the days before. Acute physiological responses following intensified 
training during a taper are evident, including increased buffering capacity (Houmard et al., 
1994), increases in oxidative enzyme activity, red blood cell volume and muscle glycogen 
(Shepley et al., 1992). However, it is unknown whether a single profound increase in 
training intensity in the final 3 days of the taper would result in such adaptation and 
improve subsequent running performance in middle-distance runners, when incorporated 
into existing tapering strategies.  
An additional aspect to consider is whether British runners should implement a greater 
reduction in continuous running volume and frequency and complete a greater volume in 
the peak intensity interval session. Kenyan runners reported a higher volume for the peak 
intensity session compared to British runners, despite no difference between nations for the 
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relative intensity of the session. This might be explained by the lower volume and 
frequency of continuous running in Kenyan athletes in the final week before competition, 
which translates into greater recovery time between training sessions than in British 
runners. It can be speculated therefore, that Kenyan athletes are able to cope with a greater 
training volume in the peak session and also a higher average intensity of interval running 
over the 7-d period before competition. 
The current British data allowed the formation of equations that linked tapering strategy to 
RT load. Taper duration, in addition to taper training volume, frequency and intensity, can 
be established based on predetermined RT load characteristics, with particularly good 
accuracy for most models. Variance is limited for interval volume (SEE: 25.7%), although 
the validity of this prediction model can be questioned since the assumption of 
homoscedasticity of residuals was violated. The size of the error term differed across 
values from the independent variable of interval volume and standard error may be biased. 
For this variable, the average value reported by British athletes in the applicable event 
group should be implemented. 
As an example, if the RT continuous running of a 1,500 m athlete consists of a frequency 
of eight runs, totalling 70 km of volume at 60% mean 1,500 m race speed, the current 
work would predict that their respective TT continuous running would be comprised of 69% 
RT volume (48 km), 76% RT frequency (6 runs) at 58% mean 1,500 m race speed. If the 
interval training in RT of the athlete consists of 3 sessions, totalling 10 km volume at 90% 
mean 1,500 m race speed, their respective interval training in TT would be predicted as 53% 
RT volume (5.3 km), 100% RT frequency (3 sessions) at 96% mean 1,500 m race speed. 
For the given RT training load, our data would predict a taper duration of 8 d. 
Although the practices of elite athletes are mimicked throughout sport, it is not clear 
whether the current strategies of these runners are optimal for performance. It is possible 
however, that the reported practices have been refined through trial and error over many 
years of competition in the sport. Further research is required to investigate the influence 
of RT training load on tapering strategy and subsequent performance in order to fully 
validate the algorithms. For the elite athlete who is travelling to international competition, 
it is not always possible to follow a prescriptive regimen due to exposure to heat or altitude 
during the taper or long-haul travel, and it might be necessary therefore to adapt the taper 
to the specific circumstances (Pyne et al., 2009). The algorithms should be implemented 
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with caution however, since only previous training is considered in prescribing the taper 
and there is the assumption therefore, that physiological rate of recovery for a given 
training load is similar among individuals. In addition, outliers were evident in the 
associations between RT and TT, most notably between continuous intensity in RT and 
taper duration. 
3.5 Conclusion 
The present data suggest that training undertaken in RT is correlated with the TT strategy. 
From an applied perspective, it may not be optimal to implement a standardised taper 
before every major competition, since athletes may not always approach competition 
having completed the same training load, although performance data is required to support 
this notion. It is clear that British LD and MAR runners increase interval intensity above 
race speed in the final days of the taper, as do Kenyan LD runners, but the possibility of a 
performance benefit from this strategy warrants further investigation. In particular in MD 
runners, for whom this strategy is not current practice. 
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Chapter IV 
The Effects of a Higher Intensity Training Bout during Tapering in 
Middle-Distance Runners 
4.0 Chapter Summary 
In chapter III, middle-distance runners did not report training at an intensity above race 
speed during the taper. This chapter examined the influence of an increase in intensity in 
the final interval session within a tapering strategy on middle-distance running 
performance and physiological responses in well-trained runners. Ten runners completed 2 
conditions, each involving a 7-d period of regular training and a 7-d period of tapering, 
separated by 3 weeks of regular training. In first condition, the taper was prescribed using 
the algorithm developed in chapter III, where interval intensity was equal to 1,500 m race 
speed (RP). In the other, the final interval training session was completed at 115% of 1,500 
m race speed (HI). Performance assessments, including a 1,500 m treadmill time trial were 
completed before and after the regular training period and after the tapering period. 
Venous blood samples were collected on 8 occasions in each condition for the 
measurement of plasma IL-6, sIL-6R, CRP, T and C concentration. 1,500 m time trial 
performance was faster after the RP taper compared to pre-taper (3.4%; 288 ± 19 s vs. 298 
± 19 s; P < 0.05; ES = 0.53), but the effects of the HI taper were unclear (1.4%; 292 ± 19 s 
vs. 296 ± 18 s; P = 0.53; ES = 0.22). The data suggested that a tapering strategy prescribed 
based on current practices of elite middle-distance runners was most likely to improve 
performance, whereas the same strategy with an increase in intensity is not recommended. 
The potential biomarkers of plasma IL-6, sIL-6R, CRP, and the T:C ratio were not 
sensitive enough to indicate changes in recovery and performance across a 7-d period of 
tapering. 
4.1 Introduction 
The inclusion of high intensity training during the taper appears to be the key to improving 
performance (Houmard et al., 1994; Shepley et al., 1992). In combination with a large 
reduction in training volume, high intensity training during the taper has led to amplified 
physiological responses including; increased buffering capacity (Houmard et al., 1994), 
increases in oxidative enzyme activity, red blood cell volume and muscle glycogen content 
(Shepley et al., 1992) in endurance runners. In practice, elite Kenyan 3,000 m steeplechase, 
5,000 m and 10,000 m runners performed their final interval sessions within the last 3 d of 
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the taper at an average running speed significantly above race pace (15 ± 4%), when 
preparing for the 2004 Olympic trials and 2005 World Championship trials (chapter III). 
On collating this data in elite British endurance runners, it became clear that long-distance 
and marathon runners also train at intensities above race speed within the final days of the 
taper period before competition, but this was not evident in middle-distance runners. 
Theoretically, an interval session completed at intensities above race speed late in the taper 
when the athlete is more fully recovered, might allow greater capacity to respond 
effectively to this type of training stimulus and further improve subsequent performance 
(Busso, 2003; Mujika, et al., 2004). In support, theoretical models have shown that a 
moderate increase in training load at the end of taper might further improve performance 
as the athlete can capitalise on additional adaptation, after initially overcoming 
accumulated fatigue from previous training (Thomas et al., 2009). Despite evidence of this 
practice in long-distance and marathon runners, it is not clear whether it would be of 
benefit to the performance of middle-distance runners. 
It is possible that individual athletes recover at different rates during the taper and it would 
be beneficial therefore, for coaches and athletes to have an objective measure of their 
readiness for competition. This would allow further refinement of training load during the 
taper, if deemed necessary. In the elite population it is not feasible to employ the invasive 
procedures such as muscle biopsies, necessary to monitor a number of the physiological 
changes associated with the taper, so any such biomarker would need to be minimally 
invasive, with rapid sample analysis to allow prompt feedback. The longitudinal 
monitoring of variations in inflammatory cytokines; IL-6, sIL-6R, CRP, and the T:C ratio 
might be indicative of training stress and energy homeostasis throughout different phases 
of training (Adlercreutz et al., 1986; Jürimäe et al., 2011, Robson-Ansley et al., 2007), 
although their sensitivity to detect taper effectiveness  in middle-distance runners requires 
investigation. 
The aims of the current study were: i) to investigate the effectiveness of an algorithm-
derived tapering strategy on 1,500 m time trial performance; and ii) to establish whether an 
increase in the intensity (115% race speed) of the final interval session during this tapering 
strategy can further enhance 1,500 time trial performance. Lastly, the aim was to explore 
potential biomarkers that might provide an objective indication of physiological readiness 
to perform. It was hypothesised that increasing the intensity of the final interval session to 
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115% of race speed will further improve post-taper performance in middle-distance 
runners. 
4.2 Methods 
4.2.1 Pilot Study  
Six well-trained male middle distance runners: (mean ± SD) age 21.4 ± 2.9 y, height 177.9 
± 7.7 cm, body mass 68.2 ± 2.8 kg, were recruited to test the reliability of 1,500 m time 
trial performance on an ‘on-response’ treadmill (MTC climb 2000, Runner, Italy). 
Personal best 1,500 m time was 251.9 ± 14.0 s (range: 231.3 – 265.7 s). Treadmill sensors 
allow the detection of user position on the belt and control belt velocity in accordance with 
user position relative to these sensors. Distance from the sensor results in acceleration, 
deceleration or maintenance of a constant speed, thus allowing the controller to initiate an 
autonomous speed adjusting system. Participants underwent familiarisation to the lab 
environment, equipment and testing protocol at least 7 d prior to testing. A standardised 
warm up was performed, consisting of 10 min running at a speed equivalent to 60% of 
individual personal best time for 1,500 m, followed  by 2 sets of 10 s at 90% and 20 s at 60%  
and a 1-min rest period (Wiles et al., 1992). After a rolling start of 30 s at 60% of personal 
best time, the participant completed a 1,500 m time trial at self-selected speed. The 
treadmill was set to a 1% gradient throughout the trial (Jones & Doust, 1996). Speed and 
time indicators were concealed from the subject, but distance remained visible. The 
treadmill time trial was performed in a fasted state on 2 separate occasions, 7 d apart, after 
controlling for physical activity and diet in the 24 h before. Individual participant data for 
time to complete each 1,500 m time trial are presented in Table 5.1. The mean CV for time 
to completion of the treadmill time trial was 0.9%, similar to the variation reported for 
1,500 m track time trial performance (0.8%) in well-trained runners (Hodges et al., 2006). 
Given that performance measures require a CV similar to, or less than the typical variation 
in competitive performance (~1% in middle-distance runners) in order to detect the 
smallest worthwhile change (Hopkins, 2005), the ‘on response’ treadmill time trial was 
considered sensitive enough for use in the main experimental trials. 
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Table 4.1. Time to complete (s) 2 repeated 1,500 m time trials on an ‘on-response’ 
treadmill. 
Participant 1 2 3 4 5 6 Mean SD 
Trial 1 265.4 281.9 267.0 265.2 287.2 321.0 281.3 21.6 
Trial 2 259.8 292.7 266.4 263.5 287.3 323.5 282.2 24.3 
Mean 262.6 287.3 266.7 264.4 287.3 322.3 281.7 22.8 
SD 4.0 7.6 0.4 1.2 0.1 1.8 
  
CV (%) 1.5 2.7 0.2 0.5 0.0 0.5 0.9 
 
 
4.2.2 Participants 
A separate group of 10 well-trained male middle distance runners: age 21.7 ± 3.0 y, height 
182.9 ± 7.0 cm, body mass 73.4 ± 6.8 kg, volunteered to take part in the main experimental 
trials. This group included 2 participants who also completed the pilot study. Inclusion 
criteria specified that participants were competitive middle distance runners (800 m & 
1,500 m) with a training history of at least 2 years and had trained consistently without 
interruption for the previous 2 months. Personal best 1,500 m time was 257.5 ± 26.9 s 
(range: 231.3 – 316.7 s).  
4.2.3 Experimental Design  
The study employed a repeated-measures cross-over design. Each of the 2 conditions 
involved a 7-d period of regular training (control) and a 7-d period of tapering (Figure 4.1). 
Conditions were separated by at least 3 weeks of regular training. Performance 
assessments were carried out on the day before the control period (day 1: baseline), on the 
day after the control period (day 9: post-control) and on the day after the taper period (day 
17: post-taper). This structure was completed for both conditions, with 6 separate 
performance trials in total. At least 1 week prior to the first condition, participants became 
accustomed to the laboratory environment, equipment and testing protocol, including 
completion of the performance measures. Participants were not informed about the precise 
differences between the conditions, but could not be blinded to the manipulation of 
training load. 
Training during the control period was determined by the participant and recorded 
objectively from their own GPS data. Participants were instructed to replicate the training 
performed in the control period of the first condition in the control week of the second 
condition. Training was categorised into continuous or interval running (described 
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previously: chapter 3.2.1) and quantified for mean weekly volume (km), frequency and 
intensity (% personal best 1,500 m race speed). During the taper period in the race-pace 
condition (RP), participants completed individualised training prescribed by the algorithms 
that were developed in chapter III, whereby the speed of the final interval session 
(described below in 4.2.4) was equivalent to the average speed of season’s best 1,500 m 
time. In the high intensity condition (HI), training during the taper period was the same as 
RP, except the final interval session was performed at 115% of the speed in RP. Training 
load was confirmed throughout all periods using GPS data. 
As an example, if continuous running in the control period consisted of a frequency of 
eight runs, totalling 70 km of volume at 60% mean 1,500 m race speed, the algorithms 
would predict that continuous running during the taper period would consisted of 69% 
volume (48 km), 76% frequency (6 runs) at 58% mean 1,500 m race speed. If the interval 
training in the control period consisted of 3 sessions, totalling 10 km volume at 90% mean 
1,500 m race speed, interval training during the taper would be predicted as 53% volume 
(5.3 km), 100% frequency (3 sessions) at 96% mean 1,500 m race speed. The 3
rd
 and final 
interval session during the taper period would be completed at 100% race speed in RP and 
115% race speed in HI. 
 
Figure 4.1. Experimental design illustrated by 2 experimental conditions, separated by at 
least 3 weeks of regular training. Arrows represent performance assessments and asterisk 
indicates laboratory interval session. 
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4.2.4 Laboratory Interval Session within Taper Period 
A controlled interval running session was completed on a motorised treadmill (Woodway, 
Germany) on day 14, 3 d prior to the final performance test. Participants arrived at the 
laboratory between 0700 h and 0900 h in a fasted state. A standardised warm up was 
performed, as described above (Wiles et al., 1992). This was followed by a series of 300 m 
interval repetitions with 90 s recovery. The individualised number of repetitions was 
dependent upon interval volume calculated from the algorithm (chapter III). Intensity of 
the effort was equivalent to season’s best 1,500 m race speed in the RP condition and 115% 
of season’s best 1,500 m race speed in the HI condition. Heart rate was recorded in the 5 s 
of each repetition and participants indicated their RPE (appendix C) immediately after 
each repetition. A cool down of 10 min running at a speed equivalent to 60% of 1,500 m 
personal best race speed was performed after completion of the session.  
4.2.5 Performance Assessment 
Participants arrived at the laboratory in a fasted state between 0700 h and 0900 h on days 1, 
9 and 17 of each condition. On arrival, body mass and height were recorded (described 
previously: chapter 2.2.2). Participants provided a venous blood sample (described 
previously: chapter 2.2.4), which was followed by assessments of muscle function. After a 
30 min rest period, a 1,500 m treadmill time trial was completed. 
4.2.5.1 Force Measurement 
Participants were strapped into a custom built isometric strength rig, in a seated position in 
order to measure peak isometric voluntary knee extension (MVC) force. Knee angle was 
fixed at 60° flexion, using the centre of the knee joint as the fulcrum in relation to the 
greater trochanter at the top of the femur and the lateral malleolus in the ankle. The ankle 
brace was adjusted to 1 cm above the lateral malleolus on the right tibia. Participants 
placed their hands across their chest to further isolate the quadriceps contraction 
measurement and minimise contribution of the upper body. Eight sub-maximal 
contractions at intensities relative to perceived maximal force were performed as a warm-
up (3x 25%, 2x 50%, 2x 75% and 1x 90%), followed by a series of 3-4 maximum 
contractions of ~3-5 seconds duration. A rest period of 30 s was enforced between 
contractions. Contraction force was displayed in real time on a computer monitor 
positioned in front of the participant in order to give feedback. Force was recorded using a 
calibrated S-beam strain gauge (0–1,500 N linear range; Force Logic, Swallowfield, UK) 
78 
 
strapped to the distal region of the tibia. Force data were sampled and recorded at 5,000 Hz 
using an external A/D converter (Micro 1401, CED, Cambridge, UK) and a PC utilising 
Spike 2 software (CED, Cambridge, UK). Force data were low pass-filtered at 500 Hz (4
th
 
order Butterworth digital filter) and notch filtered at 50 Hz (infinite impulse response 
digital filter [q-factor of 50]) to remove mains frequency noise and the peak force was used 
in data analysis. In the same position, explosive isometric voluntary knee extensor 
contractions were then performed to measure rate of force development (RFD). 
Approximately 10 attempts at explosive contractions of ~1 s duration were required. 
Participants were instructed to develop force as “fast and hard” as possible from rest.  
Approximately 20 s rest was taken between contractions. Only the explosive contractions 
that exceeded 80% of peak knee extensor force, and were performed without 
countermovement or pre-tension (<0.5 N deviation from baseline) were considered for 
analysis. Of those contractions, the 3 displaying the highest peak rate of force development 
were selected for further analysis, and the results averaged across these 3 contractions. 
RFD was assessed by measuring force at 50, 100 and 150 ms following force onset (F50, 
F100 and F150, respectively. Onset was defined as the last peak or trough before force 
exceeded the limits of the noise during the preceding 500 ms (Tillin et al., 2010). This 
systematic, manual identification of force onset has been shown to be both highly accurate 
(Allison 2003; Tillin et al. 2013) and reliable (Buckthorpe et al. 2012; Tillin et al. 2013). 
4.2.5.2 1,500 m Performance Assessment  
A 1,500 m treadmill time trial was completed after a standardised warm up (described 
above, Wiles, et al., 1992) on an ‘on-response’ treadmill (MTC climb 2000, Runner, Italy). 
After a rolling start of 30 s at 60% of personal best 1,500 speed, participants completed a 
1,500 m time trial at self-selected speed. The treadmill was set to a 1% gradient throughout 
the trial (Jones & Doust, 1996). Speed and time indicators were concealed, but distance 
remained visible to participants. Heart rate was monitored at 30 s intervals. Participants did 
not receive any verbal encouragement or performance feedback. 
4.2.6 Dietary Intake and Physical Activity Level 
Dietary intake and physical activity were monitored throughout both conditions to assess 
consistency between control and taper and between RP and HI. Subjects were instructed to 
eat and drink ad libitum during the control and tapering period of each condition and to 
weigh all food and fluid consumed using scales (Salter Arc, Kent, UK). Dietary intake was 
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recorded in a food record diary (appendix G). Total energy intake and carbohydrate intake 
was calculated for each condition using nutritional analysis software (CompEat Pro 5.8.0, 
Grantham, UK). 
Physical activity was monitored using ActiGraph GT3X+ triaxial accelerometer 
(ActiGraph, Pensacola, FL) during the control and taper periods of both HI and RP. 
Sampling frequency was set at 60 Hz, analysed in 60 s epochs. Devices were fitted at the 
midline of the right anterior hip and a total of 6 monitors were used throughout the study. 
Inter-unit reliability has been found to be acceptable (Santos-Lozano et al., 2012) but each 
participant wore the same accelerometer during all wear period to further reduce inter-
device variability. Participants were instructed to wear the device each day from waking 
until sleep; removing for water-based activities such as bathing or swimming (appendix H). 
Days with fewer than 600 min of wear time data were classified as invalid and not 
included in the analysis. Non-wear time was defined as continuous runs of zeros lasting ≥ 
60 min, with no allowance for counts greater than zero. Cut-points (counts per minute) to 
classify sedentary, light and moderate to vigorous physical activity (MVPA) were 0 - 99, 
100 - 1951 and 1952 - 9498, respectively (Freedson et al., 1998). Overall levels of physical 
activity were calculated using total average counts per minute for the control and taper 
periods in RP and HI. Time spent in sedentary, light and MVPA was calculated as a 
percentage of total wear time for the control and taper periods in RP and HI. Mean energy 
expenditure (calories per hour of wear time) was estimated from physical activity in the 
control and taper periods of both RP and HI. 
4.2.7 Blood Sampling 
In addition to days 1, 9 and 17, participants arrived at the laboratory in a fasted state to 
provide a venous blood sample on days 3, 7, 11, 14 and 15.  
After the treadmill time trials and controlled laboratory interval session, capillary blood 
samples were obtained from the fingertip using an automated lancet at 0 min, 1 min and 2 
min post-completion. An end-to-end capillary tube was used to collect 20 µl of blood for 
each sample. The tube was transferred into an eppendorf prefilled with 1 ml of haemolysis 
solution, inverted and analysed for lactate using an automated analyser (Biosen C-Line, 
EKF Diagnostics, Barleben, Germany). 
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4.2.8 Blood Analysis 
Venous blood samples were analysed for plasma IL-6, sIL-6R, CRP, T and C 
concentration via sandwich ELISAs (appendix D). Although chapter II concluded that 
capillary blood sampling could be used in the field to quantify plasma IL-6 and sIL-6R, 
venous samples were taken in the current study to allow for the additional measurement of 
CRP, T and C, and for comparison with previous findings from the literature. 
4.2.9 Statistical Analysis 
Data were analysed using SPSS (Statistical Package for Social Sciences Inc. v22.0;  
Chicago, IL, USA) and were initially tested for distribution using the Shapiro-Wilk test. 
Data are presented as mean ± SD, unless specified otherwise. Statistical significance was 
accepted at P ≤ 0.05. 
Non-parametric tests were used where the data were not normally distributed, specifically 
energy intake in the final 3 d of the taper. Plasma IL-6 and CRP concentrations were log-
transformed and included in analysis for normal data. All other data were confirmed to be 
normally distributed. Data gathered at the laboratory interval sessions were compared 
using paired samples t-tests. Performance measures from day 1 and 9 were also compared 
using a paired-samples t-test to ensure no-learning effect was present. No differences were 
evident, so the mean of the results from day 1 and day 9 were calculated to represent a 
control performance (no taper). Performance measures data, dietary intake and physical 
activity data were analysed via a 2-way repeated-measures ANOVA, with Bonferroni post-
hoc analysis. Magnitude-based inferences about the true (population) effect of the RP taper 
and HI taper on 1,500 m running performance were calculated. The uncertainty in the 
effect was expressed as 90% confidence limits and as the likelihood that the true value of 
the effect represents substantial change; harm or benefit (Batterham & Hopkins, 2006). 
The smallest meaningful change in 1,500 m performance was assumed to be a reduction or 
increase in running time of 0.5% (Hopkins, 2005). Effect size (ES) was calculated and the 
magnitude was considered either trivial (0–0.19), small (0.20–0.49), medium (0.50–0.79) 
or large (≥ 0.80) (Cohen, 1992). To ensure accelerometer wear time was consistent across 
both trials, wear time was analysed using a 1-way repeated-measures ANOVA. Mean daily 
physical activity and carbohydrate intake from the final 3 d of the taper in RP and HI were 
compared using paired samples t-tests. Energy intake during this period was analysed 
using the Wilcoxon Signed Rank test. Plasma IL-6, sIL-6R, CRP concentrations and T:C 
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ratio were compared throughout RP and HI trials using a 1-way repeated measures 
ANOVA. Post-hoc analysis was carried out using the Bonferroni method, with adjustment 
for multiple comparisons.  
4.3 Results 
4.3.1 Training 
Training completed during control and taper periods in both conditions is presented in 
Table 4.2. Outcome variables of the laboratory interval session are presented in Table 4.3. 
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 Table 4.2. Volume, frequency and intensity of training in the control and taper periods (mean ± SD; n = 10). Warm up and cool down data is 
not shown. 
 RP HI 
Training Variables Control  Taper %Δ Control Taper %Δ 
Training volume 
  
    
Continuous running (km·wk
-1
) 45 ± 13 33 ± 9
*
 -26% 41 ± 15 30 ± 9
**
 -26% 
Interval running (km·wk
-1
) 10 ± 4 6 ± 2
*
 -39% 9 ± 4 6 ± 2
**
 -39% 
Training frequency 
  
    
Continuous running (run·wk
-1
)  4 ± 1 4 ± 0
*
 -16% 4 ± 1 4 ± 0
**
 -17% 
Interval running (run·wk
-1
)  2 ± 0 2 ± 0 0% 2 ± 1 2 ± 1 0% 
Training intensity 
  
    
Continuous running (% race speed) 61 ± 8 57 ± 9
*
 -6% 62 ± 8 62 ± 8
**
 -6% 
Interval running (% race speed) 89 ± 8 95 ± 5
*
 +7% 94 ± 8 98 ± 6
**
 +5% 
Laboratory interval session (% race speed) - 100 ± 0 - - 115 ± 0
†
 - 
* 
Different to RP control, 
** 
different to HI control, 
†
 different to RP taper, all P < 0.05. 
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Table 4.3. Average speed, heart rate, rate of perceived exertion (RPE) and peak lactate 
during the controlled laboratory interval session in the race-pace (RP) condition and in 
the high intensity condition (HI) (mean ± SD).  
 Variable RP HI 
Speed (km·h
-1
) 20.8 ± 1.8 23.9 ± 2.1* 
Volume (km) 2.7 ± 0.7 2.7 ± 0.7 
Heart rate (b.min
-1
)  169 ± 9 178 ± 7* 
RPE 14 ± 1 17 ± 1* 
Peak lactate (mmol·L
-1
) 3.8 ± 1.6 9.9 ± 3.4* 
* Different to RP, P < 0.05. 
4.3.2 1,500 m Performance Assessment  
There was a main effect of taper (control training vs. taper training) on 1,500 m time trial 
performance (P < 0.05). An interaction effect (P < 0.05) suggests that time trial 
performance responded differently to the RP and HI tapers. There was no difference in 
control performance time between RP and HI (P = 1.00), however, there was a 3.4% 
improvement in performance time after the RP taper compared to control (288 ± 19 s vs. 
298 ± 19 s; P < 0.05; Figure 4.2). Performance time after the taper in HI was not different 
to control (292 ± 19 s vs. 296 ± 18 s; P = 0.53). Individual responses to RP and HI 
conditions are shown in Figure 4.2. When considered relative to the smallest worthwhile 
change in performance, qualitative inference suggests that the tapering strategy in RP 
condition was most likely to be beneficial to 1,500 m time, whereas the HI condition was 
unclear (Table 4.4). Physiological responses to the 1,500 m time trial are shown in Table 
4.5. 
Table 4.4. Differences in pre- and post-taper 1500 m time trial performance improvements 
in the RP and HI conditions. 
Taper 
condition 
Mean improvement (s) and 
90% confidence limits  
Qualitative inference 
a
 Effect size 
RP 10.0; ± 1.6 Most likely beneficial 0.53 
HI 4.2; ± 12.0 Unclear 0.22 
a
 with reference to a smallest worthwhile change of 0.5%. 
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Figure 4.2. 1,500 m time trial performance after the control period and post-taper in the 
RP condition and in the HI condition. Individual times for each participant (P1-10) are 
represented by dashed lines and group mean ± SD by solid line. * Different to control (P < 
0.05). 
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Table 4.5. Pre and post-taper physiological responses to a 1,500 m time trial in the RP and HI conditions and results of the 2-way repeated 
measures ANOVA (mean ± SD; n = 10). 
 
RP HI P value 
Variable Pre-taper Post-taper Effect size Pre-taper Post-taper Effect size Strategy Condition Interaction 
Peak blood lactate (mmol·L
-1
) 
7.1 ± 3.1 10.1 ± 2.6 1.08 7.7 ± 2.4 9.3 ± 2.5 0.63 P < 0.05 NS NS 
Peak heart rate (bpm) 182 ± 7 184 ± 9 0.20 184 ± 8 183 ± 7 0.13 NS NS NS 
(Strategy: control vs. tapering; condition: RP vs. HI; NS: non-significant).  
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4.3.3 Force Measurement 
A main effect of tapering was evident for MVC force (P < 0.05) and for RFD (P < 0.05; 
Figure 4.3). There was a main effect of time on RFD (F50 vs. F100 vs. F150; P < 0.05). No 
interaction effect on MVC force was observed (RP: 722.3 ± 149.9 vs. 663.4 ± 153.1 N; 
+9%; ES = 0.39; HI: 721.7 ± 143.3 vs. 682.3 ± 130.2 N; +6%; ES = 0.29; P = 0.40), or a 
condition × time interaction effect for RFD (RP: ES = 0.54, 0.50, 0.56; HI: ES = 0.22, 
0.34, 0.22 for F50, F100, F150, respectively; P = 0.06). 
 
Figure 4.3. Explosive force production in the first 150 ms of explosive voluntary 
contractions, measured; pre-taper (filled diamonds) and post-taper (open squares) in RP 
and HI.  
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4.3.4 Energy Intake and Physical Activity  
Mean daily energy intake remained consistent throughout both conditions (RP: 2907 ± 419 
vs. 2812 ± 506 kcal; ES = 0.21; HI: 2815 ± 366 vs. 2728 ± 456 kcal; ES = 0.21; P > 0.05), 
as did carbohydrate consumption (RP: ES = 0.05; HI: ES = 0.09; P > 0.05). A main effect 
of tapering was evident (P < 0.05) when mean daily carbohydrate consumption was 
expressed relative to mean daily running volume (km), suggesting a daily carbohydrate 
excess during tapering compared to control, but without differences between conditions 
(RP: 1.1 ± 0.3 vs. 0.7 ± 0.2 g·kg bw·km
-1
; ES = 1.50; HI: 1.1 ± 0.4 vs. 0.7 ± 0.2 g·kg 
bw·km
-1
;
 
ES = 1.01; P > 0.05). There was no change in body mass throughout both 
conditions (RP: 71.9 ± 7.0 kg vs. 72.0 ± 6.9 kg; ES = 0.01; HI: 73.1 ± 6.5 kg vs. 72.9 ± 6.8 
kg; ES = 0.04; P > 0.05). 
Daily accelerometer wear time was consistent throughout both conditions and included 
training completed (RP: ES = 0.14; HI: ES = 0.33; P > 0.05). Daily physical activity 
(counts·min
-1
) was lower during tapering compared to the control period (main effect of 
tapering; P < 0.05). Time spent in MVPA was lower during tapering compared to control 
(main effect of tapering; -1.6%; P < 0.05). Time spent sedentary or in light physical 
activity was not different between strategies or conditions (all P > 0.05). Mean energy 
expenditure from physical activity was lower during tapering compared to control (main 
effect of tapering; -8 kcal; P < 0.05). 
In the last 3 d of the taper after the laboratory interval session, there were no differences in 
physical activity (counts·min
-1
: ES = 0.48; P = 0.57) or in time spent sedentary (ES = 0.10), 
in light (ES = 0.18), or in MVPA (ES = 0.25; all P > 0.05) between RP and HI. Mean daily 
energy intake was higher in HI compared to RP (+5%; 2704  ± 358 kcal vs. 2576 ± 447 
kcal respectively; ES = 0.32; P < 0.05), but mean daily carbohydrate intake was consistent 
in both conditions (ES = 0.18; P = 0.34). 
4.3.5 Blood Plasma Measurements 
No differences in the inflammatory markers IL-6, sIL-6R and CRP were evident at any 
time point across the control and tapering periods in either RP or HI. Mean values for the 
control and taper periods in RP and HI are shown in Table 4.6. In HI, the T:C ratio was 
higher on days 1 and 17 compared to day 7 (18 ± 5 and 18 ± 4 vs. 14 ± 3; P < 0.05) and 
higher on day 9 compared to day 3 (16 ± 3 vs. 15 ± 4; P < 0.05; Figure 4.4). No differences 
in T:C ratio were evident in the RP trial.  
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Table 4.6. Mean concentration of inflammatory markers; IL-6, sIL-6R and CRP, during 
the control and taper periods in the RP and HI conditions. 
Inflammatory 
Biomarker 
RP Condition  HI Condition  
Control Taper 
Effect 
Size Control Taper 
Effect 
Size 
IL-6 (pg·ml
-1
) 2.5 ± 3.1 3.1 ± 3.5 0.18 4.2 ± 5.1 5.1 ± 6.0 0.16 
sIL-6R (ng·ml
-1
) 34.1 ± 9.7 33.1 ± 9.2 0.11 30.7 ± 6.8 31.2 ± 7.2 0.07 
CRP  (µg·ml
-1
) 1.0 ± 1.2 0.6 ± 0.6 0.44 0.9 ± 0.9 1.1 ± 2.1 0.13 
 
 
Figure 4.4. Testosterone to cortisol ratio in the RP condition (solid line) and in the HI 
condition (dashed line) (Mean ± SD; shaded blocks: performance measures on days 1, 9 
and 17; open block: laboratory interval session). * Different to day 7 (P < 0.05), ** 
different to day 3 (P < 0.05). 
4.4 Discussion 
The main finding of the present study was that 1,500 m performance time improved by 3.4% 
after a race-pace tapering strategy, but contrary to the hypothesis, the effect of an increase 
in interval intensity above race speed on performance was unclear. 
Improvements of between 0.5-6.0% can be expected in response to a successful taper 
(Mujika & Padilla, 2003). The observed improvement in performance from the RP taper 
(3.4%) falls within this range and was most likely to have a positive effect on performance. 
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As suggested by 90% confidence limits, negative results were experienced by some 
athletes implementing the HI taper. The 1
st
, 6
th
 and 8
th
 fastest participants experienced a 
worsening in performance time after the HI condition, which also demonstrates that 
individual responses did not appear to be related to performance standard. Nevertheless, 
performance time after the HI strategy was improved in 6 out of 10 individuals in excess 
of the smallest worthwhile change in performance (0.5%) for competitive 1,500 m athletes 
(Hopkins, 2005) and in excess of the time between the 1
st
 and 4
th
 placed athletes (0.6%) 
and between the 3
rd
 and 8
th
 placed athletes (0.7%) in the men’s 1,500 m final at the 
London 2012 Olympic Games. The medium effect reported here from RP therefore, likely 
represents a large performance benefit. 
The higher intensity interval session within the final 3 d of the HI taper did not result in a 
further improvement in running performance compared to RP. Although a greater capacity 
to respond effectively to high intensity training during the taper has been suggested 
previously (Houmard et al., 1994; Mujika et al., 2004; Shepley et al., 1992), the 
conservative reduction in training volume resulting from the algorithms may not allow 
sufficient recovery to respond positively to the increased intensity of this session. The 
overall volume reduction was ~30%, which represents a comparatively small adjustment 
compared to other studies where volume is reduced by up to 90% and wholly dedicated to 
high intensity training (Houmard et al, 1994; Shepley et al., 1992). The algorithm-derived 
taper was not designed for manipulation of training intensity above race speed, therefore a 
concomitant decrease in volume might be necessary to enhance performance. 
Furthermore, the volume of the final interval session itself was greater than 1,500 m race 
distance (2.7 ± 0.7 km), due to tapered training being prescribed relative to regular training, 
which was uncontrolled prior to the study. Whilst this was the case for both conditions, a 
session of this volume completed faster than race speed may have exacerbated fatigue, 
with insufficient recovery time before the performance assessment. It is also possible that 
the lack of control over training load prior to the study may have contributed to the 
worsening in performance after HI in some individuals. It has been observed previously 
that deliberate overload/overreaching can result in greater performance super-
compensation compared to habitual training, providing that the training stress from 
overload does not exceed capacity to recover during the taper (Aubry et al., 2014; Le Meur 
et al., 2013). Only 1 week of control training data was collected for the algorithm taper 
prescription and this may not have been representative of the extent to which athletes were 
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undergoing habitual/sub-optimal or overloaded training prior to the study. The addition of 
a higher intensity interval session may have influenced capacity to recover during the taper 
in some individuals in HI if they were overreaching beforehand, particularly given the 
volume and intensity of this session. In the days after the final interval session, participants 
did not modify their overall physical activity or training in HI compared to RP. This 
suggests they did not spend more time resting to compensate for the increased training 
stress compared to RP. It may be that some athletes require longer to reach peak 
performance after the final interval session in HI, perhaps due to the additional training 
stress and in light of insufficient recovery. It was not possible however, to explore the 
amplitude of the performance rebound between the RP and HI strategies, since participants 
completed one performance assessment after each taper condition.  
Differences in the performance changes from each condition (RP vs. HI) cannot be 
explained by the measured physiological indices. However, there were several main effects 
of tapering (control vs. taper). Peak blood lactate after the performance trial increased in 
both conditions after tapering compared to control. This suggests that a greater 
contribution to energy production from glycolysis occurred after tapering and supports the 
important role of glycolytic metabolism in middle-distance running performance 
(Stellingwerff et al., 2011). A consistently reported physiological response to tapering is an 
increase in muscle glycogen concentration (Neary et al., 1992; Shepley et al., 1992) which 
may facilitate increased contribution from glycolysis and maximal performance capability 
(Houmard et al., 1994; Mujika et al., 2004). Although muscle glycogen was not measured 
in the current study, carbohydrate consumption remained consistent despite a reduction in 
overall physical activity and a lower proportion of time spent undertaking MVPA during 
the taper. It is possible therefore, that the participants in the current study might have 
experienced an increase in muscle glycogen. It has been suggested that during a period of 
heavy training before tapering, athletes have low muscle glycogen content, which is 
replenished over a 7-d taper, resulting in a 15% increase in muscle glycogen (Shepley et al., 
1992). Furthermore, a 7-d taper coupled with a high carbohydrate diet increased muscle 
glycogen concentration and was associated with elevated carbohydrate oxidation, RER 
values and blood lactate concentration during cycling to volitional exhaustion at 80% 
V̇O2max (Walker et al., 2000). In the present study, there was no change in carbohydrate 
consumption in the final 3 d of HI compared to RP, despite an increase in intensity of the 
final interval session. Since glycogen is the main energy source for high intensity exercise 
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(Hargreaves, 1996; Hermansen et al., 1967; Romjin et al., 1993; Stellingwerff et al., 2011) 
and there is evidence of muscle glycogen depletion in type II fibres after high intensity 
intermittent exercise (Gollnick et al., 1973), a more direct intervention to optimise 
carbohydrate consumption after the intensified interval session in HI might have 
influenced the performance outcome.  
A large difference in performance improvement after a high intensity taper (22%) and a 
low intensity taper (6%) has been shown previously (Shepley et al., 1992). These large 
differences in performance were paralleled by modest differences in peak blood lactate (7% 
and 10% respectively), and suggests that although substrate availability may contribute to 
improved performance after tapering, the cause is multifactorial. Conversely, athletes 
should also take care to match energy intake with the reduced energy expenditure 
consequential of a taper period, to avoid changes in body composition that might be 
detrimental to performance (Margaritis et al., 2003; Mujika et al. 2004). In the present 
study, energy intake and body mass was not different between the control and taper 
periods, although body composition was not measured. 
Peak isometric leg extension force and the rate of force development were improved after 
tapering, supporting previous research (Cavanaugh & Musch, 1989; Costill et al., 1985; 
Johns et al., 1992; Raglin et al., 1996). Improvements in peak force and absolute power of 
the single muscle fibre have also been observed alongside improvements in performance 
after tapering in endurance runners (Luden et al., 2010). These parameters have been 
shown to respond to the reduced training load during the taper, potentially due to 
attenuation in function during periods of intensive training rather than an improvement per 
se. The mechanisms suggested for this have included altered protein synthesis and shifts in 
fibre type, (Neary et al., 2003), particularly after longer tapers (Johns et al., 1992; Trappe 
et al., 2000). However, improvements in performance after tapering are likely influenced 
by many physiological factors, rather than muscular force and power in isolation. Similar 
beneficial changes to maximal voluntary isometric strength were reported in middle 
distance runners after tapering and after complete rest, however endurance performance 
capacity declined by 3% after the complete rest condition (Shepley et al., 1992). 
Although it has been suggested previously that certain cytokines could represent markers 
of training stress in athletes (Jürimäe et al., 2011; Robson-Ansley et al., 2007), the 
inflammatory markers IL-6, sIL-6R and CRP were not sensitive enough to indicate 
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changes in recovery and readiness to perform across a 7-d period of tapering in middle-
distance runners in the present study. Monitoring IL-6 in long distance and marathon 
runners may be more useful however, as it could be speculated that their heavier training 
loads (chapter IV) increase the likelihood of undertaking training sessions with low muscle 
glycogen availability, often through multiple training sessions in a day (Philp et al., 2012). 
IL-6 may therefore be indicative of muscle glycogen status more so in this group, as its 
release has been shown to be elevated in glycogen depleted states (Gleeson & Bishop, 
2000).  
It is not clear why there were also no changes in plasma concentrations of sIL-6R and CRP, 
as these markers have been shown to be elevated during heavy training (Robson-Ansley et 
al., 2009). However this could be related to the lack of influence of training and tapering 
on IL-6. Increases in IL-6 in response to exercise generate acute phase reactions, including 
the release of CRP. C-reactive protein has been shown to increase concentrations of sIL-
6R in vitro, by inducing receptor shedding from neutrophils (Chalaris et al., 2007; Jones et 
al., 1999). The lack of response suggests that these biomarkers are not sensitive to detect 
the subtle changes associated with performance enhancement of ~1%, which could be the 
difference between gold and 4
th
 position in major championships. 
Similarly, although it has been suggested previously that the tapering period might create a 
hormonal milieu favourable to anabolic processes (Mujika et al., 2002), the performance 
difference induced by tapering was not reflected by clear changes in the T:C ratio. This has 
been found previously in runners (Mujika et al., 2000) and swimmers (Flynn et al., 1994; 
Mujika et al., 1996), where improvements in performance after tapering were not 
accompanied by changes in the T:C ratio.  
As opposed to blood biomarkers, it might be more useful to monitor changes in muscle 
function to evaluate the effectiveness of the taper, given the improvements in peak 
isometric leg extension force and rate of force development evident in the present study, in 
addition to previous literature (Cavanaugh & Musch, 1989; Costill et al., 1985; Johns et al., 
1992; Shepley et al., 1992; Raglin et al., 1996). Whilst it may not be practical to utilise 
‘gold standard’ laboratory measurements, an alternative non-invasive, field-based measure 
such as counter movement jump (CMJ) in conjunction with session-RPE, may indicate 
readiness to perform in elite endurance athletes. After measuring these indices across the 
season, significantly higher CMJ scores and significantly lower session-RPE scores were 
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observed in the week before the season’s best performance time compared to the season’s 
worst performance time (Balsalobre-Fernazdez et al., 2014). These variables could be 
measured simply on a regular basis without interfering with an athlete’s training 
programme and may be sensitive enough to indicate athlete readiness to perform. 
4.5 Conclusion 
A 7-d taper prescribed using an algorithm based on the current practices of elite British 
middle-distance runners is most likely to improve performance. In contrast, the addition of 
intensity above race speed in the final interval session of this taper would not be 
recommended due to unclear effects on performance. The measured physiological indices 
could not explain the difference in performance, although it is possible that a greater 
reduction in training volume may be required during this strategy to facilitate a positive 
response to the increase in intensity and improve subsequent performance. The biomarkers; 
IL-6, sIL-6R, CRP, and T:C ratio do not appear to objectively indicate the physiological 
status for performance following a 7-d taper in middle-distance runners, although the 
monitoring of muscle function may offer an alternative.  
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Chapter V 
Case Study: Training and Tapering in an Elite Female Marathon 
Runner  
5.0 Chapter Summary 
The aim of this chapter was to explore the training and tapering strategy of an elite female 
marathon runner in preparation for a marathon race. In addition, to investigate whether 
plasma IL-6 and sIL-6R concentrations were indicative of recovery status for performance 
following a marathon taper. The athlete underwent a 16 week training program (including 
the taper) followed by 2 weeks of recovery post-race. The main findings were that training 
load in the specific preparation phase (weeks 7-13) was similar to other elite marathon 
runners and that the tapering strategy partly reflected the optimal approach suggested from 
the scientific literature and that of marathon runners in chapter III, although aspects of the 
taper predicted from the algorithm were somewhat different. Resting plasma IL-6 and sIL-
6R concentrations did not appear to be indicative of recovery during tapering for the 
marathon. 
5.1 Introduction 
Despite considerable scientific interest in the physiological determinants of marathon 
running performance, in particular the possibility of a sub 2 h marathon (Joyner et al., 
2011), few studies have characterised the training and tapering strategies of elite marathon 
runners. To the author’s knowledge, chapter III was also the first to comprehensively 
document the tapering strategies implemented by elite endurance runners in events ranging 
from 800 m to marathon. The primary aim of this case study therefore, was to assess 
whether the tapering strategy of an elite female marathon runner reflects the findings of 
chapter III and whether a scientific approach to training is implemented throughout 
preparation for a marathon race. 
It would still be of benefit to identify a minimally invasive biomarker of taper 
effectiveness and readiness to perform in elite athlete. It has been suggested previously 
that certain cytokines could represent markers of training stress in athletes (Jürimäe et al., 
2011; Robson-Ansley et al., 2007), although resting plasma IL-6 and sIL-6R 
concentrations were not sensitive enough to indicate changes in readiness to perform 
across a 7-d period of tapering in middle-distance runners in chapter IV. It is unknown 
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however, whether monitoring IL-6 and sIL-6R concentrations in marathon runners may be 
more informative.  
Interleukin-6 is produced in the working muscle during exercise (Ostrowski et al., 1998) 
and a large proportion of the increase can be explained by the duration of exercise (Fischer, 
2006). Furthermore, IL-6 release has been shown to be elevated in glycogen depleted 
states (Gleeson & Bishop, 2000; Steensberg et al., 2001). Taken together, this suggests that 
marathon runners may produce significant levels of IL-6 in heavy periods of training, due 
to a large volume of prolonged training close to marathon pace (chapter III), without 
adequate time for replenishment (Coyle & Coyle, 1993). For example, marathon pace can 
occur at a high fractional utilisation of V̇O2max (75-85%) in highly trained athletes (Jones, 
2006; Maughan & Leiper, 1983; Sjödin & Svedenhag, 1985) and muscle glycogen 
becomes the primary source of fuel for intensities exceeding ~75% V̇O2max (Hermansen et 
al., 1967; Romjin et al., 1993). The secondary aim was therefore, to determine if plasma 
IL-6 and sIL-6R concentrations were elevated at rest in an elite marathon runner and 
whether changes during the taper may be indicative of readiness to perform. 
5.2 Methods 
An elite female marathon runner (personal best: 2:30:56 h:min:s; height: 1.60 m; body 
mass: 47.3 kg; age: 35 y), with a training history of over 15 y, undertook a 16 week 
training program, targeting a competitive marathon in week 16, followed by 2 weeks of 
complete rest and a further 1 week of recovery training. The athlete trained under the 
supervision of their personal coach and followed their own individual training programme, 
which was not influenced by the case study. 
5.2.1 Training 
All running during the 19 week period was recorded objectively from the participant’s own 
GPS device. Training mesocycles outlined by the personal coach included the general 
preparation phase (weeks 1-6), specific preparation phase (weeks 7-13) and taper (weeks 
14-16). During weeks 5-8 the athlete undertook an altitude sojourn to Iten, Kenya, to train 
at ~2,400 m above sea level. In week 11, the athlete competed in an International half 
marathon race (performance time; 1:14:20 h:min:s).  
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5.2.2 Training Analysis 
Training was categorised into continuous or interval running (described previously: 
chapter 3.2.1) and quantified for mean weekly volume (km), frequency and intensity (% 
personal best marathon race speed and in relation to personal best 10 km speed). The 
session that elicited the highest average speed during the taper was defined as the peak 
intensity interval training session. The volume of this session was also calculated, in 
addition to the number of days from the marathon race. Mean weekly volume, frequency 
and intensity for both continuous and interval running were entered into the algorithm 
(chapter III) for comparison. 
5.2.3 Blood Sampling and Analysis 
The athlete reported to the laboratory between 0730 h and 0830 h following a 10 h 
overnight fast on days; 1, 5, 10, 15, and 17 of the 3 week taper and 22 d after the marathon. 
After being seated in a semi-supine position, a resting venous blood sample was collected 
by venepuncture (described previously: chapter 2.2.4). Plasma IL-6 and sIL-6R 
concentrations were determined using commercially available ELISA kits (R&D Systems, 
Inc., Mineappolis, USA, supplied by Bio-Techne, Abingdon, UK) with the aid of a plate 
reader (Optica, Mikura, West Sussex, UK).  
5.3 Results 
Performance time was 2:31:46 h:min:s in the 4
th
 marathon of the athlete’s career, 50 s 
slower than personal best performance time. 
Training data in the 16 week programme prior to the marathon were based on 180 sessions, 
at a frequency of 11 ± 1 sessions per week. Highest weekly training volume was 182 km in 
the final week of the specific preparation phase, compared to 121 km in race week which 
included the marathon itself. Average weekly volume, frequency and intensity of both 
continuous and interval running during each mesocycle are shown in Table 5.1, in addition 
to a predicted taper using the algorithm (chapter III). Further non-running training such as 
strength training, drills and stability work was completed twice per week, but not included 
in the analysis. In the recovery training week after 2 weeks of complete rest, the athlete 
completed a total of 52 km of continuous running during 5 training sessions, at an intensity 
of 82 ± 2% of race speed. 
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Table 5.1. Training load during each mesocycle in the 16 week marathon programme (not including the marathon race) and prediction of the 
taper using the algorithm (chapter III). 
Training Load Variables 
General 
Preparation 
(weeks 1-6) 
Specific 
Preparation 
(weeks 7-13) 
%∆ from Specific Preparation 
Taper 
Week 14 
Taper 
Week 15 
Taper 
Week 16 
Algorithm 
(13 d taper) 
Training volume 
     
 
     Continuous running (km∙wk-1) 144 ± 1 164 ± 12 90 74 46 54 
     Interval running (km∙wk-1) 9 ± 5 4 ± 3 97 58 60 74 
Training frequency 
     
 
     Continuous running (run∙wk-1) 11 ± 1 10 ± 0 100 90 90 61 
     Interval running (run∙wk-1) 1 ± 1 1 ± 0 100 100 100 100 
Training intensity 
     
 
     Continuous running (% race speed) 84 ± 1 86 ± 3 102 101 100 96 
     Interval running (% race speed) 113 ± 3 115 ± 4 99 103 99 98 
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The peak intensity training session of the taper was completed 11 d before the marathon 
race at an average intensity of 115% race speed. The first section of the session was 6.4 km 
at 111% race speed, followed by 2 km of high intensity intervals at 119% race speed.  
Plasma IL-6 was 0.20 ± 0.07 pg·ml
-1
 during the taper (range: 0.12-0.29 pg·ml
-1
) vs. 0.43 
pg·ml
-1 
after 2 weeks of complete rest and 1 week of recovery training. Plasma sIL-6R was 
33.9 ± 2.9 pg·ml
-1 
during the taper (range: 30.8-37.3 pg·ml
-1
) vs. 30.3 pg·ml
-1
 after 2 
weeks of complete rest and one week of recovery training (Figure 5.1). 
 
Figure 5.1. Plasma IL-6 (filled circles) and sIL-6R (open squares) concentration during 
the pre-marathon taper phase and 22 d post-race. 
5.4 Discussion 
The purpose of this case study was to characterise the training and tapering strategy of an 
elite female marathon runner preparing for a marathon race and to explore the responses of 
plasma IL-6 and sIL-6R concentration to tapering and increased recovery. The main 
findings were that training load in the specific preparation phase was similar to other elite 
marathon runners and that the tapering strategy partly reflected the optimal approach 
suggested from the scientific literature and that of marathon runners in chapter III, 
although aspects of the algorithm taper were somewhat different. In addition, resting 
plasma IL-6 and sIL-6R concentrations did not appear to be indicative of recovery during 
tapering for the marathon. 
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5.4.1 Training 
Training volume during the specific preparation phase (mean: ~168 km∙wk-1) was 
comparable to that of elite French/Portuguese female marathon runners (Billat et al., 2001) 
and to that reported by other elite British marathon runners (chapter III). Elite female 
American marathon runners also reported a similar peak training volume in their build up 
to the U.S. Olympic Trials (180 km∙wk-1 vs. 182 km∙wk-1) (Karp, 2007). Training 
frequency of 10-12 sessions per week appears to be typical in elite female marathon 
runners completing such volumes (Billat et al., 2001; Karp, 2007; chapter III). Despite 
high training volumes however, elite marathon runners complete a relatively small 
proportion of training at specific marathon pace and most of their training volume at a 
slower pace. In this case, the mean percentage of training at marathon pace was 8%, with a 
very large proportion run at a slower pace (83%) and small proportions run at tempo pace 
(between marathon pace and 10 km pace, i.e. between lactate threshold and lactate 
turnpoint; Jones, 2006; Smith and Jones, 2001) (6%) and as high intensity intervals (faster 
than 10 km pace, i.e. > lactate turnpoint; Jones, 2006) (3%). A similar intensity 
distribution is described as a ‘polarised’ pattern (Seiler & Kjerland, 2006) and has been 
observed previously in elite marathon runners (Billat et al., 2001; Karp, 2007; 
Stellingwerff, 2012) and other Olympic-standard endurance athletes (Tønnesson et al., 
2014).  
5.4.2 Taper 
It has been suggested that the most effective tapering strategy to improve performance in 
competitive athletes consists of a reduction in training volume of 41-60%, whilst training 
frequency and intensity are maintained over a duration of ~2 weeks (Bosquet et al., 2007). 
The duration of the taper period in this case was ~3 weeks (20 d), 6 d longer than the 
median reported by other elite British marathon runners (14 d) and 7 d longer than the 
algorithm prediction. Since peak training volume occurred in the final week of the specific 
preparation phase (182 km∙wk-1) and was greater than the median reported prior to the 
taper in other British marathon runners, a longer taper might have been necessary to 
alleviate fatigue from previous overload and improve performance (Thomas & Busso, 
2005; Thomas et al., 2008). However, the first week of the taper for the current athlete 
involved only a 10% reduction in continuous volume and 3% reduction in interval volume 
and may not have contributed a great deal to recovery therefore. Nevertheless, positive 
physiological adaptations and/or performance improvements have been reported as a result 
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of tapering strategies lasting from 6 d to 4 weeks  (Houmard et al., 1990; McConell et al., 
1993; Mujika et al., 2002). Compared to the specific preparation phase, continuous 
running volume was progressively reduced during the taper, by 10% in the first week and 
by 26% and 54% in the second and third weeks of the taper, not including the marathon 
race itself. The average continuous volume reduction predicted from the algorithm taper 
was 46% over 13 d, compared to a 40% reduction over the last 13 d in the current case. 
Interval volume remained similar in the first week of the taper and was reduced by ~40% 
in week 2 and 3, more so than the algorithm predicted. Whilst there has been limited 
research exploring the optimal pattern to reduce training load, a systems model predicted 
that an exponential fast-decay pattern was the most effective at improving performance 
(Banister et al., 1999). In contrast to the current case, this pattern is characterised by a 
sharp decrease in training load early in the taper, followed by a levelling off closer to 
competition. A limitation to the algorithm is that it does not indicate the pattern to which 
training should be altered over the taper duration. Interval training frequency remained 
consistent throughout the taper, whilst continuous running frequency was reduced by one 
session per week (~10%) in taper weeks 2 and 3. Despite the general consensus that 
frequency should be maintained during the taper (Bosquet et al., 2007), a 10% reduction in 
this case is unlikely to have had a negative impact on performance (Mujika & Padilla, 
2003). The algorithm suggested a much larger continuous frequency reduction of 39% 
however, which would equate to 4 fewer runs per week. There was no substantial change 
in continuous or interval training intensity during the taper compared to the specific 
preparation phase, in agreement with the suggested scientific approach (Bosquet et al., 
2007) and with other elite marathon runners (Stellingwerff, 2012). It is unknown whether 
this was a deliberate practice by the athlete and coach or coincidental. A slight reduction in 
continuous (4%) and interval (2%) were predicted from the algorithm. The peak intensity 
training session of the taper was completed 11 d from the marathon race at an average 
intensity of 115% race speed, similar to other elite British marathon runners (chapter III). 
5.4.3 Inflammatory Markers 
It was expected that plasma IL-6 concentration would be highest on day 1 of the taper and 
exhibit a gradual reduction throughout the taper, particularly after peak training volume 
occurred in the final week of the specific preparation phase. The rationale was based on 
the finding that resting plasma IL-6 concentration was elevated in response to an acute 
period of intensified training in triathletes, which did not return to baseline after 1 week of 
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their regular training load (Robson-Ansley, 2007). After a longer period of intensified 
training in elite cyclists (8 weeks), the IL-6 response to a 40 km time trial was 113% 
greater than before the training period (Farhangimaleki et al., 2009). A 3 week tapering 
period where training volume was reduced by 50% was necessary to reverse the elevated 
IL-6 response. It is possible that the accumulation of training during intensified periods 
might lead to muscle glycogen depletion, a potent stimulus for IL-6 release (Steensberg, 
2000). This could also be exacerbated in marathon runners, who may consciously opt to 
train with low carbohydrate availability (Burke, 2010) or simply due to multiple training 
sessions in a day (Philp et al., 2012). In the current case however, resting plasma IL-6 
concentration remained similar throughout the taper and after 3 weeks of recovery. This 
supports the findings of Halson et al. (2003), who observed no change in resting plasma 
IL-6 concentration in response to periods of intensified and reduced cycling training. In 
addition, plasma IL-6 concentration was transiently elevated post-exercise during a 6-d 
endurance cycling event, but had returned to pre-exercise concentrations each following 
morning (Robson-Ansley et al., 2009). Although muscle glycogen and dietary intake were 
not measured in this case, it could be speculated that the athlete was not muscle glycogen 
depleted prior to the taper and therefore resting plasma IL-6 concentration was not 
chronically elevated. This could in part, be due to the large proportion of training volume 
in the specific phase (83%) that was completed slower than marathon pace and therefore 
muscle glycogen is unlikely to be the primary source of fuel at this intensity. In addition, 
strategies to train the gut to absorb more carbohydrate for exogenous oxidation 
(Jeukendrup, 2011) are common among marathon runners in the specific preparation phase 
(Stellingwerff, 2012) and may reduce reliance on muscle glycogen stores. Furthermore, 
trained athletes may exhibit an attenuated inflammatory response to exercise, compared to 
non-athletes (Gokale et al., 2007).  
Whilst elevated plasma IL-6 concentrations have been shown to be detrimental to athletic 
performance and heighten feelings of fatigue (Robson-Ansley et al., 2004), concentrations 
as low as ~5 pg·ml
-1 
have been associated with an increased perception of effort (Robson-
Ansley et al., 2007). The measured concentrations in the current case are considerably 
lower than this (0.20 pg·ml
-1 
vs. 5 pg·ml
-1
) and therefore unlikely to have negatively 
impacted performance. Elevated sIL-6R however, can increase sensitivity to IL-6 and 
concentrations were found to be persistently elevated at rest (~75 pg·ml
-1 
vs. ~50 pg·ml
-1
) 
and associated with feelings of fatigue in response to a 6-d endurance cycling event 
102 
 
(Robson-Ansley et al., 2009). In this case however, plasma sIL-6R was subtly different (~2 
pg·ml
-1
) from day 1 of the taper compared to day 17 of the taper. 
These findings confirm those of chapter IV and suggest that resting plasma IL-6 and sIL-
6R are not useful markers of recovery and readiness to perform during a 3 week taper in an 
elite marathon runner.  
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Chapter VI 
Influence of a Novel 7- Day Tapering Strategy on 1,500 m Track 
Performance and Pacing in Middle-Distance Runners 
6.0 Chapter Summary 
Chapter IV suggested that a greater reduction in training volume might be required when 
intensity of the final interval session is increased, to facilitate a positive response and 
improve subsequent performance. This chapter examined the influence of a 60% reduction 
in continuous running volume and an increase in intensity in the final interval session 
within a taper on 1,500 m track running performance and pacing strategy. Eight well-
trained middle-distance runners completed 2 conditions, each involving a 7-d period of 
tapering. In 1 condition, the taper was prescribed using the algorithm developed in chapter 
III, where continuous running volume was reduced by 28% and interval intensity was 
equal to 1,500 m race pace (RP). In the other condition, continuous running volume was 
reduced by 60% and intensity of the final interval training session was prescribed at 115% 
of 1,500 m race pace (HI). Conditions were separated by 3 weeks of regular training and 
1,500 m performance assessments were completed on an indoor 200 m track 1 day before 
and after each taper condition. Qualitative inference suggested that the tapering strategy in 
HI was very likely to be beneficial to 1,500 m time (259.0 ± 6.3 s vs. 253.8 ± 7.7 s) 
compared to likely beneficial in the RP condition (258.9 ± 7.4 s vs. 255.7 ± 8.7 s). After 
both RP and HI tapers, the first and second 300 m segments of the 1,500 m time trial were 
faster than pre-taper (both P < 0.05). It was recommended that pacing after a taper should 
be practiced to avoid an over-fast start. 
6.1 Introduction 
The inclusion of intense training during the taper is key to enhancing performance (Mujika, 
2010), however information regarding optimal practice in the final days of the taper is 
lacking (Tønnesson et al., 2014). In chapter III it was observed that long-distance runners 
train at intensities above race speed within the final days of the taper period before 
competition, which was not noted in middle-distance runners. This lead to an investigation 
on the influence of an increase in intensity (115% of race speed) in the final interval 
session of a taper on 1,500 m treadmill time trial performance in chapter IV. However, the 
effects on performance from this strategy were unclear and some athletes may experience a 
worsening in performance. In contrast, a strategy that was prescribed from the algorithms 
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based on the practices of elite middle-distance runners lowered performance time by 3.4% 
on a self-paced treadmill. Since the average training volume reduction in the high intensity 
strategy (~30%) was less than the recommendations from the literature (Bosquet et al., 
2007), it is possible that this was insufficient to overcome prior fatigue and respond 
positively to the more intense final interval session. In addition, the total volume of this 
session was greater than 1,500 m race distance itself and may have exacerbated fatigue. As 
a result, the potential augmented responses to the higher intensity session may have been 
prevented. There is a need therefore, to reassess this strategy with a further reduction in 
continuous volume and a lower final interval session volume. 
Whilst the taper is crucial to ensure athletes are ready to produce a peak performance, they 
must also be able to deliver this performance through optimal pace selection. It is thought 
that complex information processing between the brain and periphery regulates pacing, to 
avoid catastrophic failure in any physiological system (Lambert et al., 2005; St Clair 
Gibson et al., 2006; Ulmer, 1996). It is unknown however, whether the initial pace set in a 
feedforward manner might be interfered with by the effects of tapering on recovery from 
prior training overload. It is possible therefore, that the change in fatigue status after 
tapering might need to be taken into account to achieve an optimal pacing strategy. 
It appears that no study has investigated how tapering influences track performance over 
1,500 m, with chapter IV and the study by Shepley et al. (1992) previously based on 
laboratory treadmill performance. The aims of the current study are therefore: i) to 
investigate the effectiveness of an algorithm-derived tapering strategy on 1,500 m time 
trial track performance; ii) to establish whether the addition of higher intensity interval 
session (115% of race speed) and a greater overall reduction in continuous volume (60%), 
can further enhance 1,500 time trial track performance. Lastly: iii) to explore whether 
tapering influences the selected pacing strategy for 1,500 m performance. It is 
hypothesised that, the novel 7-d tapering strategy will result in a greater improvement in 
1,500 m track performance than the algorithm-derived strategy alone. 
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6.2 Methods 
6.2.1 Participants  
A group of 8 highly-trained male middle distance runners: (mean ± SD) age 21.4 ± 4.2 y, 
height 182.8 ± 7.2 cm, body mass 67.4 ± 8.0 kg, volunteered to take part in the 
experimental trials. Inclusion criteria specified that participants were competitive middle 
distance runners (800 m & 1,500 m) who had a training history of at least 2 years and had 
trained consistently without interruption for the previous 2 months. Mean personal best 
1,500 m time was 241.4 ± 9.2 s (range: 227.6 s – 251.7 s). 
6.2.2 Experimental Design  
The study employed a repeated-measures cross-over design. Each condition involved a 7-d 
period of tapering, with a 1,500 m time trial performance assessment on the day before 
(pre-taper, day 0) and the day after (post-taper, day 8) (Figure 6.1). Conditions were 
separated by at least 3 weeks of regular training. Participants were not informed about the 
precise differences between the 2 conditions, but could not be blinded to the manipulation 
of training load. 
 
Figure 6.1. Experimental design illustrated by 2 experimental conditions, separated by 3 
weeks of regular training. Arrows represent 1,500 m time trial performance assessments 
and asterisk indicates final interval session of the taper on day 5.  
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6.2.3 Training and Taper 
The investigation began in the 16
th
 week of the winter training season. Participants trained 
under the supervision of their personal coaches and followed their own individual training 
programmes, which were not manipulated prior to the experimental conditions. Training in 
the 4 weeks prior to the first condition was recorded objectively from the participant’s own 
GPS device. Training was categorised into continuous or interval running (described 
previously: chapter 3.2.1) and quantified for mean weekly volume (km), frequency and 
intensity (% personal best 1,500 m race speed). During the taper period in the race-pace 
condition (RP), participants completed individualised training relative to the mean of the 4 
weeks preceding the experimental conditions, which was prescribed using the algorithms 
from chapter III. Although prior training load was uncontrolled (as in in chapter IV), the 
mean of the 4 weeks preceding was used in this instance to ensure the taper was more 
accurately prescribed. In RP, the speed of the final interval training session was equivalent 
to the average speed of personal best 1,500 m time (described below) and continuous 
running volume was reduced by 28%. In the high intensity condition (HI), continuous 
running volume was reduced by 60% and the intensity of the final interval session of the 
taper was prescribed at 115% of the speed in RP. Training load was confirmed throughout 
both conditions using GPS data. 
6.2.4 Final Interval Session within Taper Period 
In each condition, a standardised interval running session was completed on day 5, 3 d 
prior to the final performance assessment. Both were carried out on an outdoor 400 m 
track, at the same time of day. Participants were instructed to perform the same warm up 
procedure before each session, consisting of a 10 min self-paced jog, 10 min of mobility 
drills and 5-6 progressive 80 m stride outs. Interval volume during the taper was 
distributed so that the final interval session in each condition involved 5 repetitions of 300 
m with 90 s recovery. Intensity of each repetition was instructed to be equivalent to 
personal best 1,500 m race speed in the RP condition and 115% of personal best 1,500 m 
race speed in the HI condition. A cool down of 15 min self-paced jogging was performed 
after completion of the session.  
6.2.5 Performance Assessment 
Participants completed 2 1,500 m time trial runs in each condition, before (pre-taper) and 
after (post-taper) the 7-d tapering period. All performance assessments were carried out on 
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an indoor 200 m track at the same time of day to control for consistency between 
conditions. Dietary intake in the 24 h before each performance assessment was repeated 
and caffeine consumption was prohibited during this period. Participants were allocated to 
1 of 3 separate heats based on performance standard, to avoid tactical competition among 
athletes with similar personal best times. This also ensured that participants were able to 
run on the inner lane of the track. Participants were instructed to run the time trial as an all-
out effort and to avoid drafting strategies or tactics. Overall performance time and split 
times at 100 m intervals were recorded using a radio frequency identification timing 
system (ULTRA 4, RFID Race Timing Systems, West Midlands, UK), whereby 
participants were required to wear a small transponder on their left ankle. No feedback was 
provided on split times or overall performance times until both experimental conditions 
had been completed. Mean running speed was calculated for each 300 m segment of the 
time trials using the 100 m split times. 
6.2.6 Statistical Analysis 
Data were analysed using SPSS (Statistical Package for Social Sciences Inc. v22.0;  
Chicago, IL, USA) and were initially tested for distribution using the Shapiro-Wilk test. 
Data are presented as mean ± SD, unless specified otherwise. Statistical significance was 
accepted at P ≤ 0.05. 
Non-parametric tests were used where the data were not normally distributed, specifically 
training frequency data. All other data were confirmed to be normally distributed. Training 
frequency data from the pre-experimental period, RP and HI were compared using the 
Mann-Whitney U test. All other training load data, including 300 m repetition session data 
were compared using paired samples t-tests. Pre-taper time trial performance data were 
compared using paired samples t-tests, to confirm no difference in baseline performance in 
RP and HI conditions. Time trial data from the performance assessments were analysed via 
a 2-way repeated-measures ANOVA, with taper (no taper vs. taper) and condition (RP vs. 
HI) as within-subject factors and Bonferroni post hoc analysis.  Magnitude-based 
inferences about the true (population) effect of the RP taper and HI taper on 1,500 m 
running performance were calculated. The uncertainty in the effect was expressed as 90% 
confidence limits and as the likelihood that the true value of the effect represents 
substantial change; harm or benefit (Batterham & Hopkins, 2006). The smallest 
meaningful change in 1,500 m performance was assumed to be a reduction or increase in 
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running time of 0.5% (Hopkins, 2005). Effect size (ES) was calculated and the magnitude 
was considered either trivial (0–0.19), small (0.20–0.49), medium (0.50–0.79) or large (≥ 
0.80) (Cohen, 1992). Mean running speed was compared in the corresponding 300 m 
segment of pre- and post-taper time trials for both RP and HI conditions using the 
Wilcoxon Signed Rank test. 
6.3 Results  
6.3.1 Training 
Confirmation of training completed during the pre-taper period and in both conditions is 
presented in Table 6.1. Mean 300 m repetition time in the final interval session was faster 
in the HI condition compared to the RP condition (43.8 ± 2.0 s vs. 48.0 ± 2.1 s, 
respectively; P < 0.05), but slower in HI than prescribed (43.8 ± 2.0 s vs. 41.0 ± 1.5 s; P < 
0.05). 
6.3.2 1,500 m Performance 
Pre-taper 1,500 m performance times were not different in RP and HI conditions (258.9 s ± 
7.4 s vs. 259.0 ± 6.3 s; P = 1.00). There was a main effect of taper (no taper vs. 7-d tapered 
training) on 1,500 m time trial performance (P < 0.05). There was no main effect of 
condition (RP vs. HI, P = 0.39) or an interaction effect (P = 0.40), suggesting that time 
trial performance responded similarly to the both types of taper in RP and HI (RP: 255.7 ± 
8.7 s vs. 258.9 ± 7.4 s; HI: 253.8 ± 7.7 s vs. 259.0 ± 6.3 s; Figure 6.2). When considered 
relative to the smallest worthwhile change in performance, qualitative inference suggested 
that the tapering strategy in HI condition was very likely to be beneficial to 1,500 m time, 
compared to likely beneficial in the RP condition (Table 6.2). 
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Table 6.1. Weekly volume, frequency and intensity of training in the pre-taper and taper periods (mean ± SD; n = 8). Warm up and cool down 
data is not shown.  
Training Variables Pre-taper RP Taper %Δ HI Taper %Δ 
Training volume 
  
 
  Continuous running (km·wk
-1
) 54 ± 14 37 ± 8* -28% 21 ± 5*† -60% 
Interval running (km·wk
-1
) 13 ± 4 8 ± 2* -41% 8 ± 2* -41% 
Training frequency 
   
  Continuous running (run·wk
-1
)  5 ± 1 4 ± 0* -23% 4 ± 0* -23% 
Interval running (run·wk
-1
)  2 ± 0 2 ± 0 0% 2 ± 0 0% 
Training intensity 
   
  Continuous running (% race speed) 65 ± 4 62 ± 5* -5% 62 ± 4* -5% 
Interval running (% race speed) 95 ± 3 99 ± 2* 5% 100 ± 2* 5% 
Final interval session (% race speed) - 101 ± 1 - 110 ± 3† - 
* Different to pre-taper, † different to RP taper, all P ˂ 0.05. 
 Table 6.2. Differences in pre- and post-taper 1,500 m time trial performance improvements in the RP and HI conditions. 
Taper  
Mean improvement (s) and 90% confidence 
limits  
Qualitative inference 
a
 Effect size 
RP 3.2; ± 3.8 Likely beneficial 0.40 
HI 5.2; ± 3.7 Very likely beneficial 0.74 
a
 with reference to a smallest worthwhile change of 0.5%.  
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Figure 6.2. 1,500 m time trial performance time pre-taper and post-taper in the RP 
condition and the HI condition. Individual times for each participant (P1-8) are 
represented by dashed lines and group mean ± SD by solid line. 
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6.3.3 Pacing 
Split times indicated that participants ran faster in the first (0-300 m) and second (300-600 
m) segments of the post-taper time trial compared to the pre-taper time trial in both the RP 
and HI conditions (RP: ES = 1.14 and 1.56; HI: ES = 0.97 and 2.01; all P < 0.05; Figure 
6.3).  
 
Figure 6.3. Mean speed for each 300 m segment of the 1,500 m time trial in RP and HI. 
Pre-taper time trial data is represented by the dashed line and post-taper time trial data 
by the solid line. * Different to corresponding pre-taper 300 m segment (P ≤ 0.05).   
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6.3.4 Individual Responses 
Six of 8 participants improved performance after tapering in the RP condition (range 2.4-
8.8 s) and 2 participants showed a decreased performance (4.7 s and 5.8 s). Seven of 8 
participants improved performance after tapering in the HI condition (range 3.8-11.7 s) 
and 1 participant showed a decreased performance (7.0 s). The same participant showed a 
decline in performance in both conditions. Mean 300 m segment speeds are shown for this 
individual in Figure 6.4. 
 
Figure 6.4. Mean running speed for each 300 m segment of the 1,500 m time trial in RP 
and HI for the individual participant with a decline in performance times post-taper. The 
pre-taper time trial is represented by the dashed line/open circles and post-taper time trial 
by the solid line/filled circles.   
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6.4 Discussion 
The main finding of the current study was that 1,500 m track performance improved after 
tapering. The improvement in performance from both RP (1.3%; small effect) and HI 
(2.0%; medium effect) tapers, albeit non-significant, fall within the expected range of 0.5 
to 6% (Mujika & Padilla, 2003) and are in excess of the smallest worthwhile change in 
performance (0.5%) for competitive 1,500 m athletes (Hopkins, 2005).  
6.4.1 1,500 m Performance 
Despite no interaction effect, magnitude-based inferences (Batterham & Hopkins, 2006) 
suggested that the HI taper was ‘very likely beneficial’ to 1,500 m time trial performance 
compared to ‘likely beneficial’ for the RP taper. In theory, this could be due to a higher 
intensity interval session completed late in the taper when the athlete is more fully 
recovered, allowing a greater capacity to respond positively (Busso, 2003; Mujika et al., 
2004) and thus lead to a further improvement in subsequent performance. Previously, 
theoretical models have shown that a moderate increase in training at the end of a taper 
may further improve performance as the athlete can capitalise on additional adaptations, 
after initially overcoming accumulated fatigue from previous training (Thomas et al., 
2009). These data would indirectly support this, although likely an effect of insufficient 
statistical power to detect such marginal differences in performance between RP and HI.  
Chapter IV did not demonstrate enhanced performance after HI however, perhaps due to 
the conservative reduction in training volume prescribed via the algorithm, derived from 
athletes who did not implement this higher intensity session (chapter III). In the present 
study, continuous running volume was reduced by 60% in HI, as recommended by a meta-
analysis on the available literature (Bosquet et al., 2007), which might have increased the 
likelihood of improved performance and a larger effect, although not to a level of 
statistical significance. 
The intensity of the final interval session in HI might further explain an increased 
likelihood of improved performance in the present study. In the present study, the session 
was completed on an outdoor 400 m running track and although participants were 
instructed to run at a pace equal to 115% of race-speed, training data revealed that mean 
intensity of the session was in fact 110% in the HI condition. Although faster than RP, this 
was significantly slower than prescribed. In comparison, the final interval session in 
chapter IV was carried out on a treadmill and speed was therefore fixed at 115% of race-
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speed for each individual in the HI condition. Since efforts at > 100% of race speed in 
middle-distance events equate to considerably higher absolute speeds than the same 
percentages of long-distance event race speeds, it is possible that 115% of race-speed was 
too intense for this event group, particularly so close to ‘competition’. Participants may 
have been unaccustomed to running these speeds at this time of year and may have held 
back through fear of injury. Elite marathon runners are able to complete their peak 
intensity interval session during the taper at ~114% of race speed, but this is a slower 
absolute speed than for 1,500 m runners and typically this session occurs 10 d from 
competition (chapter III) Considering the practices of marathon runners and the 
recommendations from the literature that the optimal taper duration is approximately 2 
weeks (Bosquet et al., 2007), it is possible that the 1 week taper was not sufficient to 
overcome fatigue from previous training. Therefore, athletes may have self-selected to run 
slightly slower than instructed on the track as a result of afferent feedback from the 
periphery, to avoid premature fatigue (St Clair Gibson et al., 2006). This may have 
provided protection from potentially exacerbated fatigue in HI, whilst still allowing a 
positive response to the session and enhanced subsequent time trial performance compared 
to RP.  
6.4.2 Pacing 
Participants completed the first 2 300 m segments of the time trial quicker after tapering in 
both RP and HI, followed by a similar pace in the remaining segments compared to pre-
taper. In closed-loop events, such as 1,500 m, where the aim is to complete a fixed 
distance in the shortest possible time, athletes must regulate their rate of work output to 
optimise overall race performance and prevent catastrophic changes to physiological 
homeostasis (Tucker & Noakes, 2009). The faster start in the present study suggests that 
the brain-pacing algorithm (St Clair Gibson et al., 2006, Ulmer et al., 1996) was able to 
detect and take into account the differing recovery status after tapering and perhaps 
athletes’ previous experience of racing after tapering. After the faster first 2 300 m 
segments, pace was adjusted similar to pre-taper time trials in the remaining 3 segments to 
potentially avoid premature physiological catastrophe (Noakes et al., 2005; St Clair Gibson 
et al., 2006). A positive pacing strategy such as this, is typically selected in events lasting 
< 4 min, whilst pace becomes more evenly distributed in longer events (Tucker & Noakes, 
2009). In support, 1,500 m performance might be enhanced using a fast-start strategy due 
to a speeding of V̇O2 kinetics (Bailey et al. 2011). However, it may also be harmful to 
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performance if not judged correctly (Hanon et al. 2007) and such interventions may 
require practice prior to important competition. In support, Mauger et al. (2009) found that 
cyclists were able to adopt a successful pacing strategy once prior experience of the 4 km 
time trial distance was gained, even with no distance or time feedback. 
This could explain the response of 2 individuals whose performance declined after 
tapering in the RP condition, 1 of whom also experienced a decline after tapering in HI. 
This may have contributed to the differing qualitative inferences based on the mean 
performance improvements and 90% confidence limits. In both pre-taper time trials, the 
individual with worsened performance in both conditions executed a negative pacing 
strategy, shown by a slower start and an increase in speed in the final 300 m segments, but 
opted for a positive pacing strategy in the post-taper time trials, which resulted in slower 
overall times. It had been anticipated that, as all athletes in the present study were 
experienced in racing the 1,500 m distance, this would have been avoided. On recording 
this result, it was clear from subsequent discussion with this individual that they had 
limited experience and memory of racing after implementing an optimal taper and 
therefore had unrealistic expectations about the level of performance they could achieve. 
The brain algorithmic process involved in initiating pace (St Clair Gibson et al., 2006, 
Ulmer et al., 1996) might have been provided with inaccurate information due to a lack of 
previous experience of an optimal taper and therefore the efferent neural commands sent to 
dictate starting pace might have generated inappropriate power output and pace for the 
individual’s current performance capacity. Anecdotal evidence suggests that many athletes 
feel insecure at the prospect of reducing training load prior to competition and are unlikely 
to implement large reductions in training volume, as recommended in the literature 
(Bosquet et al. 2007). In support, the individual athlete in this case was completing the 
highest training volume prior to tapering (84 km·wk
-1
) and was therefore prescribed the 
largest absolute reduction in training volume in both RP and HI. The unfamiliarity of 
implementing a large reduction such as this, likely led to heightened expectations, due to 
limited memory of competing in a tapered physiological state. It appears to be rare for 
athletes and coaches to practice different pacing strategies in low-key competition and it 
has been suggested that the learning implications from experiencing a range of pacing 
patterns may be beneficial to performance (Foster et al. 1993). It is therefore recommended 
that athletes take the opportunity to practice pacing after tapering ahead of less important 
competition or during periods of reduced volume in their normal training cycle.  
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6.5 Conclusion 
In conclusion, a novel 7-d tapering strategy where continuous training volume is reduced 
by 60% and the final interval session is completed at 110% of race pace, results in a 
greater likelihood of increased 1,500 m track performance compared to a 7-d taper based 
on the practices of elite middle-distance runners. After tapering, athletes appear to adopt a 
positive pacing strategy during 1,500 m track performance. To avoid an over-fast start 
when employing this pacing strategy however, pacing in a tapered physiological state 
should be practiced and close attention should be paid to split times early in the race to 
facilitate an optimal pacing strategy.   
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Chapter VII 
General Discussion and Application of Research 
7.0 Thesis Summary 
Tapering has been established as a fundamental strategy incorporated into the overall 
training process, to enable athletes to reach peak performance at the right time for 
important competition (Mujika & Padilla, 2003; Smith, 2003). Despite general 
recommendations from previous literature regarding optimal tapering practices (Bosquet et 
al., 2007; Houmard et al., 1990; Houmard et al., 1994; McConell et al., 1993; Mujika, 
2010; Mujika et al., 2000; Mujika et al., 2002; Shepley et al., 1992; Wittig et al., 1989), the 
application of these recommendations into elite endurance running appear to be limited by: 
1) knowledge of the current practices; 2) understanding of the relationship between 
training, tapering and performance enhancement; and therefore, 3) the ability to identify 
potential opportunities for strategy optimisation. The current thesis intended to enhance 
tapering strategies for highly trained endurance runners by exploring current practice and 
identifying potential areas for optimisation, through a more thorough understanding of the 
physiological mechanisms underpinning improved performance. Finally, the current thesis 
intended to investigate the possibility of a biomarker to monitor recovery status during the 
taper.  
The main findings of the current thesis are as follows:  
1. Middle-distance, long-distance and marathon runners reduce frequency, intensity and 
volume of continuous running and volume of interval running during the taper 
compared to regular training. Marathon runners implement a greater reduction in 
continuous volume, over a longer taper duration (47% and 14 d) than both middle- (30% 
and 6 d) and long-distance runners (29% and 6 d). Only middle-distance runners 
increase interval intensity during the taper (96% vs. 100% race speed), but do not 
typically run faster than race-speed in the peak intensity session of the taper, which 
occurred 3 d before competition. Long-distance and marathon runners run faster than 
race speed during the taper, a practice also reported in elite Kenyan long-distance 
runners (111%, 114% and 115% race speed, respectively; chapter III). 
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2. Algorithms were capable of explaining a large proportion of the variance (53-95%) in 
tapering strategy training variables (with the exception of interval volume) for a given 
regular training load in elite endurance runners (chapter III). 
3. A tapering strategy implemented using the algorithms was most likely to improve 
1,500 m treadmill performance in well-trained middle-distance runners. When the 
intensity of final interval session was increased to 115% race speed, the effect on 
treadmill performance was unclear and some athletes may experience a worsening in 
1,500 m time (chapter IV). 
4. When the algorithm-derived taper was implemented with a further reduction in 
continuous volume (60% reduction) and the final interval session intensity was 110% 
race speed, this tapering strategy was very likely to improve 1,500 m track 
performance and had a medium effect (chapter VI). 
5. The improvement in 1,500 m performance time after tapering appears to be achieved 
by adopting a positive pacing strategy and running at a faster speed in the first 600 m 
of the race distance. An over-fast start may occur after tapering in some individuals 
and result in a worsening in performance time (chapter VI).  
6. Peak leg extension force and RFD were improved in response to tapering, in addition 
to a higher peak lactate post-1,500 m time trial, but neither could explain performance 
differences between race-pace and higher intensity strategies. Well-trained middle-
distance runners maintain a consistent total energy intake and carbohydrate intake 
despite a reduced training load during tapering (chapter IV). 
7. Strong relationships were evident between capillary and venous blood samples for the 
measurement of plasma IL-6 and sIL-6R concentration, suggesting that the cytokines 
can be measured less invasively in the field from capillary samples (chapter II).  
8. Plasma IL-6 and sIL-6R do not appear to be biomarkers sensitive enough to detect 
changes in recovery status and readiness to perform during tapering in middle-distance 
(chapter IV) or marathon runners (chapter V). This was also the case for CRP, T and 
C and therefore the measurement of these biomarkers is not recommended to facilitate 
further real-time adjustment of tapering strategies (chapter IV). 
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7.1 Current Tapering Strategies in Elite Endurance Runners 
Previously, it has been demonstrated that dramatic reductions in training volume can be 
implemented during tapering (Mujika et al., 2000; Wittig et al., 1989), however training 
intensity must not be compromised (McConell et al., 1993) and high intensity interval 
training during the taper is key to enhancing performance (Houmard et al., 1994; Shepley 
et al., 1992). Chapter III found that whilst in general, elite British endurance athletes 
reduced training volume (albeit more conservatively) and retained high intensity interval 
sessions during the taper, there were notable differences between event groups. 
Specifically, marathon runners reported a greater reduction in continuous training volume, 
over a longer taper duration than both middle- and long-distance runners. This was in 
agreement with previous speculation, that a higher prior training load and subsequent 
degree of fatigue may require a more aggressive and prolonged taper (Bosquet et al., 2007; 
Kubukeli et al., 2002; Smith, 2003; Thomas et al., 2008). This strategy was also confirmed 
in chapter V, where the pre-taper training volume in an elite marathon runner was higher 
than the average reported by British marathon runners (182 km·wk
-1
 vs. 168 km·wk
-1
) and 
therefore the taper duration was longer (20 d vs. 14 d). Analysis of the relationship 
between prior training load and the extent to which training load variables were 
manipulated during the taper was subsequently carried out, using data pooled from all 
events.  
Strong relationships were evident between regular training load and the magnitude of 
manipulation during the taper, allowing for the development of algorithms. Thus, 
providing a useful tool for coaches and athletes to aid design of the tapering strategy based 
on individual training load in the preceding training phase. Given these findings, athletes 
would be discouraged from implementing the same training programme during tapering 
for different competitions, as the same training load may not have been completed 
beforehand (e.g. through injury or illness). There may be a need therefore, to re-address 
the tapering strategy for each competition to maximise performance. The event-specific 
differences between tapering strategies implemented by elite endurance athletes can also 
be utilised to facilitate taper design and might be applicable to other sports such as cycling 
and swimming, where a range of event distances with different physiological determinants 
and training practices exist. 
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7.2 Optimisation of Current Practice 
In chapter III, marathon runners and both British and Kenyan long-distance runners 
reported training at intensities well above race speed during the taper (114%, 111% and 
115% race speed, respectively; P < 0.05). Middle-distance runners however, typically 
trained at race speed. Although previous research has suggested that high intensity training 
during the taper is key to improving performance (Houmard et al., 1994) and training 
intensity should perhaps be increased during this period (Shepley et al., 1992), the 
strategies investigated were extreme and do not reflect the typical training practices of elite 
endurance athletes. For example, training volume was reduced by 85-90% and all running 
was completed as high intensity intervals (Houmard et al. 1994; Shepley et al., 1992). 
Given the anxiety and insecurity that athletes anecdotally report regarding a reduction in 
training load prior to competition and the large proportion of lower intensity continuous 
running volume that is completed habitually (chapter III), it was unlikely that such a severe 
strategy would be readily accepted by elite athletes. However, it was unknown whether a 
single profound increase in training intensity in the final days of the taper would improve 
subsequent running performance, when incorporated into the existing tapering strategies of 
middle-distance runners. For example, an interval session completed at intensities above 
race speed late in the taper when the athlete has become more fully recovered, might allow 
greater capacity to respond effectively to this type of training stimulus and further improve 
subsequent performance (Mujika, et al., 2004). In support of this concept, a theoretical 
model suggests that a moderate increase in training load at the end of taper might further 
improve performance as the athlete can capitalise on additional adaptation, after initially 
overcoming accumulated fatigue from previous training (Thomas et al., 2008).  
Chapters IV and VI therefore focused on investigating the effect of the algorithm-derived 
taper (from chapter III) on middle-distance running performance and manipulating the 
intensity of the final interval session of this taper. It was found that the current tapering 
strategy prescribed using the algorithms was most likely to improve 1,500 m treadmill 
performance in well-trained middle-distance runners. When the intensity of final interval 
session was increased to 115% race speed in this strategy however, the effect on treadmill 
performance was unclear and some athletes ran slower following the taper. The hypothesis 
predicting a greater performance improvement from the higher intensity taper was 
therefore rejected. It may be that some athletes require longer to reach peak performance 
after the high intensity session, in agreement with Thomas et al. (2009), but it was not 
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possible to explore the time course of the performance rebound between the 2 strategies, 
since only 1 performance assessment was completed after each taper. Alternatively, it was 
speculated that a conservative reduction in training volume resulting from the algorithm, 
compared to that of the previous high intensity strategies (Houmard et al, 1994; Shepley et 
al., 1992) or even general recommendations (Bosquet et al., 2007), may have prevented 
sufficient recovery to respond positively to the increased intensity interval session. Chapter 
VI thereafter assessed the effect of the high intensity taper, where continuous volume was 
also reduced by 60%, as per the recommendations of Bosquet et al., (2007). Since 
participants completed the high intensity session on a track rather than a treadmill, pace 
could not be fixed and was in fact 110% of race speed, suggesting that 115% might have 
been too intense in chapter IV and participants self-selected to run slower, albeit still faster 
than race speed. In chapter VI, 1,500 m performance was assessed using a more 
ecologically valid indoor track time trial. Whilst the inclusion of an ‘above race-speed 
session’ within the algorithm-derived taper initially resulted in equivocal effects on 
performance, the strategy was very likely to improve performance (ES = 0.74) if a greater 
concomitant reduction in continuous volume was implemented and the peak intensity 
interval session was completed at 110% race speed. The hypothesis in chapter VI was 
accepted due to a greater likelihood of improved performance and a larger effect from the 
novel high intensity strategy compared to race-speed strategy.  
Collectively, these findings suggest that coaches and athletes need to achieve a balance 
between the manipulations of volume and intensity during the taper. To maximise the 
responses to high intensity training during the taper and ultimately improve performance, 
volume should be reduced enough to alleviate the temporary physiological disturbances 
associated with heavy training such as glycogen depletion, neuromuscular fatigue, 
hematological decrements and hormonal imbalances (Halson & Jeukendrup, 2004;  Halson 
et al., 2002; Hellard et al., 2013; Mujika and Padilla, 2003), whilst intensity should not be 
increased excessively. The current findings can be readily applied to middle-distance 
runners and have also been disseminated among high performance coaches in cycling, 
triathlon and swimming. Furthermore, the findings suggest that it is not necessary to 
implement extreme volume reduction strategies (Houmard et al., 1994; Shepley et al., 
1992) that are far removed from an athlete’s typical training routine (chapter III) to 
achieve a meaningful improvement in performance. Although more research investigating 
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this type of strategy is required, employing more ecologically valid performance measures, 
such as track-based time trials.  
7.3 Physiological Mechanisms 
A number of positive physiological changes have been reported as a result of the pre-
competition taper, including increases in muscle strength and power (Luden et al., 2010; 
Shepley et al., 1992), muscle glycogen (Neary et al., 1992; Neary et al., 2003; Shepley et 
al., 1992; Walker et al., 2000), oxidative enzyme volume and activity (Neary et al., 1992; 
Neary et al., 2003; Shepley et al., 1992), blood and red cell volume (Mujika et al., 2002; 
Shepley et al., 1992) and hormonal changes (Mujika et al., 2002), all of which may 
contribute to improving endurance running performance. Given these responses, it has 
been suggested that the tapering period facilitates the restoration of physiological 
capacities that may have been previously suppressed by heavy training (Halson & 
Jeukendrup, 2004). This may also lead to amplified physiological responses to the training 
completed during the taper (Mujika et al., 2004; Thomas et al., 2008). The complexity 
arises however, when differing performance outcomes are accompanied by similar 
physiological changes, thus emphasising the multitude of factors that may contribute to 
performance.  
Chapters IV and VI attempted to gain a more thorough understanding of some of the 
physiological mechanisms underpinning the relationship between tapering and 
enhancement of performance, to facilitate the optimisation of strategies. Measures of peak 
leg extension force and rate of force development improved in response to tapering 
(chapter IV), although no differences were evident between race-speed and high intensity 
tapering strategies, despite a difference in the performance outcome. In a more extreme 
example, similar beneficial changes to maximal voluntary isometric strength were reported 
in middle distance runners after tapering and after a period of complete rest, however 
endurance performance capacity declined by 3% after the complete rest condition (Shepley 
et al., 1992). The current work perhaps confirms therefore, that improved muscle function 
occurs as part of a restorative process throughout the taper, rather than as an amplified 
response to the training done during the taper itself. Although not measured in the current 
thesis, possible mechanisms for improved strength and rate of force development might 
include; altered protein synthesis and shifts in fibre type (Luden et al., 2010; Neary et al., 
2003; Trappe et al., 2000), changes in contractile geometry (Metzger & Moss, 1987), 
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increased muscle enzyme activity (Neary et al., 1992; Neary et al., 2003; Shepley et al., 
1992), calcium sensitivity (Trappe et al., 2000) and neural control on fibre recruitment 
(Costill et al., 1985). Although, relative contribution to increased muscle performance 
from each these mechanisms is likely to be highly dependent on taper duration and 
strategy. 
Muscle glycogen has been recognised as an important determinant of performance 
capacity in both prolonged submaximal (Bergstrom et al., 1967) and supramaximal 
(Maughan & Poole, 1981) exercise. It is possible that pre-taper muscle glycogen stores 
become somewhat depleted through inadequate carbohydrate consumption, coupled with 
multiple training sessions in 1 day (Costill et al., 1972; Philp et al., 2012). Increases in 
muscle glycogen concentration have been reported after tapering previously (Neary et al., 
1992; Neary et al., 2003; Shepley et al., 1992; Walker et al., 2000), suggesting that the 
taper may provide an opportunity for athletes to replenish glycogen stores as a result of a 
reduced training load and consequently, lowered glycogen utilisation and greater recovery 
time between training sessions. Additionally, supercompensation of muscle glycogen 
stores can be achieved through a reduced training load and concomitant high carbohydrate 
diet (Costill et al., 1981; Sherman et al., 1981). Although muscle glycogen was not 
measured in the current work, it was found in chapter IV that carbohydrate consumption 
remained unchanged from pre-taper in both conditions despite a reduction in overall 
physical activity and a lower proportion of time spent undertaking MVPA during the taper. 
This habitual behaviour perhaps increases the likelihood of augmented muscle glycogen 
during the taper. There was no difference in carbohydrate consumption in the final 3 d of 
the high intensity taper compared to the race-speed taper, despite an increase in intensity of 
the final interval session. Since glycogen is the main energy source for high intensity 
exercise (Stellingwerff et al., 2011) and there is evidence of rapid muscle glycogen 
depletion in type II fibres after high intensity intermittent exercise (Gollnick et al., 1973), a 
more direct intervention to optimise carbohydrate consumption after the intensified 
interval session might have influenced the performance outcome. 
 Although positive responses, the restoration of muscle strength and power and increased 
muscle glycogen pose a potential challenge for the determination of an athlete’s pacing 
strategy after the taper. For example, athletes might train with overload prior to the taper to 
maximise adaptation (Aubry et al., 2014) and become unaccustomed to performing 
124 
 
without the accumulated fatigue that is consequential of the normal training process 
(Halson & Jeukendrup, 2004). This overload practice might influence the memory and 
negatively impact the decision making process in selecting the initial race pace (St Clair 
Gibson et al., 2006; Rauch et al., 2005). The current work found that middle-distance 
runners adopt a more positive pacing strategy after tapering in order to improve 
performance, although some athletes may succumb to an over-fast start, which results in a 
worsening in performance. This finding should encourage athletes to become accustomed 
to racing in a tapered state to ensure an optimal pacing strategy is executed, perhaps 
utilising low-key events and paying close attention to split times early in the race. 
The physiological mechanisms fundamental to the process of tapering are still not yet fully 
understood in endurance runners. It appears that a myriad of physiological changes occur 
during the taper, all of which may contribute, in some degree, to improving performance. 
However, the complex interaction of physiological determinants, coupled with recovery 
status and the influence of other factors on performance, means that physiological 
responses to tapering cannot always exclusively explain performance differences between 
strategies. 
7.4 Potential Physiological Biomarkers 
A final aim of the current thesis was to identify a physiological biomarker capable of 
monitoring recovery status during the taper, to allow further individualisation and 
optimisation of strategies in real-time. In the athlete population however, it is not feasible 
to employ the invasive procedures such as muscle biopsies, necessary to monitor a number 
of the physiological changes associated with the taper. Biomarkers are required to be 
minimally invasive, with fast sample analysis to allow prompt feedback. Previously, it has 
been suggested that the longitudinal monitoring of variations in inflammatory cytokines; 
IL-6, sIL-6R, CRP, and the T:C ratio, may be indicative of training stress and energy 
homeostasis throughout different phases of training (Adlercreutz et al., 1986; Jürimäe et al., 
2011, Robson-Ansley et al., 2007), although their sensitivity to monitor taper effectiveness 
and recovery acutely in endurance runners required investigation. 
The hypothesis in chapter II predicted that plasma IL-6 and sIL-6R measured from 
capillary blood would be strongly correlated with that from venous blood. This was 
accepted and it was deemed possible that the cytokines could be measured less invasively 
using capillary samples in the field. However, these markers did not appear to be sensitive 
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enough to detect or indicate the subtle changes in recovery status associated with tapering 
and performance in middle-distance or marathon runners. This was also the case for CRP, 
and the T:C ratio and these measures perhaps are more useful when monitored on a more 
longitudinal basis throughout different phases of training. 
Whilst the blood biomarkers measured in this thesis did not represent useful indicators of 
recovery and taper effectiveness, other non-invasive measures could be considered. In 
chapter IV for example, peak isometric leg extension force and rate of force development 
improved in response to tapering. These changes could not explain the difference in 
running performance after two different tapering strategies and it appears therefore, that 
improved muscular performance occurs as part of a restorative process throughout the 
taper, rather than as a result of further adaptation. For this reason, measurements of 
muscular performance might offer insight into readiness to perform and indicate further 
opportunities for real-time fine-tuning of tapered training. Whilst laboratory measurements 
are not practical, non-invasive, field-based measures such as a CMJ in conjunction with 
session-RPE have been shown to indicate readiness to perform in elite endurance athletes 
(Balsalobre-Fernazdez et al., 2014). Alternatively, post-exercise heart rate recovery might 
provide insight into readiness to perform in elite endurance athletes (Hug et al., 2014). 
These variables can be measured simply on a regular basis and at a lower cost, as part of 
an athlete’s regular training programme. Rapid feedback could be obtained from such 
measures and it would be of interest to carry out further investigation in response to 
tapering in elite endurance athletes. 
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7.5 Tapering Summary    
 
Figure 7.1. A model of the components of tapering, recommendations from the scientific literature and observations from the current work. 
Underlined text refers to knowledge that the current work has confirmed. Bold capitalised text in shaded boxes highlights novel findings from the 
current work. Question marks denote unknowns, where further research is required.
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7.6 Recommendations for Coaches and Athletes 
Table 7.1. Recommendations for coaches and athletes, based on observations from the 
scientific literature and findings from the current work. 
Taper Component Recommendation 
General Do not complete the same taper before different competitions; plan 
the taper relative to the preceding training load  
 Address the component parts of training load separately (volume, 
frequency, intensity, etc.)  
Pattern Consider the pattern in which training is manipulated during the 
taper (fast exponential or two-phase) 
Volume The first part of the taper should focus on reducing accumulated 
fatigue, via a rapid reduction in running volume of up to 60% 
Frequency Training frequency should be maintained, although continuous 
running can be slightly reduced if necessary (up to 23% if previous 
training volume and frequency are high) 
Intensity High intensity interval training should not be compromised 
throughout the taper  
 The intensity of interval training can be increased later in the 
taper, providing volume has been reduced adequately and there is 
enough recovery time before competition 
Duration Duration of the taper is typically 6 d to 14 d, but should be 
individualised depending on preceding training load and rate of 
recovery, if known 
Performance 
Implications 
Athletes should possess a clear pacing strategy, to prevent an over-
fast start to the race after tapering 
 Pacing in a tapered state could be practiced during less important 
competition or in training during periods of reduced volume in the 
normal cycle 
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7.7 Limitations 
The limitations of the current work are acknowledged. Firstly, it is important to highlight 
that performance can be influenced by a multitude of factors, including physiological, 
psychological, lifestyle and tactical components (Smith, 2003) and therefore it is difficult 
to isolate the effects of tapering on performance. This perhaps explains the paucity of 
literature investigating tapering strategies, despite the importance of this training phase 
prior to competition. Attempts were made to control confounding variables where possible 
in the current work (e.g. standardising warm up and prior dietary intake), in addition to 
selection of appropriate performance measures (Currell & Jeukendrup, 2008). 
The ultimate main aim of the current work was to optimise tapering strategies for elite 
endurance runners. However, given the nature of tapering in reducing training volume and 
the multiple performance assessments that were required, elite athletes were unwilling to 
participate in the experimental studies in chapters IV and VI. Attempts were made to 
preserve a high performance standard, although there was reluctance to manipulate 
training load through fear of compromising performance and sample sizes were therefore 
restricted. This resulted in a cohort heterogeneous for performance in chapter IV and 
perhaps limits application of the results to the elite population.  
In recruiting athletes of as high standard as possible, it was also not feasible to prescribe 
the same pre-taper training programme to all participants in chapters IV and VI and 
therefore prior training load was individualised and uncontrolled. This means that although 
the taper was implemented relative the prior training load as per studies in previous 
literature, the absolute training load completed during the taper was different between 
individuals. However, this could also be a strength of this experimental work, as each 
individual’s physiology and training history may vary and therefore to prescribe a 
standardised and unfamiliar training programme prior to the taper may have confounded 
the effects of the taper on performance. It would have been unrealistic to recruit 
participants with similar physiology, current training programmes and of the same 
performance level for the experimental chapters. Efforts were also made in chapter VI to 
collect prior training load data over a longer period (4 weeks vs. 1 week in chapter IV) in 
order to prescribe the taper more accurately. 
It was not possible to conduct the investigations during the competitive summer season, 
and since all training during the taper was relative to prior training, it is possible that 
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differences between winter and summer training loads may have confounded the effects of 
the algorithm-derived taper. However, a number of the participants in chapter VI were 
targeting late-winter indoor middle-distance races after the completion of the investigation 
and their training was therefore specifically focused towards this.  
It was also not feasible to assess the physiological characteristics of the elite athletes in 
chapter III prior to collecting data on training and tapering practices. This is perhaps a 
limitation, as training intensity was quantified relative to race pace, rather than to 
individual physiological landmarks (lactate threshold, lactate turnpoint, %V̇O2max 
or %vV̇O2max). It is likely that between-athlete variability exists in how performance is 
generated, particularly in middle-distance running (i.e. % energy contributions from 
aerobic vs. anaerobic sources). Two athletes with the same 1,500 m performance time for 
example, might therefore elicit different responses to a fixed intensity session at 115% of 
race speed, owing to potential differences in maximal speed, aerobic and anaerobic 
capacities. It is possible that assessing the physiological characteristics of the cohort in 
chapters IV and VI prior to the investigation might therefore have facilitated understanding 
of individual responses to the tapering strategies. Additionally, a more detailed method to 
monitor training load prior to and during the taper, might have added to understanding of 
individual responses. Although daily external load can be relatively easily quantified in 
terms of volume and intensity of training, no insight is provided into internal load using 
this method, and a combination of both might be useful to track the cumulative effects of 
training and to indicate fatigue and recovery status (Halson, 2014).  
Whilst the taper aims to ensure athletes arrive at competition in peak condition for 
performance, a final appreciation is the magnitude to which performance improvements 
from tapering investigations are transferred into actual competition, especially given the 
tactical nature of races at major championships. 
7.8 Recommendations for Future Research 
The research conducted in this thesis was of a highly applied and exploratory nature. The 
findings therefore, lead to a number of further important questions, in addition to those 
already discussed. 
Despite evidence for the inclusion of high intensity training during the taper, details 
regarding best practice during the final days prior to competition remain elusive. In the 
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current thesis, the effect of the taper was assessed in a single time trial performance. In 
practice however, middle-distance runners complete 3 rounds of competition in a major 
championship (heats, semi-finals and final). At the Rio 2016 Olympic Games, male 
1,500m runners will compete on days 5, 7 and 9. This poses the question as to whether 
athletes should begin their taper duration on count back from the heat or from the final and 
whether the early rounds provide opportunity for low volume, high intensity bouts that are 
beneficial to performance in the final. Conversely, these rounds can manifest as slow, 
tactical races and could possibly interfere with the planned taper.  
Competing at major championship also implies that the athlete will have been required to 
achieve a qualification standard and finish in a qualification position in a trial race, 
typically held several weeks beforehand. This might require the athlete to perform 
optimally in a number of races over an extended period of time and therefore the optimal 
tapering strategy for a single performance may no longer be valid. This may be 
exacerbated by the fact that athletics is not a professional sport and therefore athletes rely 
on prize money from races such as the Diamond League (series of 14 events) to support 
their income. Further investigation into the tapering process for an extended competition 
period is required, particularly since this issue also applies to a number of Olympic sports. 
The focus in the current thesis was on manipulation of running training during tapering, 
however, elite endurance athletes also incorporate aspects on non-running training into 
their schedules, such as strength training, drills and stability training (Ingham et al., 2012; 
Tjelta, 2013). Further research is therefore required to investigate the influence of non-
running training on recovery during tapering and the optimal modifications, if necessary, 
for performance. 
Finally, major championships for many sports typically take place in different host 
countries with each edition. Some locations can therefore pose environmental challenges, 
such as high temperatures or altitude. Often athletes travel to the venue for a holding camp 
in the weeks preceding the event to undergo an acclimatisation process, however it is not 
clear how the additional environmental stress would affect the tapering strategy and 
whether adjustments would be required to facilitate the peaking of performance. 
Additionally, altitude training is now incorporated into the training programmes of many 
elite endurance athletes, particularly prior to competition. Whilst the body of literature 
concerning the optimal time to compete after an altitude sojourn is expanding, little is 
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known about the influence of altitude on the tapering strategy and whether further 
modifications to training are required to optimise subsequent performance.  
7.9 Conclusion 
The findings of this thesis suggest that tapering strategies in elite endurance athletes are 
individualised and influenced by the preceding training load. In middle-distance runners, 
training above race speed in the final days of the taper might be more beneficial than 
current practice, although training volume must be further reduced to compensate. It 
appears that the physiological mechanisms underpinning improved performance after 
tapering are complex and multifaceted, although a novel finding is the change to pacing 
strategy in 1,500 m track performance. It is proposed that future studies continue to 
investigate non-invasive indicators of recovery and taper effectiveness, including measures 
of muscle function, to allow further real-time adjustment of training load to facilitate the 
peaking of performance. 
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Optimising Tapering Strategies in Middle-Distance Runners 
 
INFORMED CONSENT FORM 
(to be completed after Participant Information Sheet has been read) 
 
The purpose and details of this study have been explained to me.  I 
understand that this study is designed to further scientific knowledge 
and that all procedures have been approved by the Loughborough 
University Ethics Approvals (Human Participants) Sub-Committee. 
 
 
 
Yes  
 
 
No  
I have read and understood the information sheet and this consent 
form. 
 
Yes  No  
I have had an opportunity to ask questions about my participation. 
 
Yes  No  
I understand that I am under no obligation to take part in the study. 
 
Yes  No  
I understand that I have the right to withdraw from this study at any 
stage for any reason, and that I will not be required to explain my 
reasons for withdrawing. 
 
 
Yes  
 
No  
I understand that all the information I provide will be treated in strict 
confidence and will be kept anonymous and confidential to the 
researchers unless (under the statutory obligations of the agencies 
which the researchers are working with), it is judged that 
confidentiality will have to be breached for the safety of the participant 
or others.  
 
 
 
Yes  
 
 
 
No  
I agree to participate in this study. 
 
Yes  No  
 
Your name 
 
 
________________________________ 
Your signature 
 
________________________________ 
 
Signature of investigator 
 
 
________________________________ 
 
Date 
 
________________________________ 
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Code   ...............…….  
Health Screen Questionnaire for Study Volunteers 
As a volunteer participating in a research study, it is important that you are currently in 
good health and have had no significant medical problems in the past.  This is (i) to ensure 
your own continuing well-being and (ii) to avoid the possibility of individual health issues 
confounding study outcomes. 
Please complete this brief questionnaire to confirm your fitness to participate: 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise  Yes  No  
(b) attending your general practitioner  Yes  No  
(c) on a hospital waiting list  Yes  No  
 
2. In the past two years, have you had any illness which required you to: 
(a) consult your GP  Yes  No  
(b) attend a hospital outpatient department  Yes  No  
(c) be admitted to hospital   Yes  No  
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy   Yes  No  
(b) Asthma   Yes  No  
(c) Eczema   Yes  No  
(d) Diabetes   Yes  No  
(e) A blood disorder   Yes  No  
(f) Head injury   Yes  No  
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(g) Digestive problems   Yes  No  
(h) Heart problems   Yes  No  
(i) Problems with bones or joints      Yes  No  
(j) Disturbance of balance/coordination   Yes  No  
(k) Numbness in hands or feet   Yes  No  
(l) Disturbance of vision   Yes  No  
(m) Ear / hearing problems   Yes  No  
(n) Thyroid problems   Yes  No  
(o) Kidney or liver problems   Yes  No  
(p) Allergy to nuts   Yes  No  
 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after 
exercise?   
Yes  No  
If YES to any question, please describe briefly if you wish (eg to confirm problem 
was/is short-lived, insignificant or well controlled.) 
..................................................................................................................................................
..................................................................................................................................................
.................. 
 
5. Allergy Information 
(a) are you allergic to any food products? Yes  No  
(b) are you allergic to any medicines? Yes  No  
(c) are you allergic to plasters? Yes  No  
 
If YES to any of the above, please provide additional information on the allergy 
………………………………………………………………………………………………
……………………………….. 
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6. Please provide contact details of a suitable person for us to contact in the event 
of any incident or emergency. 
 
Name:  ………………………………………………………………………………………
………………………. 
 
Telephone 
Number:  ……………………………………………………………………………………
…………………………. 
 
 Work  Home  Mobile  
 
Relationship to 
Participant:…………………………………………………………………………………
………............ 
 
7. Are you currently involved in any other research studies at the University or 
elsewhere? 
 Yes  No  
 
If yes, please provide details of the study 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………… 
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Analysis of Blood Samples  
Plasma IL-6, sIL-6R, CRP, T and C concentrations were analysed using sandwich enzyme-
linked immunosorbent assays (ELISAs). All materials and chemical reagents were 
obtained from Sigma-Aldrich Ltd. (Poole, UK) unless otherwise specified. All samples 
from the same participant were analysed on the same plate and in consecutive wells in 
each study. All incubation periods were at room temperature and during each incubation 
stage the plate was placed on a horizontal orbital plate shaker (Mini Orbital Shaker SOB, 
Stuart Scientific, UK) at 60 rpm unless otherwise stated. Concentrations were determined 
in relation to a 4-parameter standard curve (GraphPad Prism, Version 4.00; San Diego 
California, USA). Concentrations were corrected for any changes in plasma volume 
(appendix E). 
Plasma Interleukin-6  
The plates were coated overnight with anti-human IL-6 monoclonal capture antibody 
(OptEIA, BD Biosciences, Oxford, UK) diluted 1:250 in 0.1 M sodium carbonate. The 
following day, the plates were washed and then blocked with 5% bovine serum albumin 
(BSA: Probumin, Millipore, Illinois, USA) in Tris-buffered saline (TBS). After an 
incubation period of 1 h, the plates were washed and the standards and samples were 
added to the wells. The samples were diluted 1:4 in TBS with 10% foetal calf serum (FCS). 
After a further 2 h incubation period, the plates were washed and 100 µl detection antibody 
(OptEIA, BD, Biosciences, Oxford, UK) diluted 1:250 TBS-T with 1% BSA was added in 
each well. Plates were incubated for a further 1 h and subsequently washed. Streptavidin 
alkaline phosphatase enzyme was diluted 1:2,000 in TBS with 1% BSA and 100 µl of the 
solution was added to each well and incubated for 45 min, then washed before an ELISA 
amplification system was used (Invitrogen, Paisley, UK). The reaction was stopped with 
50 µl of 10% sulphuric acid and the absorbance of the wells was read at 490 nm with a 
correction of 690 nm (Varioskan Flash, Thermo Scientific, Vantaa, Finland).  
Plasma Soluble Interleukin-6 Receptor  
Plasma sIL-6R concentration was measured using commercially available antibody pairs 
(M5 capture antibody and M182 detection antibody, BD Biosciences, Oxford, UK). The 
plate was coated with capture antibody diluted 1:250 in 0.1 M sodium carbonate for 
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incubation overnight. The following day, the plate was washed and blocked with assay 
diluent (phosphate-buffered saline (PBS) with 10% FCS). After 1 h incubation, the plate 
was washed and the standards and samples were added to the wells. The samples were 
diluted 1:200 in assay diluent. After a further 2 h incubation period, the plate was washed 
and 100 µl detection antibody diluted 1:1000 in assay diluent was added to each well. The 
plate was incubated for 1 h before washing. The enzyme streptavidin horse radish peroxide 
was diluted 1:4000 in assay diluent and added to the wells. After 45 min incubation, the 
plate was washed and a substrate solution was added for 30 min before adding a stop 
solution (10% sulphuric acid). The absorbance of the wells was read at 450 nm with a 
correction of 570 nm (Varioskan Flash, Thermo Scientific, Vantaa, Finland). 
C-Reactive Protein 
The plates were coated overnight with anti-human CRP rabbit polyclonal capture antibody 
(Calbiochem, Merck Chemicals, Nottingham, UK) diluted 1:1,000 in 0.05 M sodium 
carbonate. The following day, the plates were washed and then blocked with 1% bovine 
BSA (Probumin, Millipore, Illinois, USA) in PBS. After an incubation period of 1 h, the 
plates were washed and the standards and samples were added to the wells. The samples 
were diluted 1:100 in PBS with 1% BSA. After An overnight incubation period, the plates 
were washed and 50 µl secondary antibody (anti-human CRP mouse monoclonal antibody, 
Abcam, Cambridge, UK) diluted 1:750 in PBS was added in each well. Plates were 
incubated for a further 2 h and subsequently washed. Horseradish peroxide conjugated 
anti-mouse immunoglobulins rabbit polyclonal antibody was diluted 1:1,000 in PBS and 
50 µl of the solution was added to each well and incubated for 1 h. After washing, 50 µl of 
substrate solution was added. The reaction was stopped with 75 µl of 10% sulphuric acid 
and the absorbance of the wells was read at 490 nm with a correction of 640 nm 
(Varioskan Flash, Thermo Scientific, Vantaa, Finland).  
Testosterone and Cortisol 
Plasma T and C concentrations were determined using commercially available ELISA kits, 
with the aid of a plate reader (Varioskan Flash, Thermo Scientific, Vantaa, Finland). For 
testosterone (R&D Systems, Inc., Mineappolis, USA, supplied by Bio-Techne, Abingdon, 
UK), plasma samples were initially diluted 10-fold. The plates were coated with 50 µl 
primary anti-body solution and incubated for 1 h. After washing, 100 µl of standards, 
controls and samples were added, followed by 50 µl of testosterone conjugate to each well. 
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After 3 h incubation, plates were washed and 200 µl substrate solution added to each well. 
Plates were protected from light during a final 30 min incubation, after which 50 µl stop 
solution was added. Absorbance of the wells was read at 450 nm with a correction of 570 
nm. For cortisol (DRG Instruments GmbH, Marburg, Germany, supplied by 
Immunodiagnostic Systems, Tyne & Wear, UK), plasma samples were undiluted. Initially, 
20 µl of standards, controls and samples were added to the appropriate wells, followed by 
200 µl enzyme conjugate. Plates were thoroughly mixed for 10 s and incubated for 1 h. 
After washing, 100 µl substrate solution was added and plates were incubated for a further 
15 min. After the addition of 100 µl stop solution, absorbance of the wells was read at 450 
nm. Quality controls supplied with the assay kits were run on each plate to ensure 
precision of analysis. 
Precision of Analysis 
All samples from the same participant were analysed on the same assay plate to eliminate 
inter-assay variation. All samples were measured in duplicate. In chapter II, the inter-assay 
CV for IL-6 was 8.0% and the intra-assay CVs were; IL-6 5.8% and sIL-6R 2.6%. In 
Chapter IV, the IL-6 inter-assay CV was 5.4% and the intra-assay CV 3.2%. The sIL-6R 
inter-assay CV was 3.5% and the intra-assay CV 3.7%. For CRP, the inter-assay CV was 
9.4% and the intra-assay CV 5.4%. The inter-assay CVs were 6.2% and 6.5%, and the 
intra-assay CVs were 5.0% and 3.9% for T and C, respectively. In chapter V, the intra-
assay CV was 8.3% for IL-6 and 8.0% for sIL-6R. Quality controls supplied with 
commercial assay kits were run on each plate to ensure precision of analysis. 
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Estimation of Plasma Volume 
In chapters II and IV, estimations of plasma volume change were calculated. Haematocrit 
was measured in triplicate using the microcapillary technique and the mean was calculated. 
Whole blood was collected into non-heparinised microhaematocrit tubes, which were 
sealed with Cristaseal capillary tube sealant (Hawksley, Sussex, UK). Samples were 
centrifuged for 4 min (Haematospin 1300, Hawksley, Sussex, UK) and haematocrit 
content was determined using a microhaematocrit tube reader (Hawksley, Sussex, UK). 
Haemoglobin concentration was measured by a colorimetric method, using a commercially 
available kit (Randox, Co Antrim, UK). Samples were measured in duplicate and 
absorbance of cyanmethaemoglobin was read at 540 nm using an ultra-violet 
spectrophotometer (CECIL CE1011, Cecil Instruments Ltd., Cambridge, UK). Changes in 
plasma volume were estimated according to (Dill & Costill, 1974) using the following 
formula: 
Blood volume (BV) 
 BVA = BVB (HbB / HbA) 
Red cell volume (CV) 
 CVB = BVB (HctB / 100) 
 CVA = BVA (HctA) 
Plasma volume (PV) 
 PVB = BVB – CVB 
 PVA = BVA - CVA 
 Δ PV% = 100 (PVA - PVB) / PVB 
Where: 
 The subscripts B and A refer to ‘baseline’ and ‘after’ (i.e. subsequent samples over 
time), respectively  
 BVB = 100 
 Hb is haemoglobin concentration (g/dL) 
 Hct is haematocrit (%) 
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CONFIDENTIAL 
 
  Code ……………………………………………… 
 
 
FOOD DIARY 
 
OPTIMNSING TAPERING STRATEGIES IN MIDDLE DISTANCE 
RUNNERS 
 
 
 
Information will be treated in confidence. 
 
 
If you have any problems, please contact: K.L.Spilsbury@lboro.ac.uk 
 
School of Sport and Exercise Sciences 
Loughborough University 
Loughborough 
Leicestershire 
LE11 3TU 
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INSTRUCTION FOR USING THE FOOD DIARY 
 
Everything that you eat and drink over the course of the day should be weighed and the 
weight and type of food or drink recorded. 
 
For solid foods, the food should be placed on the scale on a plate or container. The plate or 
container must be weighed empty first and the scales can then be zeroed.  Each item of 
food can then be added to the plate and weighed individually, returning the scales to zero 
between each item. 
  
e.g.  Plate        150g zero scale 
Roast Beef  100g zero scale 
Potato       150g zero scale 
Gravy       30g zero scale 
 
For drinks, a cup or glass must first be weighed and then the scale can be returned to zero 
and the drink added. Please remember to record separately the weight of tea, milk and 
sugar put into a drink. 
 
Do not forget to weigh and record second helpings and between meal snacks. 
 
Any leftovers (eg. apple cores) should also be weighted and recorded in the leftovers 
column. 
 
Eating Out – Most people eat foods away from home each day, please do not forget to 
record these. Take your diary and scales with you where ever it is possible. If this is too 
inconvenient just record the type of food eaten with an estimated weight – but please say 
when a weight has been estimated. 
 
Most snack foods will have the weight of the food on the packet so they do no need 
weighing if you eat the whole packet yourself. 
 
Names and descriptions of foods should be as detailed as possible, including the brand 
name and any other information available.  
 
e.g. Cheese – is insufficient information. 
 Cheese, cheddar (Shape reduced fat) – is sufficient information. 
 
 
Start a new page in your diary for each day, and record each item on a separate line. 
Record the time of day in the first column of each line. 
e.g. 10:30 am  McVities  Digestive Biscuits (2)  50g 
            
The space provided at the foot of each page for general comments is for you to give any 
further information about your diet  
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e.g. Missed lunch due to stomach pains 
.DAY         
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of plate; leave a line between different ‘plate’ entries. 
A B C D E F Office 
Use   
Time Food eaten Brand name 
of each item 
(except fresh 
food) 
Full description of each item including: 
-whether fresh, frozen, dried, canned 
-cooked: boiled, grilled, fried, 
roasted. 
-what type of fat food fried in 
Weight 
Served 
Weight 
of 
Leftovers 
Actual 
Weight 
am/pm home away  
(gms) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
GENERAL COMMENTS: 
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ActiGraph Participant Information and Diary Sheet 
 
The ActiGraph activity monitor is a small red plastic box worn around the waist on an 
elastic belt. It measures human movement. It does not interfere with daily activities 
and does not pose any risk to the person wearing it.  
 
You should wear the monitor every day for the study duration. You should put it on 
first thing in the morning and continue wearing it until you go to bed. 
 
Wearing the monitor 
 
The monitor should be worn on the right hip with the black button at the top (as 
shown in the picture) or, if it does not 
have a black button, with the word 
ActiGraph the right way up. 
 
 
It is important that the belt is fastened 
tightly so it fits snugly to the body. If it 
is loose, the measurements will be 
inaccurate.  
 
 
 
 
The monitor is not waterproof. 
Please remove it when you take a bath or shower or go swimming. Whenever you 
need to remove the monitor, please re-attach it as soon as you can, and record the 
times using the log on the other side of this sheet. 
 
When to put the monitor on 
The device should be fastened around your waist as soon as you wake up. It may be 
that you take it off again soon after in order to take a shower etc but following this 
instruction means the data is as accurate as possible. We appreciate your help with 
this. 
 
When to take the monitor off 
The device should be taken off when you plan to go to sleep. If you lie in bed 
watching TV, for example, please keep the monitor on until you have finished. Again, 
this is in the interest of collecting accurate data. 
 
Returning the monitor 
Please put your activity monitor and log sheet in the envelopes provided and return 
the package to Kate on your final visit to the lab. Please return the package as soon 
as possible so the data on your monitor are not lost and so other people can use the 
monitor and take part in the study. 
 
Questions or problems 
 
If you have any questions or problems, please do not hesitate to contact: 
Kate Spilsbury (K.L.Spilsbury@lboro.ac.uk) 
 
 
 
Thank you very much for taking part in this study.  
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Activity monitor log 
When did you start wearing the monitor? 
 
Date: ____________________ Time: __________________ 
 
Sometimes you will have to remove the activity monitor. If you take it off 
during the day (for example when you take a bath or shower or go swimming), please 
write down when you took the monitor off, when you put it back on, and why you took 
it off. Please circle whether each time listed was a.m. or p.m. 
 
 Time taken off Time put back on Reason taken off 
Example 12.45 
 
AM / PM 
2.15 
 
AM / PM 
Swimming 
Day 1  
Lab testing day – 
don’t need to 
wear monitor 
 
  
Day 2 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 3 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 4 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 5 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 6 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 7 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 8 
 
 
 
 
 
AM / PM 
 
 
 
AM / PM 
 
 
 
 
Day 9  
Lab testing day – 
don’t need to 
wear monitor 
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Time taken off Time put back on Reason taken off 
Day 10  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 11  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 12  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 13  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 14  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 15  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 16  
 
 
AM / PM 
 
 
 
AM / PM 
 
Day 17 Lab testing day – 
don’t need to 
wear monitor 
(please return it) 
  
 
 
 
